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The socio-economic and geographical distribution of malaria overlaps with that of 
many parasitic helminths and in these areas co-infections are common. Co-infection 
with helminths can influence disease outcome causing either exacerbation or 
amelioration of malaria. Understanding the complex host-parasite interactions that 
lead to these different disease outcomes is important for the success of control 
programmes aimed at these parasites.  
 
The immune system has evolved diverse types of response (e.g. T-helper 1 (Th1) and 
T-helper 2 (Th2)) to efficiently combat infection with ‘microparasites’ and helminths 
respectively. When faced with co-infection however, the need for the host to multi-
task means it must manage these counter-regulatory responses. In this study a murine 
model of malaria-hookworm (Plasmodium chabaudi- Nippostrongylus brasiliensis) 
co-infection was utilised to investigate how changes in T-helper bias affect malaria 
disease outcome.  Antibody isotypes were used as indicators of Th1/Th2 bias and 
revealed that helminth co-infection reduced the malaria-specific Th1 response. 
Counter-intuitively this resulted in ‘protection’ from malaria with co-infected mice 
having reduced peak P. chabaudi parasitaemia and suffering less severe anaemia.  
 
In addition to providing a measure of Th1/Th2 bias, analysis of antibody responses 
revealed the occurrence of cross-reactive antibodies. The potential for these cross-
reactive antibodies to influence disease outcome was investigated but in this murine 
model resource-mediated mechanisms of parasite regulation appear to be responsible 
for the ‘protection’ that co-infection affords.  
 
The question of why cross-reactive antibodies are produced has important 
immunological and ecological implications. Cross-reactive responses may arise 
through some physiological constraint on the immune mechanisms that usually result 
in antibody-specificity. However experiments designed to investigate if the 
specificity of antibodies is constrained by availability of antigen suggest that this is 
not the case in the model system used here. There is also the possibility that 
production of cross-reactive antibodies represents an evolutionary optimal strategy 
for a host faced with unpredictable exposure to a variety of parasites. However a 
major finding of this study indicates these two taxonomically distinct parasite species 
share antigens, which in itself is crucial to understanding host-parasite interactions in 
a co-infection setting. 
 
The main findings of this thesis are relevant to co-infection studies in general and the 
implications for both evolutionary and applied biology are discussed. 
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ABTS – 2,2’-azino-bis(3-ethylbenzthiazoline)-6-sulphonic acid 
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HRP – Horse Radish Peroxidase 
IFN!- Interferon gamma 
Ig – Immunoglobulin 
IL – Interleukin 
IVC – Individually Ventilated Cages 
L3 – 3rd stage larvae (infective) 
MSP-119 – Merozoite Surface Protein-119 
Nb - Nippostrongylus brasiliensis 
NbA – Nippostrongylus brasiliensis antigen 
NK cell – Natural Killer cell 
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Pcc – Plasmodium chabaudi chabaudi 
Pc lysate – Plasmodium chabaudi parasitised Red Blood Cell lysate  
pNPP – p-nitrophenyl phosphate 
pRBC – parasitised (Pcc) red blood cell antigen 
RBC- red blood cell 
RPMI – Roswell Park Memorial Institute (media) 
TBS – Tris Buffered Saline 
TBST – Tris Buffered Saline with 1%Tween 
TCR – T Cell Receptor 
TGF"- Transforming Growth Factor beta 
Th – T- helper cell 
TNF#- Tumour Necrosis Factor alpha 
T-reg – regulatory T-cell 
 8 
 




Female BALB/c mice were used in all experiments and were aged 10-12 weeks at 
the start of each experiment. Mice were either bought from Harlan UK (Bicester, 
UK) or bred in house at the Anne Walker animal facility. Mice were always housed 
in individually ventilated cages (IVC) with a 12h: 12h light: dark cycle, food (41b 




Plasmodium chabaudi chabaudi (Pcc) the rodent malaria parasite was originally 
isolated from Thamnomys rutilans (thicket rats) and cloned by serial dilution and 
passage (Beale, Carter et al. 1978), in all experiments the AS strain of this parasite 
was used. Parasites were stored as frozen blood stabilates in liquid nitrogen and 
recovered by passage through donor mice prior to inoculation of experimental 
animals. Frozen stabilates were resuspended in 0.4ml citric saline and 2 donor mice 
were inoculated i.p (0.2ml/mouse). 1x106 infected red blood cells (RBC) in 100µl 
diluent (50% Foetal Calf Serum (FCS): 47.5% Ringer’s solution: 0.025% heparin) 
from these mice were passaged into 2 more donor mice and infected RBC from one 
of these donors were used to inoculate the experimental mice.  
 
Nippostrongylus brasiliensis (Nb) worms were maintained by serial passage through 
Sprague-Dawley rats. Third stage (L3) larvae were obtained by culturing the faeces 
of infected rats at 26oC for a minimum of 5 days (Lawrence, Gray et al. 1996). Prior 
to injection into mice the L3s were washed 10 times in PBS and counted on a Wild 
Heerbrugg dissecting microscope at x60 magnification. The L3s were then 





The details of infection regime (timing and parasite dose) for each set of experiments 
are reported in the relevant results chapter.  
 
N. brasiliensis infection was initiated by subcutaneous (s.cut) injection of 200 3rd 
stage infective larvae (L3) suspended in PBS (50µl). Individual syringes were 
preloaded with the Nb L3s and held in an upright position to ensure accurate doses 
were administered. Control mice received a sham injection of PBS (50µl s.cut). 
 
P. chabaudi was administered by intraperitoneal (i.p) injection of infected RBC in 
100µl diluent (50% Foetal Calf Serum (FCS): 47.5% Ringer’s solution: 0.025% 
heparin). Control mice received a sham injection of 1x105 naïve RBC in 100µl 
diluent (50% FCS: 47.5% Ringer’s solution: 0.025% heparin) i.p. 
 
MONITORING Pcc PARASITAEMIA, HOST ANAEMIA & BODY WEIGHT 
 
Parasitaemia 
Asexual Pcc parasitaemia was measured daily throughout malaria infection by 
microscopy of thin blood smears stained with Giemsa. Blood from the tail tip was 
spotted onto a microscope slide and spread into a smear, after air-drying the slide 
was fixed with 100% methanol and then immersed in 20% Giemsa for 20 minutes. 
Slides were then rinsed in water and allowed to air dry before being examined at 
x1000 magnification with oil immersion. The proportion of parasitised RBC was 
calculated by determining the total number of RBCs that had to be counted to 
discover 5 or 20 parasites (depending on stage of infection). If no parasites were 
observed in 50 fields the smear was classed as negative. Parasite density was 
calculated by multiplying the proportion of parasitised RBC by the RBC density of 
individual mice on the day of sampling. If throughout the course of infection the 
parasitised RBC density never exceeded 0.05 (109pRBC/ml) the infection was 
considered to have failed and the mouse was excluded from all further analyses.  
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Red Blood Cell Density (anaemia) 
As a measure of anaemia in experimental animals red blood cell density was 
measured, 2!l of blood from the tail vein was collected by capillary and diluted in 
80ml of ISOTON II diluent (Beckman Coulter). The number of RBCs was counted 
using the Z1 series Coulter counter (Beckman Coulter). 
 
Body weight 
As a measure of the pathology of disease body weight was measured daily using a 




Nippostrongylus brasiliensis antigen (NbA) is a crude homogenate of Nb worms 
prepared from a stock of frozen adults, which were harvested from the intestines of 
infected Sprague-Dawley rats. The worms were defrosted and crushed in 500µl of 
sterile phosphate buffered saline (PBS) using a 1ml glass homogeniser, the 
preparation was kept on ice at all times. The preparation was then left for 1 hour 
before further homogenising. Finally the preparation was centrifuged at 13, 000 rpm 
(17 000g) for 10 mins and the supernatant removed. The supernatant was passed 
through a 0.22µm syringe driven filter (Millipore) and the protein concentration 
determined by Bradford assay.  
 
Parasitised Red Blood Cell Antigen (pRBC) is a crude preparation of Pcc infected 
RBCs. Mice were infected with Pcc and the parasitaemia monitored daily. When the 
parasitaemia reached 20% or more the mice were bled under anaesthetic by cardiac 
puncture with a heparinised syringe. The RBC were washed in PBS and centrifuged 
at 1000g for 10 mins. The preparation was then lysed by repeated cycles of freeze (-
80oC) thaw. Finally the protein concentration was determined by Bradford assay.  
 
Plasmodium chabaudi lysate (Pc lysate) is also a crude preparation of malaria 
infected RBCs but undergoes further purification than pRBC (see above) to remove 
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host proteins. Mice were infected with Pcc and the parasitaemia monitored daily. 
When the parasitaemia reached 20% or more the mice were bled under anaesthetic 
by cardiac puncture with a heparinised syringe. This whole blood was diluted in 
10ml RPMI media. 15ml of 67% Percoll was then underlayed by slowly pipetting it 
to the base of the tube. The sample was centrifuged at 3000rpm (6450g) for 10 min 
to allow separation of cells in the Percoll gradient and the interface containing 
parasitised RBC was harvested. The cells were washed twice with 50ml RPMI media 
by centrifugation at 2000rpm (6450g) for 5 mins. Antibodies were cleaved from the 
cells by incubation with trypsin at 37oC for 10 mins. Cells were washed twice in 
RPMI as before and then resuspended in 10ml of 0.05% saponin to lyse the RBC 
membrane. Cells were then centrifuged at 2000rpm (6450g) for 10 min and washed 
with PBS until the supernatant was clear. The pellet was resuspended in 1ml sterile 
PBS and the parasites lysed by 5 cycles of freeze (-80oC) thaw. Finally the protein 
concentration was determined by Bradford assay.  
 
Merozoite Surface Protein-119 is a recombinant malaria protein, which was 
originally sequenced, cloned and expressed from Pcc AS clone, as described 
previously [39]. In brief the MSP-119 nucleotide sequence was inserted into Pichia 
pastoris vector pIC9K and protein expression carried out in Pichia pastoris strain 
SMD1169. An initial stock of MSP-119 protein was a kind gift from Jean Langhorne 
as was the plasmid, which enabled large-scale in house expression of the 
recombinant protein. The recombinant protein is HIS-tagged and was secreted into 
the yeast culture supernatant. This allowed purification of the protein from the 
supernatant via binding to a Nickel Sepharose column (HisTrapTM HP column  
17-5248-01 GE healthcare) using the AKTAPrime plus purification system. This 
one-step purification step yielded large quantities of MSP-119 protein that were 
dialysed against 1 x PBS before being stored at -20oC or -80oC until use. The purity 
of the recombinant protein was verified by SDS-page gel and revealed a single band 
(Figure 1). The potential for Pichia to artificially glycosylate the recombinant  
MSP-119 should be noted. 
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Figure 1: SDS-page gel showing MSP-119 recombinant protein post-purification.  
Each lane of the gel represents a fraction of the AktaPrime purification of MSP-119 from the 
culture supernatant, 4-12% BIS-TRIS gel, numbers represent the size of the protein markers 





On the final day of all experiments a terminal bleed from the brachial artery was 
performed under anaesthetic. Blood was either collected on Serasieve (Hughes & 
Hughes Ltd) or in heparin coated eppendorph tubes. The sample was then 
centrifuged at 13 000 rpm (17 000g) to separate the serum/ plasma fraction which 
was removed and stored at -80oC. 
 
In a subset of experiments blood samples were also collected on a daily basis for 
antibody analysis. 5!l of blood from the tail vein was collected by capillary and 
diluted in 5!l of heparin (1000U/ml)(SIGMA). The sample was centrifuged at  







Enzyme Linked Immunosorbent Assay (ELISA) 
 
Total IgE and IgG2a antibody responses were measured by sandwich ELISA. This 
method involved using immobilised ‘capture’ antibodies specific for a given isotype 
to bind the antibodies present in host plasma. A secondary, enzyme-conjugated 
antibody is added and the resulting sandwich complex is identified by a colorimetric 
change with the addition of substrate. 
 
96 well maxisorp immunoplates (Nunc) were coated with capture antibody (see 
Table 1 for details) diluted in 0.06M carbonate buffer at a concentration of 2!g/ml in 
a final volume of 50!l/well. Plates were kept at 4oC overnight to allow the antibodies 
to bind. Excess antibody was removed and non-specific binding sites were blocked 
with 5% Marvel diluted in Tris Buffered Saline (TBS) with 1%Tween (TBST), 
100!l/well. Plates were incubated at 37 oC for 2 hours. At this stage and after each 
subsequent step the plates were washed five times with TBST. Plasma samples were 
added to the wells in a series of doubling dilutions from 1/100 – 1/800 using TBST 
as a diluent in a final volume of 50!l/well with the exception of IgE in plasma 
samples from terminal bleeds when a dilution of 1/20 was used. Purified antibodies 
of the relevant isotype were also added (50!l/well) to create a standard curve (see 
Table 1 for details) against which the sample concentrations were calibrated. Again 
TBST was used as a diluent. Plates containing the samples and standards were 
incubated at 37 oC for 2 hours. Secondary biotinylated ‘detection’ antibodies (see 
Table 1 for details) were diluted in TBST with 0.5% (FCS) (SIGMA) and added at a 
concentration of 2!g/ml in a final volume of 100!l/well. Plates were incubated at 
37oC for 1 hour before adding 100!l/ well of a 1/8000 dilution of Extravadin 
Peroxidase: TBST-5%FCS. Plates were incubated at 37oC for 30 mins. Following the 
final three washes in TBST plates received an additional wash in distilled water 
before the TMB substrate was added (100!l/well). The development of the 
colorimetric change with the addition of substrate was allowed to develop at room 
temperature in the dark. The reaction was stopped with 100!l/well of 1M HCl that 
causes a final colour change from blue to yellow. The optical density was then 
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determined using an “Emax” ELISA microplate reader (Molecular Devices) with a 
450nm filter.  
 
Total IgG antibody responses were also measured by sandwich ELISA as described 
above. The details of the capture and detection antibodies used are given in Table 1. 
The detection antibody was HRP conjugated and so the addition of extravadin 
peroxidase was not required and rather than TMB, ABTS was used as the substrate. 
 
 
















Antigen Specific antibodies of the IgG, IgG1, IgG2a and IgG3 isotypes were 
measured by ELISA. 96 well maxisorp immunoplates (Nunc) were coated at 4oC 
overnight with either recombinant or crude antigen preparations in 0.06M carbonate 
buffer in a final volume of 50µl per well. Recombinant MSP-119 was used at a 
concentration of 1µg/ml, the crude antigens NbA and pRBC at 5µg/ml and Pc Lysate 
at 2µg/ml. Excess antigen was removed and non-specific binding sites were blocked 
with 5% FCS diluted in carbonate buffer (200µl/well) for 2 hours at 37oC. Wells 
were washed three times in TBST at this stage and following each subsequent step. 
Serum samples were added in serial dilutions 1/100- 1/204800 using TBST as a 
diluent, in a final volume of 50µl per well and incubated for 2 hours at 37o C. Isotype 
specific detection antibodies were diluted in TBST in a final volume of 50µl per 
well. For IgG HRP conjugated rabbit anti-mouse IgG (DAKO P0260) was used at 
1/2000. For IgG1, Horse Radish Peroxidase (HRP) conjugated goat anti-mouse IgG1 
Antibody Manufacturer and code Concentration used in ELISA 
   
IgG capture AbD serotec 101001 1µg/ml 
IgE capture BD Pharmingen 553413 2µg/ml 
IgG2a capture BD Pharmingen 553446 2µg/ml 
   
IgG detection DAKO P0260 0.65µg/ml  
IgE detection BD Pharmingen 553419 2µg/ml 
IgG2a detection BD Pharmingen 553388 2µg/ml 
   
IgE standard BD Pharmingen 557079 Highest conc. 5µg/ml 
IgG2a standard BD Pharmingen 553459 Highest conc. 200µg/ml 
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(Southern Biotech 1070-05) was used at 1/6000, HRP conjugated goat anti-mouse 
IgG2a (Southern Biotech 1080-05) at 1/4000 and HRP conjugated goat anti-mouse 
IgG3 (Southern Biotech 1100-05) was used at 1/1000. Plates were incubated for 1 
hour at 37oC. An additional wash in distilled water was carried out before the 
substrate 2,2'-azino-bis(3-ethylbenzthiazoline)-6-sulphonic acid (ABTS) (Insight 
Biotechnology) was added at 100µl per well. The reaction was allowed to develop 
for 20 minutes at room temperature. Optical density (OD) was determined using an 
“Emax” ELISA microplate reader (Molecular Devices) with a 405nm filter. 
 
Antibody Titre Measures. For antigen-specific responses, in which a serial dilution 
of sera is measured by ELISA antibody titres can be calculated from the OD values. 
The mean plus 3 standard deviations of the optical density measured in control mice 
at 1/200 sera dilution was assigned as a ‘cut-off’ value. Titre was calculated in 
experimental mice as the reciprocal of the highest dilution at which the OD exceeded 
this cut-off. For example if at 1:800 sera dilution the OD value is greater than the 
cut-off this mouse has an antibody titre of 800. Any OD value that fell beneath the 
cut-off was deemed zero. 
 
Protein-specific antibodies were measured by detection of antibodies that bound to 
antigen pre-treated with periodate. The ELISA was carried out as detailed for 
detection of antigen-specific antibodies (see above) with the following additional 
steps included after blocking with 5% FCS: carbonate buffer, prior to sample 
addition. TBST wash was followed by the addition of 10mM sodium (meta) 
periodate diluted in 50 mM sodium acetate in a final volume of 100 µl/well. 
Periodate oxidises carbohydrate to aldehydes and thus disrupts the carbohydrate 
epitope on the antigen. Plates were incubated at 37°C for 1 hour and then washed in 
50 mM sodium acetate. To stop the activity of periodate, 100µl of 50 mM sodium 
borohydride solution was added to each well.  
 
High avidity antibodies of the IgG1and IgG2a isotype were also measured by 
modifying the protocol used for ELISA of antigen specific responses. The 
modification involved an extra wash step with 6M Urea following incubation of the 
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serum samples. 6M urea is a hydrogen-bond dissociating agent and washing with this 
removed antibodies that were only weakly bound to the antigen coating the plate. 
This assay was always run in parallel to the standard antigen-specific ELISA 
protocol (detailed above) so that the ‘avidity index’ could be calculated by dividing 




Gel electrophoresis was carried out with the XCell SureLock mini-cell system 
(Invitrogen). H. polygyrus, L. sigmodontis, N. brasiliensis or P. chabaudi lysate 
antigens were prepared at a concentration of 25µg or 50µg in Nupage LDS Sample 
buffer (Invitrogen NP0007) with 20%NuPage sample reducing buffer (Invitrogen 
NP0009). Each antigen preparation was loaded into a separate well of a Nu-Page 4-
12% Bis-Tris gel (Invitrogen NP0304). Gel electrophoresis was carried out at 200V 
for 35 mins in NuPage MES SDS Running buffer (Invitrogen NP0002) as per the 
manufacturer’s instructions.  
 
Transfer to Western blot membrane was carried out immediately after gel 
electrophoresis using the XCell II Blot module (Invitrogen). Each gel and 
nitrocellulose membrane (Amersham Hybond- ECL RPN303D) was sandwiched 
together between filter paper and blotting pads that had been presoaked in NuPage 
Transfer Buffer (Invitrogen NP0006-1) with 20% methanol. Transfer conditions of 
35V for 75 mins were used.  
 
Probing blot with Pcc anti-sera. Following transfer nitrocellulose membranes were 
blocked with 5% Marvel: TBST for 1 hour at room temperature (RT). Blots were 
incubated (with rocking) overnight at 4OC with Pcc anti-sera (1:100 dilution in 
5%Marvel: TBST). Blots were washed 5 times in TBST (20 min/ wash). Blots were 
then incubated for 1 hour at RT with rabbit anti-mouse IgG (DAKO P0260) (1:1000 
dilution in 5%Marvel: TBST). Blots were washed again 5 times in TBST (20 min/ 
wash) and finally in TBS (2x 20 min wash). Blots were then incubated with 
ChemiGlow West (Alpha Innotech 60-12596-00) for 5 mins. The 
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chemiluminescence resulting from the reaction of the ‘ChemiGlow’ and bound 




All analyses were carried out in the statistical package JMP 8.0 (SAS) using 





Phosphate Buffered Saline (PBS): As per manufacturers instructions, PBS tablets 
(SIGMA P4417) were dissolved in distilled water.  
 
Tris Buffered Saline (TBS):  Stock TBS (10x) – 437.5g NaCl, 121g Trisma base 
diluted in 5L of distilled water. TBS was used at 1x concentration (1:10 dilution of 
the 10x stock). 
  
TBS-Tween (TBST): 1x TBS with addition of 1% Tween 20 Viscous Liquid 
(polyoxyethylenesorbitan monolaureate) (SIGMA P1379) 
 
Carbonate Buffer: (0.06M Carbonate Buffer pH 9.6) is made by combining two 
carbonate solutions (A and B see below) in a 2:1 ratio i.e. 45.3ml of A and 18.2ml of 
B in 936.5ml dH2O. 
Solution A: 8.5g NaH2CO3 in 100ml dH2O (1M) 
Solution B: 10.6g Na2CO3 in 100ml dH2O (1M) 
 
Citrate Saline: 8.5g NaCl, 15g tri-sodium citrate (SIGMA S-4641) dissolved in 1L 
of distilled water. 
 
Ringer’s solution: 0.2g KCl, 9.0g NaCl, 0.2g CaCl2 dissolved in 1L of distilled 
water.  
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The intimate relationship of parasites with their hosts is one of the features that make 
them so fascinating. As an undergraduate I was captivated by the ability of parasites 
to manipulate their host’s behaviour to meet their own needs. Taenia multiceps 
parasites literally have their intermediate host (sheep) running round in circles as 
cysts develop in the brain. Circling has never been noted as the greatest strategy for 
evading predation by cunning canines. Perhaps the most striking example of 
parasites enhancing the predation of the host is the colourful, pulsating antennae of 
snails infected with Leucochloridium paradoxum that are simply irresistible to birds. 
These examples of parasite infestation provide sensational imagery for engaging 
undergraduates but it is the interactions between host and parasite that mediate 
disease outcome that has maintained my interest in the field of parasitology.  
 
One of the fascinating things about parasites is the complex multi-stage life cycles 
that have evolved to promote invasion of, reproduction within and transmission 
between hosts. The vast diversity of parasite species means that is hard to think of an 
organ or cell that is not exploited as a niche for growth or reproduction. Exposure to 
an unpredictable array of parasite species each with its own complex life cycle and 
reproductive strategy presents a serious challenge to the host in terms of combating 
infection. For example a host must be equally capable of controlling the rapid 
replication of an intracellular parasite as expelling large multi-cellular parasitic 
helminths. The immune system has risen to the challenge and evolved diverse 
responses adapted to coping with these different parasites. However, in natural 
populations hosts are very rarely (if ever) infected by only one species of parasite, so 
the host must be able to multi-task. A core interest of mine is to understand how a 
host maximises its own fitness when simultaneously infected by multiple, potentially 
competing, parasite species.  
 
 20 
Disease-causing parasites of humans rightly receive a great deal of attention and 
malaria probably warrants being the front-runner: in 2009 alone 225 million cases of 
malaria were reported including 781 000 deaths (W.H.O 2010). The ‘neglected 
tropical diseases’ of Leprosy, Trachoma, Onchocerciasis, Lymphatic filariasis, 
Schistosomiasis and soil-transmitted helminths are endemic in many of the same 
countries as malaria (Hotez and Molyneux 2008). In general these diseases are not 
fatal but cause chronic disability and can impact the severity of potentially fatal 
diseases such as malaria (Brooker, Akhwale et al. 2007). Targeting these diseases for 
control or eradication has been a focus of the World Health Organisation for several 
decades and the formulation of a Global plan for the eradication of these diseases 
(2008-2015) demonstrates the continued commitment to this cause (W.H.O 2010). It 
is pertinent to understand the effect of co-infection with these diseases on malaria 
disease outcome, as unfortunately although progress has been made neither the 
neglected diseases nor malaria is likely to be eradicated in the near future (W.H.O 
2010; Zhang, MacArthur et al. 2010).  
 
Several of the ‘neglected tropical diseases’ are caused by parasitic helminths 
(Kyelem, Fischer et al. 2011) and in areas where these parasites coincide with 
malaria, co-infection is common (Mazigo, Waihenya et al. 2010). Studies of co-
infection in humans reveal contrasting affects of helminths on malaria disease 
outcome. In most cases exacerbation of disease is observed with increased severity 
of malarial attacks (Nacher, Singhasivanon et al. 2002; Spiegel, Tall et al. 2003; 
Sokhna, Le Hesran et al. 2004), or increased severity of malaria pathology such as 
anaemia and hepatosplenomegaly (Mwatha, Jones et al. 2003; Brooker, Akhwale et 
al. 2007). There are however reports of helminths reducing malaria parasite density 
(Briand, Watier et al. 2005) and protecting against cerebral malaria (Nacher, Gay et 
al. 2000). Understanding the intricacies of how these parasitic infections influence 
one another has important implications for the success of vaccination and drug 
administration programmes. If helminths do indeed increase the severity or 
prevalence of malaria then treating with anthelmintics may provide an affordable 
method of improving malaria control (Druilhe, Tall et al. 2005). In support of this 
idea, a study by Kirwan et al (Kirwan, Jackson et al. 2010) in which anthelmintics 
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were used to treat preschool children for Ascaris lumbricoides resulted in a 
significant reduction in the prevalence of malaria. On the flip side any protective 
effect of co-infection could easily be lost through drug clearance of helminths 
(Specht and Hoerauf 2007). This thesis tackles some of the complex within-host 
interactions that potentially mediate disease outcome in co-infection; focussing on 
the induction of the diverse immune responses that target malaria and helminths and 
the potential effect of competition between these parasites. 
 
1.2 Plasmodium infection 
 
Infection with Plasmodium species is initiated by the injection of sporozoites via the 
bite of an infected mosquito. These infectious forms migrate to the liver where they 
invade hepatocytes and undergo asexual replication resulting in the release of 
merozoites, which enter the circulatory system and invade red blood cells (RBC). 
Within the RBC a cycle of asexual replication occurs progressing through the 
trophozoite and schizont stages and culminating in the release of merozoites when 
the RBC ruptures. These free merozoites must then rapidly invade a new RBC to 
begin the cycle again (Figure 1).  
 
 




































Figure 1: Life cycle of Plasmodium species.  
Injection of sporozoites from infected mosquito (A) that migrate to the liver and 
invade hepatocytes (B). Replication within the liver produces merozoites that invade 
red blood cells and undergo asexual replication to produce more merozoites, which 
perpetuate the cycle (C). Some replication within red blood cells leads to the 
development of the sexual transmission forms (gametocytes) (D). These are 
ingested by the mosquito with a blood meal (E) and development within the vector 
results in sporozoites that can be injected to a new host.  Figure reproduced with 
permission from Lamikanra et al (Lamikanra, Brown et al. 2007). 
 
It is the cycle of invasion and rupturing of RBCs and the immune response to this 
stage of the parasite that causes most of the pathology associated with the disease 
(Tilley, Dixon et al. 2011). In particular the severe anaemia characteristic of malaria 
infection results partly from the mechanical destruction of RBC as they rupture on 
merozoite release. This anaemia is exacerbated by clearance of both infected and 
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uninfected RBC by phagocytosis and suppression of erythropoiesis (Totino, 
Magalhaes et al. 2010), as well as splenic retention of both infected and uninfected 
RBCs (Buffet, Safeukui et al. 2009). In addition to the uncomplicated symptoms of 
malarial disease (e.g. anaemia, fever) there are also complications such as cerebral 
malaria that can induce coma. Sequestration of infected RBC in the venules and 
capillaries of the brain combined with systemic inflammation (Good, Xu et al. 2005; 
Awandare, Goka et al. 2006) causes cerebral malaria in humans. The phenomenon of 
rosetting in which uninfected RBC adhere to infected RBC can also add to the 
blockage of blood vessels in the brain (White, Turner et al. 2010). 
 
1.3 Soil-transmitted helminth infection 
 
Whilst many helminth species are co-endemic with malaria, soil-transmitted 
helminths are the most prevalent and abundant in these areas (Brooker, Akhwale et 
al. 2007). The soil-transmitted helminths of humans include Ascaris lumbricoides, 
Trichuris trichuria and hookworms (Ancylostoma duodenale and Necator 
americanus). These infections are all contracted by ingestion of, or contact with, soil 
contaminated with eggs or larvae of these parasites. I will focus here on hookworm 
infection. Hookworm eggs hatch in soil and develop to produce infective 3rd stage 
larvae (L3), which are able to penetrate the skin of their host. Once they have entered 
the host the larvae migrate to the lungs and undergo further development to 4th stage 
larvae (L4). They then penetrate the airspace of the lungs and are coughed up and 
swallowed to the small intestine where they mature to adults. The eggs produced by 
the adults are passed out in the faeces and contaminate the environment (Figure 2). 
 
The pathology of these helminths, which is proportional to parasite burden 
(Crompton and Nesheim 2002), relates to the anaemia and iron-deficiency caused by 
the adults directly consuming RBC and the tissue damage they cause by attaching to 
the gut wall (Gilman 1982; Crompton and Nesheim 2002). Migration of these worms 
through the lungs may also cause significant tissue damage and deterioration of lung 
function akin to emphysema and chronic obstructive pulmonary disease, although to 
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date this has only been explored in animal models of hookworm infection (Marsland, 




             
 












Figure 2: Life cycle of hookworm species.  
Hookworm eggs in the soil (1) hatch to produce larvae (2) that develop and moult 
into the infective 3rd stage, which penetrate the skin of the host (3 and 4). On 
entering the host they migrate to the lungs from where they are coughed up and 
swallowed to the small intestine where they reside as adults (5) and release eggs 
back into the environment via faeces. Figure taken from Centres for Disease control 
and Prevention (CDC) website.  
 
 
1.4 Malaria and helminths induce mutually inhibitory immune responses. 
 
Asexual reproduction of Plasmodium parasites in RBCs results in the characteristic 
anaemia associated with malaria infection. In the murine model direct injection of 
merozoite-infected RBC is used as the mode of infection. It should be noted that 
sporozoite infection of mice via the bite of an infected mosquito results in lower peak 
asexual parasitaemia and a reduction in the magnitude of the immune response 
(Fonseca, Seixas et al. 2007). However, the quality of the immune response is similar 
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(Fonseca, Seixas et al. 2007) and using direct injection of merozoites means that the 
inoculating dose can be accurately controlled. Here I will concentrate on the immune 
response to the intra-erythrocytic stage. 
 
Both innate and adaptive immune responses are required for the efficient control of 
malaria parasite growth. The initial control of parasite replication involves early 
production of the pro-inflammatory cytokines TNF# and IFN! from macrophages 
and Natural Killer (NK) cells, which activate macrophages to produce anti-parasitic 
nitric oxide (Choudhury, Sheikh et al. 2000). The adaptive immune system promotes 
parasite-specific responses through T and B-cell receptor binding of parasite antigens 
and the early production of IFN! by innate cells may play an important role in 
determining the type of adaptive immune response that is elicited by influencing T-
cell differentiation (Su and Stevenson 2000). The dominant cytokines produced 
during malaria infection (TNF#, IFN! and IL-12) drive the development of Th1 cells 
from naïve T-cells (Mosmann and Sad 1996). These Th1 cells perpetuate the 
production of IFN! that results in isotype class switching in B-cells to produce IgG2a 
antibodies (Paul, Brown et al. 1987; Collins and Dunnick 1993; Else and Finkelman 
1998). The production of these antibodies is crucial for the ultimate clearance of 
malaria infection (Weidanz, Batchelder et al. 2005) via opsonisation of parasitised 
RBC to facilitate phagocytosis by macrophages and by direct neutralisation of free 
merozoites before they can re-invade RBCs (Cavinato, Bastos et al. 2001; Mota, 
Brown et al. 2001; Bergmann-Leitner, Duncan et al. 2006; Bergmann-Leitner, 
Duncan et al. 2009). 
 
Whilst the production of pro-inflammatory cytokines (TNF#, IFN!) is beneficial in 
controlling initial parasite replication there is a fine line between benefit and cost as 
excessive production of these cytokines can exacerbate malaria pathology if they are 
not kept in check by the anti-inflammatory cytokines TGF" and IL-10 (Omer and 
Riley 1998; Li, Sanni et al. 2003; Omer, de Souza et al. 2003). For example, the 
anaemia that is caused by the rupturing of RBC as merozoites burst out can be 
exacerbated by TNF#-mediated suppression of erythropoiesis (Li, Sanni et al. 2003). 
Other symptoms of pathology such as hypothermia and weight loss are also 
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associated with elevated levels of pro-inflammatory cytokines (Lamb, Brown et al. 
2006). The main function of T-regulatory cells (T-regs) is to prevent excessive 
immune responses that could cause collateral damage (immunopathology) by 
suppressing T-cell proliferation via TGF" and IL-10 (Pandiyan, Zheng et al. 2007). 
These cells occur naturally but can also be induced from naïve T-cells by TGF" 
(Dardalhon, Awasthi et al. 2008). Of particular relevance to this study is the potential 
for the immune response induced by helminth infection to exert suppressive effects 
on malaria-specific Th1 response due to the counter-regulatory nature of Th1 and 
Th2 responses, discussed below. 
 
Helminths induce potent Th2 immune responses characterised by the production of 
IL-4, IL-5 and IL-13 associated with infiltration of mast cells, eosinophils and 
basophils (Jackson, Friberg et al. 2009). Basophils in particular have recently been 
described as the innate cell crucial to the development of Th2 responses in 
Nippostrongylus brasiliensis infection (Nel, Hams et al. 2011). In contrast to Th1 
cytokines that drive production of IgG2a antibodies, Th2 cytokines drive the 
production of IgE (Finkelman, Holmes et al. 1990) and IgG1 antibodies (Paul, 
Brown et al. 1987; Purkerson and Isakson 1992). The precise Th2 effector 
mechanisms that mediate protection against helminths are likely to vary amongst 
helminth species (Patel, Kreider et al. 2009). For example, alternative activation of 
macrophages driven by IL-4 is common to many helminth infections (Jenkins and 
Allen 2010) and has been described as having a protective effect in 
Heligmosomoides polygyrus infection by damaging migrating larvae (Anthony, 
Urban et al. 2006), whilst in other model systems neutrophils are associated with 
parasite killing – e.g. Strongyloides stercoralis and Litomosoides sigmodontis (Al-
Qaoud, Pearlman et al. 2000; Padigel, Stein et al. 2007). More physiological 
processes are also involved with protection against gut-dwelling helminths such as 
Nippostrongylus brasiliensis and Trichuris muris; the so-called ‘weep and sweep’ 
mechanism whereby increased smooth muscle contractility combined with 
overproduction of mucous (both under the control of Th2-associated cytokines (Khan 
and Collins 2004)) lead to worm expulsion (de Veer, Kemp et al. 2007). 
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One of the key features of infection with helminths is the induction of T-regs, which 
combined with the predominant Th2 response provide an anti-inflammatory 
environment in which chronic helminth infection can persist (Maizels, Balic et al. 
2004). Induction of suppressive T-regs, which as discussed previously, is essential 
for preventing excessive immune responses, has been hijacked by helminths to aid 
immune-evasion. The excretory/ secretory molecules of H. polygyrus have been 
shown to induce functional T-regs that suppress effector responses (Grainger, Smith 
et al. 2010). Helminth-induction of T-regs via the TGF" pathway may well involve 
parasite homologues that mimic the action of mammalian TGF", such molecules 
have been identified in H. polygyrus and N. brasiliensis for example (Grainger, 
Smith et al. 2010; McSorley, Grainger et al. 2010). TGF" in combination with IL-6 
is also associated with the differentiation of Th17 cells, which are involved with the 
antimicrobial response to extracellular bacteria and inflammatory tissue responses 
(Ouyang, Kolls et al. 2008; Korn, Bettelli et al. 2009). IL-17 production by these 
cells is also associated with pathology in both helminth and malaria infection 
(Rutitzky, Lopes da Rosa et al. 2005; Wu, Chen et al. 2010). The cytokine driven 





Figure 3: Cytokine-driven differentiation of different T-cell subsets. Naïve T-cells 
circulating in the periphery can be induced to differentiate to T-helper 1 (Th1) cells 
primarily via exposure to IFN!, T-helper 2 (Th2) cells by IL-4, T-helper 17 (Th17) 
cells by TGF" and IL-6 and T-regulatory cells (T-regs) can be induced by TGF". The 
main cytokines that these T-cell subsets secrete are shown. 
 
Of particular importance to this study of co-infection is the fact that Th1 and Th2 
responses induced by malaria and helminths respectively are counter-regulatory, 
such that mounting a strong response of one type suppresses the magnitude of the 
other (Mosmann and Sad 1996). In addition to Th1 and Th2 cytokines having 
inhibitory effects on one another helminth-driven induction of T-regs is also a 
mechanism through which responses to other infections such as malaria are 
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suppressed during co-infection (Tetsutani, Ishiwata et al. 2009; Metenou, Dembele et 
al. 2011). The modulation of Th1 responses in co-infection, apparent in both human 
(Hartgers, Obeng et al. 2009) and animal models (Su, Segura et al. 2005), has 
important implications for the severity of malaria disease. There is no consistent 
effect of helminth co-infection on malaria and it seems likely that the outcome is 
dependent on the pairings of different helminth and malaria species and host 
genotype (Helmby 2009). Schistosoma mansoni-malaria co-infection in particular 
has been well studied and can result in protection against cerebral malaria during P. 
berghei infection (Waknine-Grinberg, Gold et al. 2010). Similarly, schistosome 
infection reduced P. chabaudi associated mortality (Yoshida, Maruyama et al. 2000). 
However, S. mansoni in combination with these same malaria species has been 
reported to increase parasitaemia (Helmby, Kullberg et al. 1998; Legesse, Erko et al. 
2004). Infection with the filarial nematode L. sigmodontis also elicits contrasting 
responses to malaria, exacerbating P. chabaudi parasitaemia (Graham, Lamb et al. 
2005) yet protecting against challenge with P. berghei (Fernandez Ruiz, Dubben et 
al. 2009). The intestinal parasites H. polygyrus and N. brasiliensis seem to protect 
against the uncomplicated symptoms of malaria, for example anaemia and 
parasitaemia (Hoeve, Mylonas et al. 2009), hypothermia and hypoglycaemia 
(Segura, Matte et al. 2009). 
 
Whilst understanding the influence of immune-mediated mechanisms of regulation 
on parasite growth is important, they are not the only means by which disease 
outcome may be affected. For a parasite the host is exploited as both a shelter and a 
food source and there is a strong likelihood that co-infecting parasites will compete 
for these resources. Consider malaria and helminths, Plasmodium absolutely requires 
host RBCs as a niche in which to replicate, whereas for many helminths these cells 
are a food source (Gilman 1982; Attout, Babayan et al. 2005). Hookworms in 
particular can cause severe anaemia (Hotez and Molyneux 2008) and this may 
impact on the availability of RBC for Plasmodium replication in a co-infection 
setting. Few studies consider both the resource- and immune-mediated mechanisms 
that may influence co-infection dynamics, although there are notable exceptions 
(Pedersen and Fenton 2007; Graham 2008). 
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1.5 Antibodies: technicality and serendipity of cross-reactivity. 
 
The assays for measurement of antibodies are well established and I envisaged that 
using antibody isotypes as indicators of Th1/ Th2 bias in co-infection could provide 
a technically simple alternative to measuring other immune-molecules such as 
cytokines. The advantage of using antibodies is that they can be measured in small 
volumes of serum and are thus amenable to sampling in natural populations. One of 
the beauties of scientific research is that the findings can be unexpected, as is the 
case with the occurrence of cross-reactive antibodies that recognised antigens from a 
parasite they had never encountered. As I’ve mentioned something that fascinates me 
is how the host contends with the vast diversity of pathogens it is exposed to. The 
flexibility of these antibodies to bind different antigens (parasites) struck me as a 
potential way for the host to combat diverse parasites whilst conserving ‘immune 
costs’. Of course this relies on the cross-reactive antibodies being functional in vivo. 
These cross-reactive antibodies also raise interesting immunological questions as to 
why they occur at all. 
 
In theory, the diversity of B-cell receptors (BCR) and the process of somatic 
hypermutation enable the generation of an antibody that is perfectly matched to its 
cognate antigen (Pancer and Cooper 2006). The process of somatic hypermutation, 
which is initiated by antigen binding, is unique to B-cells and involves mutation of 
the antigen-binding site of the BCR. This ‘new’ receptor is selected for if it improves 
antigen binding and the culmination of this process is the secretion of antibodies of 
the same specificity as the BCR from plasma cells (Tarlinton and Smith 2000). If 
some constraint was imposed on somatic hypermutation, such as antigen availability 
or the numbers of rounds of B-cell division, it is feasible that cross-reactivity could 
occur. Imagine a baseball mitt that is moulded to the ball as the pitcher tosses the ball 
to and fro, repeated catches cement the impression of the ball in the leather so that it 
is unsuitable to catch other objects that it may have fit when brand new (e.g. a rubiks 
cube). The amount of catches determines the mitt’s fit to the ball in the same way 
that binding to antigen determines the antibody’s fit to antigen. With fewer catches 
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(exposure to antigen/ rounds of somatic hypermutation) the mitt may still fit other 
objects and an antibody may recognise other antigens (cross-react).  
 
An alternative explanation for the occurrence of cross-reactive antibodies is that they 
are beneficial to the host. A beautiful example of when ‘error’ is beneficial is seen in 
the waggle-dance of the honeybee decoded by Karl von Frisch (Frisch 1967); 
foraging bees returning to the hive perform complicated dances, the angle and 
fervour of which communicate the direction and distance of food-sources. There is a 
certain amount of error in the dances repeated by an individual on returning to the 
hive (Okada, Ikeno et al. 2008) and this is thought to be an adaptation to encourage 
dance-followers to forage over a wider area than the dance directions convey 
(Weidenmuller and Seeley 1999), rather than an inability of bees to dance perfectly.  
This is analogous to antibody specificity/ cross-reactivity; if we suppose that the 
immune system is in fact capable of producing antibodies that are perfectly matched 
to their antigen then the maintenance of cross-reactivity (‘error’) is a strategy of the 
host to achieve a broader range of antigen recognition (binding) (Fairlie-Clarke, 
Shuker et al. 2009).  
 
1.6 Are you a man or a mouse? : Animal models of malaria- helminth co-
infection. 
 
Dissecting the host-pathogen interactions that result in exacerbation or amelioration 
of disease in natural populations is complicated by variation in exposure to parasites, 
unknown infection histories and of course variation in host and parasite genotypes. 
Much of this variation can be controlled in animal models, which therefore provide a 
useful means of investigating the potential for immune- or resource-mediated 
mechanisms to influence disease outcome in co-infection. Although animal models 
are an invaluable tool care must nonetheless be taken in extrapolating the findings of 
these models to human disease, some of the reasons for this are discussed in more 
detail below.  
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It should thus be noted that no single species of murine malaria captures all the 
properties of Plasmodium infection in humans but by choosing particular 
combinations of laboratory mouse strain (e.g. BALB/c, C57BL/6, CBA) and parasite 
species (e.g. Plasmodium berghei, Plasmodium yoelli, Plasmodium chabaudi) many 
pathological aspects of the disease can accurately be reproduced. For example 
infection with P. berghei ANKA or P. yoelli 17XL results in cerebral malaria (Li, 
Seixas et al. 2001) reflecting one of the most severe complications of P. falciparum 
infection in humans. The characteristic symptoms of uncomplicated malaria, 
anaemia and fever associated with parasite replication, are reflected in P. chabaudi 
infection of C57BL/6 or BALB/c mice (Lamb, Brown et al. 2006), although in mice 
fever manifests as a drop in body-temperature (Li, Sanni et al. 2003). The diversity 
of helminth parasites in natural populations e.g. filarial, schistosome and hookworm 
infections are also represented in animal models (Yamada, Nakazawa et al. 1992; 
Hoffmann, Petit et al. 2000; Pearce and MacDonald 2002; Bungiro, Sun et al. 2008). 
Of greatest relevance to this thesis is the N. brasiliensis model that represents an 
acute hookworm infection and the P. chabaudi model of malaria in which asexual 
parasitaemia, anaemia and weight loss are all readily measured but cerebral malaria 
is not a symptom.  
 
In combination these animal models provide systems in which to study the effects of 
co-infection on disease outcome. Importantly, animal models reflect the contrasting 
effects observed in human studies providing the opportunity to investigate the 
mechanistic causes of these different outcomes. Most murine studies of helminth co-
infection report increases in malaria parasitaemia (Helmby, Kullberg et al. 1998; Su, 
Segura et al. 2005; Tetsutani, Ishiwata et al. 2009) and exacerbation of 
hepatosplenomegaly was also apparent in a murine model of Schistosome-malaria 
co-infection (Sangweme, Shiff et al. 2009). By contrast, a protective effect of 
Schistosoma mansoni on the cerebral malaria caused by P. berghei (Waknine-
Grinberg, Gold et al. 2010) reflects the observation in humans co-infected with 
Ascaris lumbricoides and P. falciparum (Nacher, Gay et al. 2000). Two meta-
analyses have attempted to make sense of some of the variation in these systems and 
draw general conclusions regarding the affect of helminth co-infection. The first 
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focussed on helminth-microparasite  (viruses, fungi, bacteria or protozoa) co-
infections and using a community ecology framework revealed that the control of 
microparasites was most severely impaired when the underlying helminth infection 
didn’t impose resource limitation but strongly reduced the Th1 response (Graham 
2008). The second concentrated on murine models of malaria-helminth co-infection 
and concluded that the response of hosts to malaria in single infection was important; 
if infection with malaria normally resolved then helminths increased malaria 
mortality as the host was unable to control malaria parasite replication. In contrast 
malaria-related pathology was reduced if in single infection the malaria was 
normally lethal (Knowles 2011). 
 
Of course no animal model is perfect. There is dispute, for example, about the 
usefulness of P. berghei infection as a model for cerebral malaria as mice and 
humans exhibit different pathology that seems to be driven by different mechanisms; 
in mice there is an unequivocal role for pro-inflammatory cytokines in the 
development of cerebral malaria characterised by an accumulation of leukocytes and 
platelets in the brain whereas in humans blockage of the venules of the brain by 
sequestration of parasitized red blood cells is the main cause of cerebral malaria and 
the role of pro-inflammatory responses seems to be less important than in mice 
(White, Turner et al. 2010). Similarly, it should be noted that the parasitaemia 
associated with P. chabaudi is often much greater than that in human Plasmodium 
infection, where chronic low-level parasitaemia causes severe anaemia (Lamikanra, 
Brown et al. 2007). There are however similarities in the immune mediated 
mechanisms that influence anaemia and asexual parasitaemia in mice and humans. 
Increased levels of pro-inflammatory cytokines (e.g TNF#) are involved with 
suppression of erythropoiesis in mice (Li, Sanni et al. 2003) and an imbalance of the 
IL-10: TNF# ratio in Gambian children is associated with severe anaemia 
(Akanmori, Kurtzhals et al. 2000). Similarly the involvement of cytokines in Th1 
cell-mediated control of parasitaemia is evident in mice and humans as is the 
protective function of cytophilic antibodies (Li, Seixas et al. 2001). Helminth 
infection models also have limitations; in some cases the mouse host does not 
support the full life cycle (Lawrence 1996) or if it does, the length of infection is 
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sometimes curtailed in comparison to the natural host (Maizels and Yazdanbakhsh 
2003; Reece, Siracusa et al. 2008). However, the immune response to gastro-
intestinal helminths in mice and humans is similar; a potent Th2 cytokine response is 
associated with enhanced eosinophilia and basophilia (Mearns, Horsnell et al. 2008; 
McSorley and Loukas 2010; Nel, Hams et al. 2011). Production of protective IgE 
antibody responses is also a common feature of helminth infection in these different 
hosts (Turner, Faulkner et al. 2005; Perona-Wright, Mohrs et al. 2008). Despite the 
caveats outlined here a wealth of research in animal models highlights their 
suitability for detailed investigation of immune responses throughout infection that 
would not be possible in humans. In this study I focus on a murine model of malaria-
hookworm co-infection using the rodent malaria Plasmodium chabaudi and 
Nippostrongylus brasiliensis.  
 
1.7 The Plasmodium chabaudi- Nippostrongylus brasiliensis co-infection model 
 
The results presented in this thesis relate to the use of Nippostrongylus brasiliensis 
and Plasmodium chabaudi infection in BALB/c mice. I was particularly interested in 
investigating the potential for counter-regulation of Th1/ Th2 responses to be 
operating in this system. In order to minimise the induction of helminth associated T-
reg responses I chose to use a parasite which in the mouse causes an acute infection 
i.e. Nippostrongylus brasiliensis. This helminth infection in mice captures the 
migratory phase of the infective larvae and their development to adults in the gut but 
rather than establishing a chronic infection, the adults are expelled within 7 days post 
infection ({Hoeve, 2009 #433} and Chapter 3). The blood stage of the rodent malaria 
parasite Plasmodium chabaudi (AS strain) was chosen as a model of asexual parasite 
replication within host RBC. The AS strain is considered to have moderate virulence 
{Mackinnon, 1999 #5} causing minimal mortality in BALB/c and thus allows the 
full course of infection to be monitored. Infection in this model is characterised by 
cycles of asexual replication that culminate in a peak of parasitaemia by day 10 post 
infection ({Hoeve, 2009 #433} and Chapter 3). This ‘acute’ phase of infection is 
largely controlled by pro-inflammatory cytokine responses (e.g., IFN! and TNF#) 
and the initial peak of parasitaemia is resolved. It should be noted that cytophilic 
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antibodies are absolutely required for the ultimate resolution of infection without 
them mice fail to resolve the initial peak in asexual parasitaemia and suffer more 
severe recrudescence throughout infection {von der Weid, 1996 #82}. 
 
1.8 Why this thesis? 
 
Within the context of a larger project to investigate cytokine signalling and disease 
outcomes in the context of malaria- helminth co-infection I undertook the study 
reported in this thesis. I was motivated by an interest in understanding how hosts 
preserve their fitness when faced with infection by diverse parasites such as malaria 
and helminths. I envisaged that this would require management of the counter-
regulatory Th1/ Th2 immune responses that had previously been reported in other 
co-infection systems. Using a murine model of malaria-hookworm co-infection and 
antibody isotypes as indicators of immune bias I discovered that the malaria-specific 
Th1 response was reduced during co-infection and interestingly that cross-reactive 
antibodies were induced by single parasite infection. Disease outcome was affected 
in a way that seemed counter-intuitive to the reduction in malaria-specific Th1 
response, in that parasitaemia and anaemia were less severe. Intrigued by this and 
keen to acknowledge the importance of considering host-parasite interactions in a 
community ecology framework I investigated the potential for resource-mediated 
mechanisms to have a role in disease outcome. My findings indicated that in this 
model of co-infection the timing of helminth infection – and thus helminth-induced 
anaemia- may be particularly relevant in determining malaria disease outcome.  
 
The serendipitous discovery of cross-reactive antibodies opened up several avenues 
of investigation; pertinent to disease ecology is the idea that these cross-reactive 
antibodies could have functional consequences in co-infection. Interesting 
immunological questions are also raised as to whether these cross-reactive antibodies 
arise because of a constraint on the immune processes that result in antigen 
specificity. It is also possible that these two distinct pathogens actually share 
antigens and western blots of antigen probed with P. chabaudi anti-sera provide 
evidence that this may indeed be the case.  The final results chapter brings together 
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the themes and findings of the preceding chapters and addresses how increasing 
parasite dose may influence immune bias and antibody specificity/ cross-reactivity 
and is to my knowledge one of the few studies that considers this in the context of 
co-infection. 
 
The order in which the results chapters of this thesis are presented reflects the 








Figure 4: Guide to the results chapters in this thesis. Arrows indicate chapters that 










A wealth of research on infectious disease documents the need for different arms of 
the immune response to be deployed when combating bacteria, viruses and 
intracellular parasites (collectively ‘microparasites’) versus large extracellular 
organisms like parasitic helminths.  Typically a T-helper 1 response (Th1) is induced 
by microparasites and a T-helper 2 (Th2) response during helminth infection (Abbas, 
Murphy et al. 1996; Miller, Smith et al. 2009; Kolbaum, Ritter et al. 2011). In 
addition Th17 cells have recently been described and are associated with the control 
of microbial infections (Liang, Tan et al. 2006). Importantly, T-regulatory cells (T-
regs) prevent excessive inflammatory responses by suppressing the function of these 
effector T-cell subsets (Th1, Th2, Th17)(Pandiyan, Zheng et al. 2007). Th1 
responses are characterised by the production of the cytokine IFN! and the activation 
of cytotoxic and inflammatory responses (Mosmann and Sad 1996). For Th2 
responses, the signature cytokines are IL-4, IL-5 and IL-13, which are associated 
with an increase in eosinophils, mast cells, basophils and alternatively activated 
macrophages (Jenkins and Allen 2010). Of fundamental importance is the fact that 
these Th1/Th2 responses are counter-regulatory which results in polarisation of the 
immune response toward Th1 or Th2 depending on the predominant cytokines in the 
milieu (Mosmann and Sad 1996). In individual infections polarisation of the immune 
response ensures the appropriate effector mechanisms are induced to combat 
infection. For a host co-infected with microparasites and helminths however both 
Th1 and Th2 responses are required and a skew in immune-bias toward Th1 or Th2 
could have a significant impact on control of one of these infections. In addition 
helminths can stimulate expansion of T-regs (Finney, Taylor et al. 2007; Grainger, 
Smith et al. 2010), which could further influence immune bias through suppression 
of the Th1 response to microparasites (Metenou, Dembele et al. 2011). Parasite-
induced polarisation of the immune response can also determine the host’s response 
to other antigens, such as vaccines. Helminth-induced Th2 polarisation for example 
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impairs the protective Th1 response to tetanus and cholera vaccines and reduces their 
efficacy (Sabin, Araujo et al. 1996; Cooper, Chico et al. 2001; Nookala, Srinivasan et 
al. 2004). Similarly the challenge of creating a malaria vaccine is further complicated 
by an existing helminth-induced Th2 immune environment (Nacher 2001; Su, Segura 
et al. 2006). I am particularly interested in how helminth infection modulates the Th1 
response necessary for the control of malaria (Li, Seixas et al. 2001) and use a 
murine model of malaria-hookworm co-infection (P. chabaudi- N. brasiliensis) to 
explore this.  
 
In order to reach an understanding of how co-infection affects immune bias it is 
crucial to find a reliable indicator of both Th1 and Th2 responses. The distinct T-cell 
subsets that initiate the Th1 or Th2 response can be defined by their cytokine profile; 
an overproduction of IFN! over IL-4 or IL-13 indicating Th1 for example. Whilst 
analysing cytokine production by antigen-specific T-cell recall assays (i.e. in-vitro 
stimulation of lymph node or spleen cell cultures with parasite antigens) can provide 
an accurate measure of Th1/ Th2 immune bias in murine models this requires 
sacrificing the individual. In malaria infection in particular it can also be difficult to 
assess T-cell responses due to immune-suppression associated with the peak of 
infection and apoptosis of splenocytes (Sanchez-Torres, Rodriguez-Ropon et al. 
2001). Furthermore the production of cytokines by T-cells is often ‘spiky’ with a 
sharp peak being followed by a rapid waning of the response so their detection can 
be very sensitive to the time of sampling. It may be desirable to track the change in 
immune response throughout infection and for cytokines this requires sacrificing 
individuals at various timepoints. This greatly increases the number of animals 
required for an experiment and has the drawback that time-courses are not compiled 
from the same individual. Cytokine production can also be measured in serum but 
the sample volumes required for this can also prohibit repeated sampling. Ideally 
measuring immune bias should be achievable in a sample volume that facilitates 
repeated measures to be taken from the same individual, so that longitudinal data can 




Antibody isotypes are an attractive alternative to cytokines as indicators of Th1/Th2 
bias as the cytokine environment drives their production by B-cells. In mice antibody 
isotype class switching in response to IFN! results in B cells producing antibodies of 
the IgG2a isotype (Paul, Brown et al. 1987; Collins and Dunnick 1993; Else and 
Finkelman 1998), whereas the Th2 cytokine IL-4 switches B cells to produce IgG1 
(Paul, Brown et al. 1987; Purkerson and Isakson 1992). Although the generation of 
IgG1 as a marker of Th2-type response is less definitive than IgG2a as a marker of a 
Th1-type response, the ratio of IgG1 to IgG2a provides a powerful indicator of 
immune bias (Da'Dara, Skelly et al. 2003; Arnold, Bumann et al. 2004; Li, Rush et 
al. 2004; Taylor, Ziman et al. 2007). IgE is also a useful marker of helminth-induced 
(Th2) responses (Perona-Wright, Mohrs et al. 2008; McCoy, Finkelman et al. 2010) 
and is driven by IL-4 production (Finkelman, Holmes et al. 1990). Measurement of 
antibody responses can be achieved with smaller sample volumes and poses fewer 
technical challenges than T-cell recall assays. Furthermore, antibody analysis 
captures more fully the history of infection as it reflects cumulative immunological 
activity, in contrast to the ex-vivo ‘snapshot’ of the immune environment provided 
by T-cell cytokine responses, which are readily altered by changes in the timing of 
sampling both in vivo and in vitro. Analysis of antibody responses of co-infected 
animals might therefore provide evidence of overall Th1-Th2 cell cross-regulation 
even when cytokine analysis may not.  
 
This chapter focuses on the dynamics and interpretation of parasite antigen-specific 
antibody responses as indicators of immune bias in a host co-infected with P. 
chabaudi (Pcc) and N. brasiliensis (Nb). This type of data will provide the platform 
for investigating the overarching theme of this thesis, within-host ecology of immune 
responses during co-infection. 
 
2.2 Experimental Design 
 
Female BALB/c mice were infected with Pcc at a dose of 1x105 parasitised RBC 
(i.p) with or without co-infection of 200 Nb L3 larvae (s.cut) on day 0. A group of 
mice infected with Nb only (200 L3 larvae s.cut) were also included in addition to a 
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control group, which received nRBC (1x105) and PBS as sham injections for Pcc and 
Nb respectively. There were 8 mice per infection group. Bodyweight, RBC density 
and asexual parasite density were measured daily throughout the course of infection. 
Serum was collected on day 20 p.i and ELISA was used to measure antigen-specific 
antibody responses to Nb crude antigen (NbA), crude malaria antigen (pRBC) and 
recombinant malaria antigen MSP-119. For details of how these antibody titres were 
calculated see Materials and Methods chapter.  
 
To investigate the production of antibodies over the course of infection two further 
experiments were undertaken. The infection regime for singly or co-infected mice 
was as detailed above with the exception that one of these experiments continued 
until day 35 p.i. In addition to daily sampling of bodyweight, RBC density and 
asexual parasitaemia, 5µl of blood was taken from the tail daily and diluted in 5µl of 
heparin. This enabled a time-course of total IgG2a and IgE antibody production to be 
measured by ELISA, the concentration of each antibody isotype was calculated by 
comparison of optical density to a standard dilution series (see Materials & Methods 
chapter for details). Combining the data from these 2 time-course studies, excluding 
11 mice with failed Pcc infection (peak parasite density <0.05 pRBC 109/ml) gave 
sample sizes of n=30 for Nb, n=39 for Pcc, n=29 for Pcc-Nb and n=18 for controls. 


























BOX 1: Details of the number of infections from each of the 3 experiments that 
contribute to the data presented in this chapter. A note is also made of the  




2.3 Statistical Analysis 
 
The analyses of antigen-specific antibody responses at day 20 p.i were based on 24 
mice (n=8 per infection group). All analyses were carried out in the statistical 
package JMP 8.0 (SAS) using generalised linear models (GLM). The generation of 
antibody titre creates ordinal data that were log10 transformed to satisfy the model 
assumptions of homogeneity-of-variance and normal distribution. Infection status 
(Nb, Pcc or Pcc-Nb) was included as a categorical factor and its ability to predict 
antibody response was formally evaluated. The maximal model was fitted first and 
minimal models were reached by sequentially removing non-significant terms (P-
value > 0.05), beginning with interactions.  Finally, whenever a factor was 
significant (P < 0.05), an All Pairs Tukey post-hoc test was carried out to identify 
EXPERIMENT Infection group Sample size Other chapters contributed to 
1 Nb 8 Chapters 3 & 5 
(Figure 1 & 2) Pcc 8  
 Pcc-Nb 9  
 Control 4  
2 Nb 14 Chapter 3 
(Figure 3 & 4) Pcc 9  
 Pcc-Nb 7  
 Control 8  
3 Nb 16 Chapter 3 
(Figure 3 & 4) Pcc 30  
 Pcc-Nb 24  
 Control 10  
 43 
which groups of mice differed significantly in antibody induction, with respect to 
infection status.   
 
To determine if differences in antibody isotype induction were apparent throughout 
infection I analysed the total antibody time-series data from two experiments 
combined. To analyse the time-series daily antibody concentrations (µg/ml) were 
averaged for each mouse and log10 transformed to satisfy the model assumptions of 
homogeneity-of-variance and normal distribution. Again GLMs were used for 
statistical analyses; main effects were worm presence or absence (Nb) and malaria 
presence or absence (Pcc) fitted as categorical variables, the main effects and the 
interaction between them (Nb*Pcc) test whether the response variable (antibody 
induction) is affected by Pcc infection, Nb infection or both. The effect of infection 
on immune response did not differ between experiments although the magnitude of 
responses did. Including “experiment” as a factor in all the analyses controlled for 
this difference between the two experiments. Maximal models were first fit to the 
data and the minimal models were reached by removing non-significant terms (p 
>0.05) beginning with interactions. Significant interactions with “experiment” were 
removed if they were purely quantitative provided this did not alter the significance 
of the main effects remaining in the model. Finally, significant pairwise differences 
(p<0.05) between groups were determined using the Tukey’s All Pairs adjusted p-
values for the most complex significant term in the minimal model (i.e. the 




Antibody responses are effective indicators of immune bias in both single and  
co-infection 
 
In the Pcc-Nb model of co-infection the nematode is cleared by day 7 and the peak of 
malaria parasitaemia is controlled by day 10 ((Hoeve, Mylonas et al. 2009) and 
Chapter 3 results). Antigen-specific serum antibody responses were measured by 
ELISA after 20 days of Pcc-Nb co-infection to investigate whether this could provide 
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a method to rapidly and quantitatively assess cumulated immune bias. In Pcc-only 
infected mice the typical Th1-cell response induced by malaria (Cavinato, Bastos et 
al. 2001; Su and Stevenson 2002) was reflected in the IgG2a response to the 
recombinant malaria antigen MSP-119 (Figure 1a & Table 1) and a corresponding 
absence of the Th2 isotype (IgG1) to this antigen (Figure 1b). A significant up-
regulation of IgG2a to the crude malaria antigen (pRBC) was not seen in Pcc-only 
mice when compared to Nb or Pcc-Nb mice (Figure 1c & Table 1). However a highly 
biased Th1-cell response to this antigen was indicated by the weak pRBC-specific 
IgG1 response (Figure 1d). In contrast, Nb-only infected mice had a characteristic 
Th2-biased antibody response (IgG1) to worm antigen (NbA) (Figure 1f & Table 1).  
 
Having confirmed that the antibody response in single infections reflected the Th1 
and Th2-cell biased response elicited by nematode and malaria infections 
respectively, I used antibody isotype analysis of IgG2a (Th1) and IgG1 (Th2) 
responses to both nematode and malaria specific antigens to determine if changes in 
bias due to co-infection could be detected in these responses.  In other words would 
co-infection skew the Th1 cell response to Pcc to a more Th2 cell biased response 
and conversely, would the Th1 cell response induced by malaria have the capacity to 
alter the characteristic Th2-biased response to a nematode infection? The 
intermediate IgG1 response against NbA produced by co-infected mice (Pcc-Nb) 
(Figure 1f & Table 1) suggests that co-infection with Pcc down-regulated the anti-Nb 
specific Th2 response. It also appeared that responses in Pcc-Nb mice were further 
biased toward a Th1 cell response through the induction of IgG2a to NbA (Figure 1e 
& Table 1).  However, the strong IgG2a response to the recombinant malaria antigen 
MSP-1 19 detected in Pcc-only mice (Figure 1a) was also significantly reduced in 
Pcc-Nb mice (Figure 1a & Table1). These results strongly suggest that the isotype 
and hence cytokine bias of each single-species infection was significantly impacted 
by co-infection.  
 
Levels of total IgE (Figure 2) support this observation where Nb mice have the 
highest level of IgE, Pcc mice are indistinguishable from control mice and the co-
infected mice show intermediate levels. The immune bias that is apparent in serum 
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antibody isotype responses of Pcc-Nb infected mice is supported by cytokine 
responses in the lymph nodes of these mice, which were analysed as part of a 
different study. Again the bias of each single species infection was affected by co-
infection; the Pcc associated IFN! response (Th1) was significantly reduced in 
comparison to Pcc-only mice and the Th2 cytokines IL-13 and IL-5 were reduced in 
comparison to Nb-only mice (Hoeve, Mylonas et al. 2009). 
 
 
TABLE 1: Results of GLM for antigen-specific and total IgE antibody responses at 
day 20 p.i. F statistics and P values of significant terms (P<0.05 denoted with *) 
come from the minimal model. Significant pairwise differences were determined 
from the Tukeyʼs adjusted P-values of the most complex significant term in the 




Response Variable Factor df F ratio P value 
     
Anti-MSP-119 IgG1 Infection F2,21 22.87 <0.0001* 
Anti-MSP-119 IgG2a Infection F2,21 41.40 <0.0001* 
     
Anti-pRBC IgG1 Infection F2,21 9.28 <0.0013* 
Anti-pRBC IgG2a Infection F2,21 2.55 0.1021 
     
Anti-NbA IgG1 Infection F2,21 5.57 <0.0119* 
Anti-NbA IgG2a Infection F2,21 10.09   0.0009* 
     
Total IgE Infection F3,23 11.13 <0.0001* 
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Figure 1: Antibody isotype responses in infection and co-infection with N. brasiliensis and 
malaria. Mice were infected with 200 Nb L3 larvae and/or 1x105 Pcc-infected RBCs on day 0. 
Serum antibody titres were measured at day 20 post-infection to worm antigen (NbA) and 
malaria antigens (MSP-119 and pRBC), Th1 responses indicated by IgG2a and Th2 
responses by IgG1 are shown. All titres are above the mean +3 standard deviations of 
control mice at serum dilution of 1/200. This cutoff is represented as 0 on the y-axis. Single 
Pcc infections are shown in white bars, single Nb infections in black bars and co-infected 
mice (Pcc-Nb) are shown in the chequered bars. Graph shows mean and standard errors of 
8 mice per group. Groups not connected by the same letter denote pairs that are significantly 
different (p<0.05) according to Tukeyʼs Pairwise analysis. The letter X highlights those 




Figure 2: Total IgE responses in infection and co-infection with N. brasiliensis and 
malaria. Mice were infected with 200 Nb L3 larvae and/or 1x105 Pcc-infected RBCs 
on day 0. Serum antibody concentrations were measured at day 20 p.i. Nb-only 
mice are shown in black bars, single Pcc infection is shown in white bars and co-
infected (Pcc-Nb) mice are shown in the chequered bars. Control mice are shown in 
grey. Graph shows mean and standard errors of 16 mice per group. Significant 
pairwise differences according to Tukeyʼs adjusted P-values are indicated by letters. 
Groups that do not share letters are significantly different (P< 0.05 for all 
comparisons). 
 
Cross-reactive antibody responses are observed in Pcc-Nb co-infection 
 
Interestingly in the course of analyzing antibody responses I observed cross-
reactivity, whereby Nb mice mounted detectable IgG2a and IgG1 responses to both 
recombinant and crude malaria antigens, which they were not exposed to during 
infection (indicated by X1 & X2 in Figures 1a & 1c and X4 & X5 in Figures 1b & d, 
respectively). The magnitude of these cross-reactive responses is particularly 
striking, with Nb-induced IgG2a titres against crude and recombinant malaria 
antigens reaching 2500 and 200 respectively. Also the cross-reactive Nb-induced 
IgG1 response to malaria antigens is comparable to the Nb-specific response (Figure 

















1f). Similarly, Pcc mice mounted cross-reactive responses to NbA (X3 in Figure 1e 
and X6 in Figure 1f). It is important to note that these titres although low are 
markedly greater than background responses (more than 3 standard deviations above 
mean concentration in control mice, which is represented as zero on the y-axis). 
 
Determining the qualitative and quantitative aspects of the cross-reacting antibody 
responses are not only important for the practical analysis of immune bias but could 
be of real biological relevance during co-infection. As outlined above, antibody 
responses were biased, in terms of isotype, by infection status. The bias in isotype 
due to a particular infection (Th2 associated IgG1 induced during Nb infection, for 
example) was extended to non-specific antigens, as seen in the IgG1 response of Nb 
mice to both MSP-119 and pRBC (X4 and X5 in Figures 1b & 1d). This raised the 
concern that cross-reactive antibodies may hinder the interpretation of immune bias 
in co-infection. However in the majority of cases, calculating titre from serial 
dilutions of sera and capitalising on the differences in strength of antigen-specific 
and cross-reactive responses clarified interpretation of immune bias in co-infected 
mice. For example, Pcc-specific IgG2a titres in Pcc mice were significantly higher 
than the cross-reactive response induced in Nb mice (Figure 1a). Thus, although Nb 
mice made cross-reactive IgG2a responses, these were no longer detectable with 
increasing dilution of sera (Figure 1a). Similarly, IgG1 responses to NbA were 
significantly higher in Nb mice than the cross-reactive response induced by Pcc mice 
(Figure 1f). 
 
I concluded from this analysis that cross-reactive IgG1 responses to NbA were only 
detectable at dilutions less than 1:100 and thus higher dilutions could be used to 
avoid cross-reactivity when assessing antigen-specific antibody isotype profiles for 
the purpose of interpreting immune bias. However, increasing sera dilution did not 
always overcome the cross-reactivity observed, as IgG2a responses to NbA in Pcc 
mice were still observed at 1:2500 and did not differ significantly from the titre in Nb 
mice (X3 in Figure 1e). This cross-reactivity warrants further investigation, as it is 
likely to be important biologically. Indeed even cross-reactive responses detectable 
only at high serum concentrations may still have functional relevance in vivo.  
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Antibody responses measured over time demonstrate dynamic changes in immune 
bias 
 
One advantage of using antibody responses as indicators of Th1/ Th2-cell bias is that 
unlike cytokines they can be measured in small sample volumes e.g. 2-5µl – one 
tenth of that required for cytokine assays. This enabled repeated measures to be taken 
from the same animal so a profile of the antibody response throughout infection 
could be determined. To gain an overall picture of antibody responses in the different 
infection groups total (rather than antigen-specific) responses were measured by 
ELISA. IgM, IgG1, IgG2a and IgE responses were measured but as the IgM and 
IgG1 means were not different amongst the groups (data not shown) only the IgG2a 
and IgE data are discussed here. As expected from the analysis of antigen-specific 
data at day 20 p.i Pcc infection (Pcc or Pcc-Nb) resulted in production of IgG2a 
above the level seen in control or Nb-only mice from day 10 onwards (Figure 3a). 
Similarly, Nb (single or co-infection) showed production of IgE above the level 
measured in control or Pcc-mice from approximately day 8 p.i onwards (Figure 3b). 
Interestingly the down-regulation of IgE production evident in co-infected mice 
(Figure 2) is apparent from day 10 p.i but perhaps most striking at day 16 p.i. (Figure 
3b) In an attempt to quantify these profiles of antibody production the average daily 




Figure 3: Timecourse of total antibody responses throughout infection and co-
infection with N. brasiliensis and malaria. Mice were infected with 200 Nb L3 larvae 
and/or 1x105 Pcc-infected RBCs on day 0. Total antibody responses in serum were 
measured daily. IgG2a (Th1) responses a) and IgE (Th2) responses b) are shown. 
Nb-only mice are shown in red n=30, Pcc-only mice in blue n=39, co-infected (Pcc-
Nb) mice in purple n=29 and control mice in grey n=18. Graph shows mean and 






For IgG2a the average daily antibody concentration in Pcc mice (singly or co-
infected) was significantly greater than that of Nb-only and control mice (Figure 4a 
& Table 2). The lack of difference between Pcc and Pcc-Nb mice reflects the 
antigen-specific response to crude malaria antigen (pRBC) (Figure 1c). This 
summary of the antibody profile throughout the course of infection revealed 
significant differences in the level of IgE production between Nb and Pcc-Nb 
infected mice (Tukey’s adjusted P-value 0.0302)(Figure 4b and Table2). 
Interestingly the down-regulation of IgE in co-infected mice seen from day 10 to day 
16 p.i which was captured by analysis of average daily antibody concentrations 
(Figure 4b) was also evident in antibody responses measured in serum from the 
terminal bleed collected at the end of the infection, day 20 or day 35 (Figure 4c and 
Table 2). It should be noted that end point serum was collected through 
exsanguination via the brachial artery whereas daily samples were taken from the 
tail. The different source of sera may explain why day 33 timepoints (Figure 3b) do 
not reflect the differences evident at day 35 (Figure 4c). Examining immune 
responses throughout infection is extremely valuable for understanding the dynamics 
of changes in immune-bias. The fact that endpoint serum antibody concentrations 
accurately reflected changes occurring midway through infection highlights the use 
of antibodies as indicators of cumulated immune bias. Importantly measuring a time-
series of antibody responses or analyzing endpoint responses are both compatible 





Figure 4: Total antibody responses throughout infection and co-infection with N. brasiliensis 
and malaria. Daily average concentrations for IgG2a a) and IgE b). Total IgE responses at 
the end of infection are shown c). Nb-only mice are shown in black bars n=30, Pcc-only mice 
in white bars n=39 and co-infected (Pcc-Nb) mice in chequered bars n=29. Control mice are 
shown in grey n=18. Graph shows mean and standard errors of antibody concentrations 
(μg/ml). Significant pairwise differences according to Tukeyʼs adjusted P-values are 
indicated by letters. Groups that do not share letters are significantly different (P values for 
all comparisons are indicated). 
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TABLE 2: Results of GLM for the average daily production of total antibodies and the level of 
IgE antibody measured in serum harvested by terminal bleed (END DAY). Non-significant 
terms come from the last model before term was dropped and are shown in square brackets. 
F statistics and P values of significant terms (P<0.05 denoted with *) come from the minimal 
model. Significant pairwise differences were determined from the Tukeyʼs adjusted P-values 




        
2.5 Discussion 
 
In natural populations co-infection with multiple parasites is the norm and can result 
in either exacerbation or amelioration of disease (Petney and Andrews 1998; Cox 
2001). Co-infection often exerts an influence on the host’s immune response by 
altering the polarization of the Th1 and Th2 cell response; in various systems 
microparasites have been shown to down-regulate production of Th2 cytokines and 
helminths to suppress Th1 responses (Brady, O'Neill et al. 1999; Liesenfeld, Dunay 
et al. 2004; Kolbaum, Ritter et al. 2011). Whilst analysis of cytokine responses is 
definitive in describing Th1 and Th2-cell subsets it is not without its drawbacks; 
measurement of antigen-specific cytokine production by T-cells requires culture of 
spleen or lymph node cells and to obtain these in murine models involves sacrificing 
the host. Even measurement of cytokines in serum may necessitate sacrificing the 
animal due to the sample volumes required to perform these assays.  In addition 
Response 
Variable 
df Factor F ratio P value Experiment effect size 
estimates (mean ± SE) 
total IgG2a       
 F1, 113 Experiment 887.48 <0.0001* -0.87 ± 0.029 
 [F1, 112 Nb 0.90 0.3442]  
 F1, 113 Pcc  628.00 <0.0001*  
 [F1, 111 Nb*Pcc  0.23 0.6301]  
      
total IgE      
 F1, 111 Experiment 81.97 <0.0001* 0.17 ± 0.019 
 F1, 111 Nb 160.07 <0.0001*  
 F1, 111 Pcc  2.46 0.1196  
 F1, 111 Nb*Pcc  4.86 0.0295*  
      
END DAY  IgE       
 F1, 111 Experiment 2.19 0.1417  
 F1, 111 Nb 52.85 <0.0001*  
 F1, 111 Pcc  6.31 0.0134*  
 F1, 111 Nb*Pcc  11.21 0.0011*  
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sudden spikes and rapid falls in cytokine production mean that the response must be 
sampled at its peak otherwise it could go undetected. The need to sacrifice mice to 
sample cytokine responses at their peak is incompatible with observing the full 
course of infection and thus the consequence of immune effects on parasite control 
or pathology. In human studies serum cytokine analysis is a viable option and avoids 
the technical challenges of harvesting and storing T-cells in the field. However 
cytokines can be sensitive to collection and storage methods and this may complicate 
their accurate measurement from field isolates (Flower, Ahuja et al. 2000; Kenis, 
Teunissen et al. 2002). 
 
The cytokine environment directly influences antibody isotype production 
(Finkelman, Holmes et al. 1990) and as antibodies are more robust to freeze-thaw 
and can be measured in small volumes of serum they are a useful alternative to 
cytokines as indicators of immune bias. Analysis of antigen-specific antibody isotype 
reflected the Th1 or Th2 bias in mice singly infected with Pcc or Nb respectively; 
IgG2a (Th1) responses to Pcc antigens were enhanced in Pcc-only mice and 
conversely IgG1 (Th2) responses to worm antigen were significantly greater in Nb-
only mice. The interpretation of Th1/Th2 antibody bias in co-infected animals was 
complicated by cross-reactivity and this is not a problem unique to the co-infection 
model used here (Naus, Jones et al. 2003; Lamb, Graham et al. 2005; Pierrot, Wilson 
et al. 2006; Fairlie-Clarke, Lamb et al. 2010).  It is worth noting that cross-reactive 
responses were observed regardless of whether recombinant or crude antigens were 
used. Conclusions can still be drawn regarding the influence of a co-infecting 
parasite on immune bias using serum antibodies even when cross-reactivity is 
observed but this relies on the calculation of antibody titres to capitalise on the 
relative differences in antibody production amongst the different infection groups. In 
practical terms the change in bias due to a co-infecting parasite can be inferred by 
subtracting the cross-reactive response in single infection from that of co-infected 
mice. It is important to emphasise the need to calculate titre, as many models that 
aim to dissect the real effect of a co-infecting parasite on immune bias rely on 
antibody analysis at a fixed serum concentration, previously determined to fall within 
the linear range of the dilution curve (Rodriguez, Terrazas et al. 1999; Mutapi, 
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Ndhlovu et al. 2000; Mwatha, Jones et al. 2003; Naus, Jones et al. 2003; Lamb, 
Graham et al. 2005; Miller, Smith et al. 2009; Tetsutani, Ishiwata et al. 2009; 
Kolbaum, Ritter et al. 2011). This approach is usually taken in the interests of saving 
time and reagents as these kinds of studies use large numbers of animals to detect 
significant differences in antigen-specific responses between single and dual 
infection. This could prove to be a false economy as it may provide insufficient 
information to distinguish cross-reactive from bias-altering immune responses.    
 
When antibody titres were calculated in this Pcc-Nb study, I was able to determine 
whether apparent alterations in antibody isotype profile on co-infection were due to 
actual changes in parasite-specific responses or reflected a cross-reactive response.  
For example, determining that cross-reactive IgG2a antibody titres in Nb mice were 
significantly lower than the antigen-specific response of Pcc mice meant that cross-
reactivity contributed very little to the titre observed in Pcc-Nb mice (see Box 1 
Figure a). This allowed me to conclude that the reduction in Th1 type antibody in 
Pcc-Nb mice was due to suppression of Pcc-specific Th1 responses by nematode 
infection. It is worth noting that had I not calculated titre and relied on optical 
density data derived from a single dilution of sera I may not have observed the 
difference between Pcc and Pcc-Nb mice and thus incorrectly concluded that there 
was no effect of co-infection on Th1 responses.  Similarly, analysis of antibody titre 
enabled me to detect the reduction in anti-NbA IgG1 antibody in Pcc-Nb mice 
(Figure 1f), which suggests a Pcc-mediated bias toward a Th1 cell response.  
Antibody cross-reactivity poses more of a problem for the interpretation of changes 
in immune bias due to co-infection when it is of the isotype not typically associated 
with the parasite it recognises i.e. Th2 (IgG1) responses to malaria antigens or Th1 
(IgG2a) responses to Nb antigens. For example, due to the magnitude of the Nb-
induced IgG1 response to MSP-119 it is impossible to tell if the response in Pcc-Nb 
mice is due entirely to this cross-reactivity or is a ‘real’ effect of Nb infection on 
cytokine and so antibody bias (see Box1 Figure b). The Pcc-induced IgG2a cross-
reactive response to NbA is of a similar magnitude to the antigen-specific response 
of Nb-mice, yet the response in co-infected mice is significantly greater so even after 
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taking into consideration the proportion of this response that could be deemed cross-




The induction of cross-reactive antibodies has important implications with regard to 
biological function.  For example immune responses to malaria infection are 
typically characterised by a Th1 type (IgG2a) response, as we observed for Pcc-
induced responses to the malaria antigens (pRBC and MSP-119).  The propensity for 
Nb mice to induce atypical IgG1 antibody isotypes to malaria antigens is likely due 
to the helminth parasite promoting Th2 cytokines in the environment where the 
antibody response is established (e.g. lymph nodes)(Perona-Wright, Mohrs et al.). 
The biological consequences of the Nb driven IgG1 response to malaria antigens 
remains to be investigated, but as cytophilic IgG2a antibodies convey greater 
protection against malaria parasites than IgG1 antibodies (Su and Stevenson 2000; 
Cavinato, Bastos et al. 2001) there is the potential for cross-reactive Nb-induced 
IgG1 antibodies to be detrimental to parasite clearance and thus have real 
consequences in terms of disease outcome. The potential for cross-reactive responses 
of the appropriate isotype to have a functional role during infection raises the 
intriguing possibility that their production is a deliberate strategy of the host to 
combat diverse parasites (Fairlie-Clarke, Shuker et al. 2009). 
 
In summary, the results presented in this chapter demonstrate that analysis of 
antibody isotype titres can be used to indicate Th1/Th2 immune bias in co-infection. 
Overall co-infected hosts exhibit intermediate antibody responses: Pcc-specific Th1 
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(IgG2a) responses were lower than Pcc-only mice and Th2 responses (Nb-specific 
IgG1 and total IgE) were reduced compared to Nb-only infected mice. Such 
intermediate responses are not intuitive when considering Th1-Th2 cross-regulation 
and the polarising effect of parasites. However, it should be noted that Th1/Th2 
polarisation may well be compartmentalised to the lymph nodes at the site of 
infection (e.g mesenteric lymph nodes for gastro-intestinal N. brasiliensis infection) 
(Lamb, Graham et al. 2005), whereas serum antibody responses represent systemic 
effects. Ultimately, the intermediate Th1/Th2 bias observed in Pcc-Nb mice likely 
reflects the need to mount both Th1 and Th2 responses as a result of infection. The 
question of how the reduction in Th1 bias will affect control of Plasmodium 
chabaudi in co-infection will be the focus of the next chapter. Furthermore the 
antibody cross-reactivity observed in this system raises interesting biological, 
ecological and biochemical questions, which I aim to address throughout this thesis –
Do these cross-reactive antibodies have functional relevance in co-infection? Is the 
production of cross-reactive antibodies a deliberate strategy of the host to conserve 
immune ‘costs’ of targeting diverse parasites? Is there a shared epitope on the 
antigens of these two distinct pathogens? These last two questions allude to 
adaptations of the host or parasite and the constraints that are placed on them. For 
example if cross-reactivity is a deliberate strategy of the host to combating diverse 
parasites this adaptation places a constraint on the parasites as they may fail to evade 
immune targeting. In contrast if parasites do indeed share an antigenic epitope, 
perhaps due to the parasites’ adaptation to living in a particular niche within the host 
(e.g. circulatory system) this places a constraint on the host’s ability to discriminate 











Chapter 3: Effect of co-infection on malaria parasitaemia and 




The geographical and socio-economic distribution of malaria overlaps with that of 
parasitic helminths and co-infections in these areas are common (Brooker, Akhwale 
et al. 2007; Mazigo, Waihenya et al. 2010). Co-infection with helminths has been 
shown to affect the severity of malaria in humans but the outcome is not consistent, 
as both amelioration and exacerbation have been observed (Nacher, Gay et al. 2000; 
Nacher, Singhasivanon et al. 2002; Le Hesran, Akiana et al. 2004; Lyke, Dicko et al. 
2005). Perhaps this variation is not so unexpected in human populations where host 
heterogeneity, environment, species of co-infecting parasite, level of exposure and 
timing of infection may all contribute to outcome (Supali, Verweij et al. 2010). In 
addition immune pleiotropy may explain the heterogeneity of disease outcomes. For 
example the anti-inflammatory cytokine IL-10 and T-regulatory cells (T-regs) can 
impair control of parasites by reducing Th1 responses (Walther, Tongren et al. 2005) 
but may also serve to protect the host from excessive inflammatory reactions 
(Walther, Jeffries et al. 2009) that are associated with cerebral malaria (Awandare, 
Goka et al. 2006).  
 
Different rodent malaria models accurately reflect many pathological aspects of the 
disease in humans, for example infection with P. chabaudi can be used as a model 
for uncomplicated malaria (parasite replication and associated anaemia), whilst P. 
berghei or P. yoelii are useful models of cerebral or complicated malaria (Li, Seixas 
et al. 2001). As discussed in the general introduction, exact mechanisms underlying 
the development of malaria pathology may differ between mice and humans.  The 
parasitaemia associated with P. chabaudi is often much greater than that in human 
Plasmodium infection, where chronic low-level parasitaemia causes severe anaemia 
(Lamikanra, Brown et al. 2007). However there are important similarities in the 
immune mediated mechanisms that influence anaemia and asexual parasitaemia in 
mice and humans. Increased levels of pro-inflammatory cytokines (e.g TNF#) are 
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involved with suppression of erythropoiesis in mice (Li, Sanni et al. 2003) and an 
imbalance of the IL-10: TNF# ratio in Gambian children is associated with severe 
anaemia (Akanmori, Kurtzhals et al. 2000). Similarly the involvement of cytokines 
in Th1 cell-mediated control of parasitaemia is evident in mice and humans as is the 
protective function of cytophilic antibodies (Li, Seixas et al. 2001). Experimental 
animal models thus provide an opportunity to investigate potential mechanisms of 
how co-infection influences the outcome of malaria. As with humans, murine 
malaria-helminth co-infection results in differential effects on the control of parasite 
growth, or development of pathology associated with malaria infection.  S. mansoni 
and H. polygyrus have been shown to exacerbate P. chabaudi and P. yoelii infection 
in terms of parasitaemia and host mortality (Helmby, Kullberg et al. 1998; Su, 
Segura et al. 2005; Helmby 2009; Sangweme, Shiff et al. 2009; Tetsutani, Ishiwata et 
al. 2009), whilst in other studies S. mansoni protects from cerebral malaria 
(Waknine-Grinberg, Gold et al. 2010) and reduces host mortality (Yoshida, 
Maruyama et al. 2000).  
 
Many of these studies highlight the importance of immunological mechanisms in 
mediating the effect of co-infection on disease outcome. In murine models initial 
control of the erythrocytic stage of malaria parasites relies on the induction of a Th1 
response via IFN! and TNF# activation of macrophages (Stevenson, Huang et al. 
1992; Li, Sanni et al. 2003). For the ultimate resolution and clearance of malaria 
infection B-cells and antibodies are absolutely required (von der Weid, Honarvar et 
al. 1996); in particular antibodies of the IgG2a (Th1) isotype are protective as they 
neutralise free merozoites and opsonise parasitised RBC for uptake by macrophages 
(Mota, Brown et al. 1998; Cavinato, Bastos et al. 2001). However, the protective 
pro-inflammatory Th1 response must be carefully controlled via the anti-
inflammatory cytokines IL-10 and TGF" to minimise the risk of immunopathology 
to the host (Stevenson, Huang et al. 1992; Li, Sanni et al. 2003). During co-infection 
helminths may negatively impact the response to malaria by weakening protective 
Th1 responses or positively influence the outcome by antagonising inflammatory 
responses. For example Su et al (Su, Segura et al. 2005) report that H. polygyrus 
infection leads to a reduction in IFN! and impairment of the protective P. chabaudi-
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specific IgG2a response. Infection with S. mansoni was associated with a switch to 
an anti-inflammatory Th2 environment and amelioration of cerebral pathology 
caused by P. berghei (Waknine-Grinberg, Gold et al. 2010). Helminth-induced 
dysregulation of the host’s response to malaria has repercussions in terms of 
controlling parasite replication, which in addition to influencing host health/ disease 
outcome has implications in terms of parasite transmission and epidemiology 
because of effects on gametocytes (Noland, Graczyk et al. 2007).  
 
I have shown that in the murine model of malaria-hookworm (Pcc-Nb) co-infection 
the Pcc-specific Th1 response is reduced, as indicated by analysis of antigen-specific 
antibody responses (see Chapter 2 results). In this chapter I focus on how this 
decrease in Th1 response affects the outcome of Pcc-Nb co-infection in terms of host 
pathology (anaemia, measured by loss of RBC density) and Pcc asexual 
parasitaemia.  My hypothesis was that reduced IgG2a antibody production, indicative 
of reduced IFN! levels, will increase the severity of Pcc infection in a manner similar 
to that reported by Su et al regarding the effect of H. polygyrus on Pcc, i.e. via 
increased peak parasite density (Su, Segura et al. 2005).  
 
3.2 Experimental Design 
 
Female BALB/c mice were infected on day 0 with Pcc at a dose of 1x105 parasitised 
RBC with or without co-infection of 200 L3 Nb larvae. A group of mice infected 
with Nb only (200 L3 larvae s.cut) were also included in addition to a control group, 
which received nRBC (1x105) and PBS as sham injections for Pcc and Nb 
respectively. Bodyweight, RBC density (anaemia) and asexual parasite density 
(parasitaemia) were measured daily throughout the course of infection, which lasted 
a minimum of 20 days (see Materials and Methods chapter for details). Bodyweight 
was monitored as an indicator of host health and was primarily used to ensure that 
animals were fit to progress through infection in accordance with Home Office 
regulations. Animals lost weight both during peak of malaria infection and also co-
incident with Nb larvae migrating through the lung {Hoeve, 2009 #433}. This data 
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was not formally analysed as due to the continued growth of the animals it was more 
variable and less informative as a measure of host pathology.  
 
3.3 Statistical Analysis 
 
The analysis of RBC density and asexual parasitaemia was performed on data 
compiled from 5 experiments (see Table 1 for details), and was carried out in the 
statistical package JMP 8.0 (SAS) using generalised linear models (GLM).  
Following the methods of Hoeve et al (Hoeve, Mylonas et al. 2009) the minimum 
RBC density data were analysed in two time frames, the first week post-infection 
(day 0-6 p.i inclusive) and the entirety of the infection. After exclusion of any mice 
with failed Pcc infection (peak parasite density < 0.05 pRBC 109/ml) the analysis 
focussed on 234 mice; n=65 Pcc-Nb, n=71 Pcc, n=62 Nb and n=36 controls. The 
main fixed effects of the model were worm presence or absence (Nb) and malaria 
presence or absence (Pcc) fitted as categorical variables. ‘Experiment’ was fitted as a 
random effect and the model was run with and without this factor to determine the 
difference between the -2 log likelihood measure for the two models. The 
significance of this difference was tested by Chi-square with 1 degree of freedom. 
The main effects and the interaction between them (Nb*Pcc) test whether the 
response variable (minimum RBC density) was affected by Pcc infection, Nb 
infection or both. To account for differences in initial RBC density, Day 0 values 
were included as a fixed covariate. Maximal models were first fit to the data and the 
minimal models were reached by removing non-significant terms (p >0.05) 
beginning with interactions. Finally, significant pairwise differences (p<0.05) 
between groups were determined using the Tukey’s All Pairs adjusted p-values for 
the most complex term in the minimal model. 
 
Asexual parasitaemia was analysed only for animals experiencing Pcc infection (i.e. 
Pcc-Nb n=66, Pcc n=71). The effect of co-infection on Pcc peak parasite density was 
evaluated by GLM.  Worm presence or absence (Nb) was included as a fixed 
categorical factor in the model. Experiment was again included as a random effect in 
the model (see above). Finally, significant pairwise differences (p<0.05) between 
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groups were determined using the Tukey’s All Pairs adjusted p-values for the most 
complex term in the minimal model. 
 
 
TABLE 1: Details of the number of infections from each of the 5 experiments that 
contribute to the host pathology data presented in this chapter. A note is also made 
of the results chapter in which corresponding immunology data can be found. Those 
experiments that only contribute to pathology data were initially conducted as part of 





































EXPERIMENT Infection group Sample size Other chapters 
contributed to 
1 Nb 8 Chapter 2&5 
 Pcc 8  
 Pcc-Nb 9  
 Control 4  
2 Nb 14 Chapter 2 
 Pcc 9  
 Pcc-Nb 7  
 Control 8  
3 Nb 16 Chapter 2 
 Pcc 30  
 Pcc-Nb 24  
 Control 10  
4 Nb 14 - 
 Pcc 14  
 Pcc-Nb 16  
 Control 6  
5 Nb 10 - 
 Pcc 10  
 Pcc-Nb 9  




Co-infection reduces peak Pcc parasitaemia and the severity of associated anaemia. 
 
Asexual malaria parasitaemia was measured on a daily basis by microscopic 
examination of Giemsa stained blood smears. For both singly- (Pcc) and co-infected 
(Pcc-Nb) mice the peak of parasitaemia occurred on day 8 p.i. However, parasite 
density was significantly reduced in Pcc-Nb mice on this day (effect of Nb on peak 
parasite density F1,127 =4.23, P=0.0417) (See Figure 1a and Table 2). Peak 
parasitaemia was associated with a loss in RBC density (anaemia) (effect of Pcc on 
minimum RBC density throughout infection F1,226=2234.04, P<0.0001) in all animals 
infected with Pcc as asexual parasite replication within the RBC leads to cell rupture 
and the release of new merozoites resulting in a reduction in RBC numbers. 
However, the trough of anaemia on day 10 p.i was less severe in Pcc-Nb mice than in 
the singly infected animals (Tukey’s pairwise analysis Pcc-Nb vs Pcc P=0.0230) 
(See Figure 1b). 
 
Nb-infection induces significant anaemia in the first week post-infection. 
 
Monitoring RBC density on a daily basis revealed not only the expected anaemia 
associated with the peak of Pcc infection but also a significant reduction in RBC 
density in Nb-infected mice in the early stages of infection (effect of Nb on minimum 
RBC density to day 7p.i F1,225=15.77, P<0.0001; see Figure 1b and Table 2). This 
Nb-induced RBC loss was resolved over the course of infection in Nb-only mice but 
as noted above Pcc-Nb mice endured further Pcc-induced RBC loss albeit less severe 













TABLE 2: Results of GLM for anaemia and malaria parasitology data. Non-
significant terms come from last model before term was dropped and are shown in 
square brackets. F statistics and P values of significant terms (P<0.05) come from 
the minimal model with experiment fitted as a random effect. Significant pairwise 
differences were determined from the Tukeyʼs adjusted P-values of the most 
complex significant term in the minimal model. Experiment was fitted as a random 
effect and the model was run with and without this factor to determine its 
significance. The test statistic in this case is the difference between the -2log 
likelihood measure for the two models and its significance was tested by Chi-square 
(Chi-square P value). All effect size estimates are taken from the minimal model with 














(mean ± SE) 
       
RBC minima  
(to d6 p.i 
inclusive) 
      
 Day 0 RBC F1,225 62.87 <0.0001* - 0.417±0.05 
 Nb F1,225 15.76 <0.0001* - 0.09±0.02 
 [Pcc F1,224 0.13 0.7176] -  
 [Pcc*Nb F1,223 1.05 0.3055] -  
 Experiment  1 96.32 - 0.001 0.132±0.097 
       
RBC minima  
(to end day) 
      
 [Day 0 
RBC 
F1,223 2.35 0.1272] -  
 Nb F1,226 3.05 0.0821 -  
 Pcc F1,226 2234.04 <0.0001* - 2.056±0.04 
 Pcc*Nb F1,226 3.62 0.0584 -  
 Experiment  1 62.75 - 0.001 0.193±0.143 
Peak parasite 
density 
      
 Nb F1,127 4.23 0.0417* - 0.046±0.02 
 Experiment  1 98.9 - 0.001 0.149±0.108 
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Figure 1: Malaria parasitaemia and anaemia timecourses.  
Daily parasitised RBC density throughout infection a) Pcc-mice are shown in blue 
and co-infected (Pcc-Nb) mice in purple. Graph shows mean and standard error of 
n=66 (Pcc-Nb) and n=71 (Pcc). Daily RBC density throughout infection b) Nb mice 
are shown in red, Pcc-mice in blue, Pcc-Nb mice in purple and controls in grey. 
Graph shows mean and standard error of n=66 (Pcc-Nb), n=71 (Pcc), n=62 (Nb) 






Co-infection often exerts an influence on the host’s immune response by altering the 
polarization of the Th1 and Th2 cell response, for example in various systems 
helminths have been shown to suppress Th1 responses (Brady, O'Neill et al. 1999; 
Tetsutani, Ishiwata et al. 2009; Kolbaum, Ritter et al. 2011). This helminth-induced 
reduction in Th1 responses can significantly impact disease outcome; for example 
exacerbation of the bacteria Bordetella pertussis was observed in mice co-infected 
with Fasciola hepatica (Brady, O'Neill et al. 1999), whilst infection with 
Strongyloides ratti reduced infection with Trypanosoma brucei (Onah, Onyenwe et 
al. 2004). Of relevance to the co-infection model used here both amelioration and 
exacerbation of disease have also been observed in helminth-malaria co-infections 
(e.g. (Helmby, Kullberg et al. 1998; Yoshida, Maruyama et al. 2000; Legesse, Erko 
et al. 2004; Helmby 2009; Sangweme, Shiff et al. 2009; Waknine-Grinberg, Gold et 
al. 2010) ).  
 
Previously (Chapter 2 and (Fairlie-Clarke, Lamb et al. 2010)) I have shown that Pcc-
Nb co-infection results in a reduced Th1 bias as measured by Pcc-specific IgG2a. As 
antibodies are absolutely required for the clearance of malaria parasites (von der 
Weid, Honarvar et al. 1996) and IgG2a in particular has been shown to be protective 
against the asexual stage of Pcc (Cavinato, Bastos et al. 2001; Mota, Brown et al. 
2001) I hypothesised that malaria parasitaemia would be increased and the associated 
anaemia would be worse in co-infected mice. This prediction however was not borne 
out; co-infected mice showed a significant reduction in peak parasitaemia and a 
corresponding reduction in the trough of RBC loss. This suggests that despite the 
overall reduction in Th1 immune-bias the host is able to control Pcc infection as 
efficiently, if not better than a singly infected host. Co-infected mice most likely 
experienced less severe anaemia as they harboured fewer parasites and so suffered 
less destruction of RBC through parasite replication. It is also possible that a 
reduction in the pro-inflammatory Th1 response contributed to the effect if less 
cytokine (TNF#)-driven suppression of erythropoiesis (Li, Seixas et al. 2001) 
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enabled co-infected mice to compensate better for the parasite-induced anaemia. The 
reduction in malaria-specific Th1 response being associated with reduced peak 
parasitaemia is not easy to reconcile.  A recent meta-analysis of the murine literature 
suggests that Pcc-helminth co-infection more commonly results in exacerbation of 
Pcc parasitaemia (Knowles 2011). For example, S. mansoni paired with P. berghei, 
P. yoelii or P. chabaudi resulted in increased peak parasitaemias (Helmby, Kullberg 
et al. 1998; Legesse, Erko et al. 2004; Sangweme, Shiff et al. 2009) as did the 
combination of H. polygyrus and P. chabaudi (Su, Segura et al. 2005). This 
increased parasitaemia was attributed to reduction in the Th1 response, in those 
studies where it was measured (Helmby, Kullberg et al. 1998; Su, Segura et al. 
2005). However these studies used chronic helminth infections rather than acute 
infections such as Nb and in some cases the host genotype (C57BL/6) differed from 
that used here (BALB/c). Perhaps the Th2 response induced by chronic helminth 
infection is of greater magnitude than that of acute Nb infection and therefore results 
in greater down-regulation of the Th1 response to malaria leading to more severe 
parasitaemia. In other words the reduction in Th1 response during Pcc-Nb co-
infection although statistically significant may not be biologically relevant. This 
however does not account for the fact that peak parasitaemia was significantly 
reduced. In humans there are reports that co-infection with Schistosoma 
haematobium reduces the parasite density of Plasmodium falciparum (Briand, Watier 
et al. 2005). This may be due to co-infection increasing the production of protective 
anti-malarial antibodies (Diallo, Remoue et al. 2010). Although I did not see an 
increase in Pcc-specific antibody in co-infected mice (Chapter 2 (Fairlie-Clarke, 
Lamb et al. 2010)) there is perhaps potential for cross-reactive antibodies induced by 
Nb to act in concert with the Pcc-induced response. Both IgG1 and IgG2a cross-
reactive antibodies are induced by Nb-infection and although vaccine-induced IgG1 
has been shown to be protective against malaria (Burns, Flaherty et al. 2004) it is the 
IgG2a isotype that is more commonly involved in antibody-mediated protection 
against Pcc (Cavinato, Bastos et al. 2001). 
 
Of course the effect of co-infection is not limited to its influence on immune 
responses. Helminth infection can also limit RBC availability and this has been 
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shown to limit parasite replication (Lwin, Last et al. 1982). The reduction of RBC 
density induced by Nb in the early stages of infection (to d6 p.i) is likely caused by 
haemorrhaging, as the larvae migrate into the airspace of the lungs prior to being 
coughed up and swallowed (Marsland, Kurrer et al. 2008). Gross examination of the 
lungs of a cohort of mice from this experimental set-up that were culled at days 3, 5 
and 7 p.i revealed substantial haemorrhaging and leakage of blood into the airways 
(Hoeve, Mylonas et al. 2009). RBCs are a key resource for Pcc as they provide the 
niche in which asexual parasite replication occurs and the availability of RBCs for 
new merozoites to invade is crucial in propagating this process (Hetzel and Anderson 
1996).  The timing of Nb-induced reduction in the availability of RBCs may 
therefore hinder the establishment and replication of Pcc-parasites culminating in 
reduced peak parasitaemia in co-infection. The transient Nb-induced anaemia may be 
too small to directly influence the actual number of RBCs available for Pcc invasion 
but it may alter their age-structure and reduce the number of mature RBCs that Pcc 
preferentially invades (Ott 1968).  
 
Immune- and resource-mediated effects of co-infection are not necessarily mutually 
exclusive mechanisms (Graham 2008) but it would be interesting to quantify the role 
of each and determine which (if any) has the more potent effect. This is impossible 
with the infection regime used in this experiment, as I cannot distinguish the effect of 
Nb-induced RBC depletion early in infection from the down-regulation of the Th1 
response and induction of cross-reactive antibodies. The next chapter aims to address 
this by manipulating the timing of Nb-infection -and thus the timing of Nb-induced 










Chapter 4: Untangling the influence of ‘top-down’ and ‘bottom-up’ 





The terms ‘top-down’ and ‘bottom-up’ to describe interactions amongst organisms 
are borrowed from community ecology and are commonly used to describe the 
processes which govern ecosystem structure (Smith, Hunter et al. 2010). The classic 
example is the regulation of hare populations via food availability and predation by 
lynx, where ‘bottom-up’ interactions refer to the availability of plants and ‘top-
down’ to predation levels (Stenseth, Falck et al. 1997). If we apply this analogy to 
host-pathogen interactions then immune-mediated pathogen killing takes on the role 
of predator (top-down) and host resources the plants (bottom-up). Both of these 
mechanisms can be influenced by co-infection. Parasites may compete with each 
other for host resources, such as the niche they occupy: in horses, competition for 
space in the caecum between two species of gastro-intestinal helminths reduced the 
number of the helminth species that in the absence of competition favoured this site 
(Stancampiano, Mughini Gras et al. 2010). Such resource-competition is also evident 
amongst polystome parasites of clawed toads and, depending on the composition of 
the competing species, can lead to the competitive-exclusion of one parasite species 
(Jackson, Pleass et al. 2006). Co-infecting species can also exert an effect on host 
immune responses; for example, an entomopathogenic fungus of leaf-cutter ants, 
releases toxins that inhibit immune responses and increase infection with a second 
fungal pathogen (Hughes and Boomsma 2004). In general, research on the within-
host interactions that influence disease outcome focuses on the influence of one or 
other of these mechanisms, but seldom both. 
 
The counter-regulatory nature of Th1 and Th2 responses that are required to combat 
microparasites and helminths (Mosmann and Sad 1996) makes the immunological 
setting of co-infection with these two types of parasite particularly interesting. 
Helminth infection is also associated with a general dampening of immune 
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responses, brought about by the induction of T-regulatory cells (T-regs), which 
suppress T-effector cells. This appears to be an adaptation of the helminth to achieve 
chronic infection in the host. Indeed, some species can persist for several years 
(Bradley and Jackson 2004; Zaccone, Fehervari et al. 2006; Figueiredo, Barreto et al. 
2010; Taylor, Hoerauf et al. 2010). This helminth-induced regulation of immune 
responses via T-regs is also evident in mice (Maizels, Balic et al. 2004; Gillan and 
Devaney 2005; Grainger, Smith et al. 2010). The implications for helminth-induced 
reduction or suppression of immune responses that target micro-parasites has been 
the focus of several experimental studies in mice and reveals a whole range of effects 
on micro-parasite infection; amelioration (Waknine-Grinberg, Gold et al. 2010), 
exacerbation (Brady, O'Neill et al. 1999; La Flamme, Scott et al. 2002; Graham, 
Lamb et al. 2005; Helmby 2009) or even a neutral outcome (Yoshida, Maruyama et 
al. 1999; Liesenfeld, Dunay et al. 2004), have all been reported. A recent meta-
analysis performed on helminth-microparasite co-infections in laboratory mice 
confirms these varying effects of helminth infection on microparasite growth 
(Graham 2008). More importantly, this study highlights the need to consider both 
top-down and bottom-up mechanisms of microparasite control when trying to predict 
the effect of co-infection (Graham 2008), as the relative influence of helminth 
infection on immune- or resource-mediated mechanisms will depend on the ecology 
of the microparasite it is paired with. The immuno-modulatory effects of helminths 
may be more detrimental to the host in the absence of resource-competition as 
microparasite growth is comparatively unchecked (Graham 2008). 
 
Helminths can influence microparasite growth via bottom-up mechanisms if they 
compete for a shared resource. For example the asexual form of Plasmodium species 
is reliant on red blood cells for its replication, and various helminth species can 
affect the availability of red blood cells by causing anaemia through adults feeding or 
larvae migrating (Gilman 1982; Attout, Babayan et al. 2005; Marsland, Kurrer et al. 
2008). This helminth-induced anaemia is significant (Robertson, Crompton et al. 
1992) and has been linked to the severity of malarial disease in human populations 
although conflicting results are reported; the combined effect of hook-worm and P. 
falciparum on haemoglobin loss exacerbates severe malarial anaemia (Brooker, 
 71 
Akhwale et al. 2007), whilst co-infection with soil-transmitted helminths (including 
hookworm) protects against haemoglobin reduction during P. vivax malaria attacks 
(Melo, Reyes-Lecca et al. 2010). 
 
Immunological studies in laboratory mice rarely consider the resource-mediated 
effects of co-infection on disease outcome, and the difficulty of disentangling the 
influence of top-down and bottom-up mechanisms in natural populations means there 
is a paucity of information in this research area. Recent work has called for co-
infection studies that consider within-host interactions in a community ecology 
framework (Pedersen and Fenton 2007; Graham 2008) and bring together insights 
from immunology and ecology. This study takes inspiration from that and, using the 
P. chabaudi- N. brasiliensis (Pcc-Nb) model of co-infection, attempts to untangle the 
influence of helminth-induced anaemia (bottom-up) and down-regulation of the Pcc-
specific immune response (top-down) on Pcc disease outcome. In other words, can 
the apparent protection against Pcc that Nb infection afforded (Chapter 3) be 
explained by RBC limitation, changes in the immune response – such as reduced Th1 
responses or the induction of cross-reactive antibodies – or both? 
 
4.2 Experimental Design 
 
In order to investigate whether resource- or immune-mediated effects of Nb co-
infection are more influential in determining Pcc disease outcome, I manipulated the 
timing of Nb-infection so that Nb-induced anaemia was resolved before the 
introduction of Pcc (See Figure 1). On day 0 mice were infected with Nb (200 L3 
s.cut) or a sham PBS injection, in the following week RBC density and bodyweight 
were measured. Once the Nb-induced anaemia had resolved, the mice were left for 1 
month before being infected with Pcc (1x105 parasitised RBC i.p) or a sham 
injection of naïve RBC (1x105). Throughout Pcc infection RBC density, asexual 
malaria parasite density and bodyweight were measured on a daily basis. The 
experimental design also involved taking a 50µl blood sample for analysis of 
antibody responses prior to any infection (day -7) and 1 week prior to Pcc infection 
(day 28). Serum was also harvested on termination of the experiment, 55 days post-
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Nb infection corresponding to 20 days post-Pcc infection. Mice that experienced Nb 
infection followed by Pcc infection are designated ‘Nb--Pcc’ n=30, Pcc infection 
only ‘Pcc’ n=30, Nb infection only ‘Nb’ n=16 and mice receiving only sham 





Figure 1: Infection regime detailing days when blood samples for antibody analysis 
were taken. Mice were infected at Day 0 with 200 L3 Nb larvae or received a sham 
PBS injection. The red line represents the typical duration of Nb infection in the host 
throughout which daily RBC density and bodyweight were measured. Mice were 
later (Day 35 p.i) infected with 1x105 Pcc-infected RBC or received a sham injection 
of naive RBC. The blue line represents the duration of Pcc infection (20 days). At 
day -7 all mice were sampled to establish antibody levels pre-infection. Mice that 
received Nb-only are designated “Nb”, mice that received Nb followed 35 days later 
by Pcc are designated “Nb--Pcc”, mice that received Pcc-only are designated “Pcc” 
and those that received both sham injections “control”. Blood samples for antibody 
analysis were taken pre-infection (day -7), 1 week prior to Pcc infection (day 28 p.i) 






4.3 Statistical Analysis 
 
The data reported here were compiled from 2 experiments, and analysed in the 
statistical package JMP 8.0 (SAS) using generalised linear models (GLM). RBC 
density was analysed in two time frames, the first 7 days representing the duration of 
Nb-infection and day 35 to 55p.i to capture the dynamics of Pcc-induced anaemia. 
Minimum RBC density in the first week was analysed with respect to Nb status 
(presence/ absence) fitted as a categorical variable. To account for differences among 
initial RBC density Day 0 values were included as a covariate. There were no 
differences between experiments regarding the effect of Nb status on RBC density. 
Including “experiment” as a factor in all the analyses controlled for any difference in 
the magnitude of RBC density between the experiments. Significant interactions with 
“experiment” were removed if they were purely quantitative and if their removal did 
not alter the significance of the main effects remaining in the model. Finally, 
significant pairwise differences (p<0.05) between groups were determined by 
Student’s t-test for the most complex term in the minimal model. For analysis of 
minimum RBC density during Pcc infection the main effects of the model were 
worm presence or absence (Nb) and malaria presence or absence (Pcc) fitted as 
categorical variables. The main effects and the interaction between them (Nb*Pcc) 
test whether the response variable (minimum RBC density) was affected by Pcc 
infection, Nb infection or both. To account for differences among RBC density prior 
to the introduction of Pcc Day 35 values were included as a covariate. As detailed 
above, possible differences in the magnitude of the response between experiments 
were controlled for, by including ‘experiment’ as a factor. Minimal models were 
reached as described above and significant pairwise differences (p<0.05) among 
groups were determined using the Tukey’s All Pairs adjusted p-values for the most 
complex term in the minimal model. 
 
Asexual parasitaemia was analysed only for animals experiencing Pcc infection (i.e. 
Pcc-Nb, Pcc). The effect of co-infection on Pcc peak parasite density was evaluated 
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by GLM.  Worm presence or absence (Nb) was included as a categorical factor in the 
model. The effect of co-infection on parasitaemia did not differ between 
experiments. Any differences in the magnitude of parasitaemia between the 
experiments were controlled for by including experiment as a factor in the model 
(see above). The interaction term “Nb*experiment” was removed if it was purely 
quantitative and if its removal did not alter the significance of the main effects 
remaining in the model. Finally, significant pairwise differences (p<0.05) between 
groups were determined using the Tukey’s All Pairs adjusted p-values for the most 
complex term in the minimal model. 
 
Antibody responses were measured on days -7, 28, and 55 to analyse responses prior 
to infection, following Nb infection (prior to Pcc) and following both Nb and Pcc 
infection respectively. Antibody titres were log10 transformed to satisfy the model 
assumptions of homogeneity of variance and normal distribution. In the first 28 days 
p.i mice were classified according to worm presence/ absence only (i.e Nb+ or Nb-). 
Antibody titres were calculated with respect to a cut-off value (mean +3 std. dev of 
Nb- mice) termed “zero”. Significant production of antibody was then determined by 
comparison of the mean response of Nb+ mice to “zero” by a t-test. Day 55 
responses were measured following the full course of both Nb and Pcc infection and 
responses were analysed by GLM. The main effects of the model were worm 
presence or absence (Nb) and malaria presence or absence (Pcc) fitted as categorical 
variables. The main effects and the interaction between them (Nb*Pcc) test whether 
the antibody responses are affected by Pcc infection, Nb infection or both. As 
detailed above, possible differences in the magnitude of the response between 
experiments were controlled for, by including ‘experiment’ as a factor. Minimal 
models were reached as described above and significant pairwise differences 
(p<0.05) among groups were determined using the Tukey’s All Pairs adjusted p-










Nb infection induces anaemia in the first week post-infection. 
 
The aim of this experiment was to investigate whether anaemia or reduction of the 
Pcc-specific Th1 response induced by Nb were more influential in determining the 
outcome of Pcc infection. To confirm that Nb-induced anaemia was apparent in this 
experiment I measured RBC density on a daily basis for the first 7 days p.i. As 
observed in previous experiments, Nb infection resulted in a significant reduction 
(~3.5%) in the RBC minima experienced in the first week p.i (see Figure 2 and Table 
1). This observation confirms that the effect of Nb-infection previously observed in 
the head to head co-infection regime is reproduced here. However in this 
experimental set-up Nb-induced anaemia was completely resolved prior to Pcc 
infection (on day 35p.i) so that competition for resources between the two parasites 
should not apply. In other words by manipulating the timing of Nb-infection (and so 
Nb-induced anaemia) we have removed the potential for this bottom-up mechanism 
of regulation to influence the outcome of Pcc infection.   
 
 
TABLE 1: Results of GLM for anaemia data in first week p.i. Non-significant terms 
come from last model before term was dropped and are shown in square brackets. 
F statistics and P values of significant terms (P<0.05 denoted *) come from the 
minimal model. Significant pairwise differences were determined by Studentʼs t-test 




Response Variable Factor df F ratio P value Effect size 
estimates 
(mean ± SE) 
      
RBC minima  
(to d7 p.i) 
Day 0 RBC density F1, 88 20.45 <0.0001* 0.315±0.07 
 [Experiment F1, 87 2.93 0.0903]  
 Nb F1, 88 16.85 <0.0001*  






Figure 2: Effect of Nb infection on RBC density. Minimum RBC density in the first 7 
days of infection (Nb-induced) is shown a) mice infected with Nb (Nb+) are shown in 
black bars and mice receiving sham injections (Nb-) are shown in white bars. Graph 
shows mean and standard error for 46 mice (Nb+) and 45 mice (Nb-). Groups were 
significantly different according to Studentʼs T-test and this P-value is indicated.  
 
 
Potential for Nb-induced cross-reactive antibody responses to influence Pcc 
infection.  
 
The occurrence of cross-reactive antibodies in this Pcc-Nb co-infection model 
(Chapter 2 and (Fairlie-Clarke, Lamb et al. 2010)) raises the intriguing possibility 
that they may be functional and act in concert with Pcc-specific responses to control 
Pcc infection. In the experiments described here, significant levels of cross-reactive 
antibodies to Pcc antigens were also detected. To determine the level of cross-
reactive antibodies that were induced by Nb infection antibody responses to the 
malaria antigens PcL and MSP-119 were measured at day 28 p.i (1 week prior to Pcc 
infection). Nb infected mice (Nb+) produced titres of PcL IgG2a that were 
significantly greater than the levels detected in mice that had not experienced Nb 
infection (Nb-) (t44= 3.93, P=0.0003; see Figure 3a). Similarly, the Nb-induced cross-
reactive IgG2a response to the recombinant malaria antigen MSP-119, although low 
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in magnitude, was significantly greater than that of Nb- mice (t44= 3.31, P=0.0019; 
see Figure 3b).  
 
 
Figure 3: Nb-induced cross-reactive responses to malaria antigens. 
Th1 (IgG2a) antibody responses to malaria antigens Pc Lysate (PcL) a) and  
MSP-119 b) on day 28 p.i are shown. Nb infected mice (Nb+) are represented by 
black bars. Graph shows mean and standard error for 46 mice. The response 
observed in mice receiving sham Nb injection is shown as zero on the y-axis. 
 
 
Effect of manipulating timing of Nb-induced anaemia on Pcc-infection. 
 
Infecting hosts with Nb one month prior to introduction of Pcc allows the influence 
of bottom-up (resource) and top-down (immune)-mediated mechanisms of regulation 
to be disentangled as Nb-induced anaemia is resolved prior to Pcc infection. The 
influence of prior Nb infection on Pcc infection was assessed by measuring asexual 
parasitaemia by microscopic examination of blood smears on a daily basis 
throughout Pcc infection, accompanied by daily measurements of host RBC density. 
There was no significant difference in the peak of asexual parasite density between 
singly or ‘co-infected’ mice (Figure 4a and Table 2). In accordance with this there 
was no significant difference in the loss of RBC density at the trough of Pcc 
associated anaemia between singly or ‘co-infected’ mice (Figure 4b, 4c and Table 2). 
In other words the ‘protective’ effect of co-infection observed during simultaneous 
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Pcc-Nb co-infection (Chapter 3 and (Hoeve, Mylonas et al. 2009)) was not apparent 
when Nb-induced anaemia was resolved prior to Pcc infection.  
 
TABLE 2: Results of GLM for malaria associated anaemia and parasitology data. 
Non-significant terms come from last model before term was dropped and are 
shown in square brackets. F statistics and P values of significant terms (P<0.05) 
come from the minimal model. Significant pairwise differences were determined 
from the Tukeyʼs adjusted P-values of the most complex significant term in the 
model and are shown in Figure 4. 
 
 
Response Variable Factor df F ratio P value Effect size 
estimates 
(mean ± SE) 
      
RBC minima  
(to d55 p.i) 
Day 35 RBC 
density 
F1, 86 12.20 0.0008* 0.195±0.06 
 [Experiment F1, 85 0.00 0.9412]  
 Pcc F1, 86 4336.2 <0.0001*  
 Nb F1, 86 3.72 0.0570  
 Nb*Pcc F1, 86 4.47 0.0374*  
      
Peak parasite 
density 
Experiment F1, 57 53.26 <0.0001* 0.133±0.02 
 Nb F1, 57 0.12 0.7301  
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Figure 4: Daily parasitised RBC density throughout Pcc infection is shown a) Pcc mice are 
shown in blue and “co-infected” mice that previously experienced Nb infection (Nb--Pcc) are 
shown in purple. Daily RBC density throughout infection b) prior to Pcc infection (day 0-7 Nb 
infection) mice are designated Nb+ (n=46) shown in red or Nb- (n=45) shown in black. From 
day 35 p.i (Day 0 Pcc infection) Nb+ mice are subdivided into those with Pcc infection (Nb--
Pcc; n=30) shown in purple and those that received naïve RBC (Nb; n=16) shown in red. 
Pcc-only mice (n=30) are shown in blue and controls (n=16) in grey. Minimum RBC density 
c). Nb-only mice are shown in black bars, Pcc-only mice in grey bars, Nb--Pcc mice in 
chequered bars and control mice in grey bars. Significant pairwise differences according to 
Tukeyʼs post-hoc test are indicated by letters. Groups that do not share the same letters are 
significantly different and the Tukeyʼs adjusted P-values are indicated. Graphs show mean 
and standard errors. 
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Altering the timing of Nb infection did not affect the immune response in ‘co-
infected’ mice. 
 
To ensure that immune responses of co-infected mice under this infection regime 
were consistent with those of the simultaneous co-infection used in prior 
experiments, the antibody responses in the mice were analysed at the end of infection 
(day 55 i.e. 20 days post-Pcc infection, Figure 1). In particular, it was important to 
establish that in accordance with previous observations (Chapter 2 and (Hoeve, 
Mylonas et al. 2009; Fairlie-Clarke, Lamb et al. 2010)) Nb given a month prior to 
Pcc was capable of exerting a down-regulatory effect on the Pcc-specific Th1 
response. The Pcc-specific IgG2a response in ‘co-infected’ mice (Nb--Pcc) to the 
crude malaria antigen (PcL) was significantly reduced in comparison to Pcc-only 
mice (see Figure 5a and Table 3), confirming that Nb infection reduced the Th1 
response. A similar though non-significant trend (P=0.1) was also observed for the 
anti-MSP-119 IgG2a response in co-infected versus Pcc-only mice (see Figure 5b).  
 
TABLE 3: Results of GLM for antigen-specific antibody responses at day 55 p.i. 
Non-significant terms come from last model before term was dropped and are 
shown in square brackets. F statistics and P values of significant terms (P<0.05 
denoted *) come from the minimal model. Significant pairwise differences were 
determined from the Tukeyʼs adjusted P-values of the most complex significant term 
in the model and are shown in Figure 5. 
 
 
Response Variable Factor df F ratio P value Effect size  
estimates 
(mean ± SE) 
DAY 55:      
anti PcL IgG2a  Experiment F1, 72 48.75 <0.0001*  
 Infection F2, 72 14.94 <0.0001*  
      
anti MSP-119 IgG2a  Experiment F1, 72 79.25 <0.0001* 0.55±0.06 
 Infection F2, 72 96.82 <0.0001*  





































Figure 5: Antibody responses to malaria antigens at day 55 p.i.  
IgG2a responses to crude malaria antigen PcL a) and recombinant malaria antigen 
MSP-119 b) are shown. Mice infected with Nb (Nb) are shown in black bars, Pcc 
infected mice (Pcc) are shown in white bars and co-infected mice (Nb--Pcc) are 
shown in chequered bars. Graph shows mean and standard error for 30 mice per 
group Pcc and Nb--Pcc and 16 mice for the Nb group. Significant pairwise 
differences according to Tukeyʼs post-hoc test are indicated by letters. Groups that 
do not share the same letters are significantly different and the Tukeyʼs adjusted P-





The intermediate Th1/Th2 immune-bias seen previously in co-infected mice 
(Chapter 2 and (Fairlie-Clarke, Lamb et al. 2010)) is also replicated here; a reduced 
total IgE (Th2) response was detected in Nb--Pcc mice at d55 post-Nb infection (see 
Figure 6a and Table 4). A timecourse of the total IgE response was determined by 
measuring the antibody in serum taken at various timepoints throughout infection. 
Day -7 shows pre-infection responses did not differ amongst the mice (see Figure 6b 
and Table 4). As expected, Nb infection (Nb+) results in a significant increase in IgE 
prior to Pcc infection (Day 28 Figure 6b and Table 4) that decreased slightly over 
time (day 55 Figure 6b and Table 4). The cohort of ‘Nb+’ mice that also experienced 
Pcc infection (Nb--Pcc) showed a further reduction in the IgE (Th2) response at day 
55 (Figure 6a, 6b and Table 4).  
 
TABLE 4: Results of GLM for total IgE responses taken at day -7, day 28 p.i and 
day 55 p.i. Non-significant terms come from last model before term was dropped 
and are shown in square brackets. F statistics and P values of significant terms 
(P<0.05 denoted *) come from the minimal model. Significant pairwise differences 
were determined from the Tukeyʼs adjusted P-values of the most complex significant 





Factor df F ratio P value Effect size  
estimates 
 (mean ± SE) 
      
IgE day -7  Experiment F1, 87 341.19 <0.0001* -0.211±0.01 
 Nb F1, 87 1.83 0.1792  
      
IgE day 28 Experiment F1, 86 117.01 <0.0001* -0.196±0.02 
 Nb F1, 86 282.69 <0.0001*  
      
IgE day 55 Experiment F1, 85 188.73 <0.0001* -0.202±13.74 
 Pcc F1, 85 6.46 0.0129*  
 Nb F1, 85 184.57 <0.0001*  
 Nb*Pcc F1, 85 2.15 0.1464  
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Figure 6: Total IgE responses throughout infection.  
Total IgE responses (μg/ml) at the end of infection (day 55) are shown a) Nb-only mice are 
represented by black bars, Pcc-only mice by white bars, “co-infected” mice (Nb--Pcc) by 
chequered bars and control mice by grey bars. Graph shows mean and standard error for 30 
mice per group Pcc and Nb—Pcc, 16 mice for the Nb group and 15 mice for the control 
group. Significant pairwise differences according to Tukeyʼs post-hoc test are indicated by 
letters. IgE responses on day -7, day 35 p.i and day 55 p.i are plotted together to show the 
change in IgE concentration over time b) prior to Pcc infection at day -7 and day 28p.i Nb+ 
mice are shown in black bars. Nb- mice destined to receive Pcc at day 35 p.i  are shown in 
white bars. Significant pairwise differences (within day)were analysed by Tukeyʼs post-hoc 
test, Groups that do not share the same letters are significantly different and the Tukeyʼs 
adjusted P-values are indicated. 
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Nb-induced antibody responses are not increased by exposure to Pcc. 
 
The infection regime used in these experiments is analogous to a vaccination 
protocol; mice were ‘immunised’ with Nb and then subsequently ‘challenged’ with 
Pcc. This provides an opportunity to test whether responses to Nb antigen are 
‘boosted’ by exposure to Pcc, which I would predict if Pcc displayed antigens that 
are shared with Nb. Nb-specific IgG responses measured at day 55 were not 
significantly higher in mice that were infected with Nb and subsequently challenged 
with Pcc (Nb--Pcc). In fact, responses in Nb--Pcc mice were significantly reduced in 
comparison to Nb mice and no different to the cross-reactive response observed in 
Pcc-only mice (see Figure 7a and Table 5). Th1 responses are more typically induced 
by Pcc infection so I investigated whether the IgG2a response to NbA was ‘boosted’ 
in Nb--Pcc mice at day 55 p.i. Although anti-NbA IgG2a responses in Nb--Pcc were 
increased in comparison to Nb mice they were not significantly different to the cross-
reactive response induced by Pcc infection alone (See Figure 7b and Table 5).   
 
 
TABLE 5: Results of GLM for antigen-specific antibody responses at day 55 p.i. 
Non-significant terms come from last model before term was dropped and are 
shown in square brackets. F statistics and P values of significant terms (P<0.05 
denoted *) come from the minimal model. Significant pairwise differences were 
determined from the Tukeyʼs adjusted P-values of the most complex significant term 
in the model and are shown in Figure 7. 
 
 
Response Variable Factor df F ratio P value Effect size  
estimates 
(mean ± SE) 
      
DAY 55:      
anti-NbA IgG2a  Experiment F1, 72 64.09 <0.0001* 0.54±0.07 
 Infection F2, 72 78.28 <0.0001*  
      
anti-NbA IgG  Experiment F1, 72 42.56 <0.0001* 0.58±0.09 
 Infection F2, 72 8.73 0.0004*  
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Figure 7: Antibody responses to N. brasiliensis antigen at day 55 post-infection.  
Total IgG responses to Nb antigen (NbA) a) and Th1 antibody responses (IgG2a) to 
NbA b) were measured at day 55 p.i. Nb-only mice are represented by black bars, 
Pcc-only mice by white bars and “co-infected” mice (Nb--Pcc) by chequered bars. 
Graph shows mean and standard error for 30 mice per group Pcc and Nb—Pcc and 
16 mice for the Nb group. Significant pairwise differences according to Tukeyʼs post-
hoc test are indicated by letters. Groups that do not share the same letters are 







Considering the host as an ecosystem, and the host-parasite interactions that govern 
within-host infection dynamics in a community-ecology framework, is useful for 
understanding the complexity of these interactions in the context of co-infection 
(Pedersen and Fenton 2007). Community ecologists take into account the potential 
for both top-down (predator) and bottom-up (resource) interactions to regulate the 
numbers or diversity of species (Burkepile and Hay 2006; Elmhagen and Rushton 
2007). For an infection, top-down regulation refers to the influence of parasite-
killing mechanisms and bottom-up to resource availability. It is important to note 
that immune-mediated mechanisms of parasite control can act via top-down 
mechanisms (i.e. direct, immune-mediated killing) or via bottom-up mechanisms (i.e. 
a starvation strategy to kill parasites). For example, direct killing of malaria parasites 
can be antibody mediated (Cavinato, Bastos et al. 2001), whereas ‘bystander killing’ 
of uninfected RBC by macrophages (Tippett, Fernandes et al. 2007) or retention of 
RBCs in the spleen (Buffet, Safeukui et al. 2009) are immune-mediated bottom-up 
control mechanisms that reduce availability of RBC for parasite invasion. In co-
infections, one parasite species may influence another through bottom-up 
mechanisms by directly competing for resources (Lwin, Last et al. 1982), or via top-
down mechanisms by influencing the host immune response (Supali, Verweij et al. 
2010). In helminth-malaria co-infection, host red blood cells (RBCs) are the most 
significant shared resource: malaria parasites require RBCs for asexual parasite 
replication (Paul and Brey 2003) and parasitic helminths consume RBC when 
feeding as adults or indirectly deplete RBCs by causing haemorrhaging and tissue 
damage as larval stages migrate (Gilman 1982; Attout, Babayan et al. 2005; 
Marsland, Kurrer et al. 2008). Helminths also have the potential to moderate the 
immune response to malaria as the Th2 response induced by helminths has a counter-
regulatory affect on the protective Th1 response to malaria (Mosmann and Sad 1996; 
Su, Segura et al. 2005).  
 
These mechanisms are by no means mutually exclusive and may have differential 
effects depending on the context of co-infection (Graham 2008). In previous 
experiments (see Chapter 3) simultaneous infection of Nb and Pcc revealed a 
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‘protective’ effect of co-infection in terms of reduced peak Pcc parasite density and 
associated anaemia. The potential for both bottom-up and top-down mechanisms to 
have a role in this outcome is evident in the Nb-induced depletion of RBC density in 
the early stages of infection (Chapter 3 and (Hoeve, Mylonas et al. 2009)) and the 
reduction of Pcc-specific Th1 antibody responses (Chapter 2 and (Fairlie-Clarke, 
Lamb et al. 2010)).  Here, my aim was to investigate whether top-down or bottom-up 
mechanisms of regulation were more important for determining malaria (Pcc) 
disease outcome in the context of Nb co-infection. A distinct advantage of using an 
experimental murine model of co-infection to address this question is the ability to 
manipulate the timing of Nb infection (and so Nb-induced anaemia) to untangle the 
relative effects of resource- and immune-mediated control of Pcc parasite numbers. 
When Nb-induced anaemia was resolved well before the introduction of Pcc there 
was no reduction in asexual parasite density or Pcc associated anaemia, suggesting 
that in this co-infection model resource availability (rather than an immune-mediated 
mechanism) is more influential in the control of Pcc parasite replication. However, it 
is impossible with this experimental design to rule out the possibility that Nb-induced 
changes in the immune response (e.g. production of cytokines, activation of 
macrophages) did not affect Pcc parasite density in simultanaeous infection.  As by 
altering the timing of Nb-induced anaemia (relative to Pcc infection) I have also 
altered the timing of these immune mechanisms. Interestingly, the reduced Pcc-
specific Th1 response in Nb--Pcc mice (as indicated by antibody isotype bias) was 
able to control parasite numbers as efficiently as the ‘full-blown’ response in Pcc-
only mice. 
  
The anaemia detected in the early stages of Nb infection is likely to have resulted 
from tissue damage as the larvae migrate from the circulation into the airways of the 
lung (Marsland, Kurrer et al. 2008; Hoeve, Mylonas et al. 2009). When this depletion 
of RBCs occurs just prior to the detection of asexual parasites in the blood, as is the 
case in simultaneous Pcc-Nb infection, it is possible that reduced availability of 
RBCs slows the propagation of asexual malaria parasites. Indirect support for this 
hypothesis exists as blood transfusion to alleviate anaemia and supplement RBC 
availability led to a prolonged period of patency in Pcc infected mice (Yap and 
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Stevenson 1994). It is also apparent from experiments involving immunodeficient 
mice that RBC availability alone can influence parasitaemia; in T-cell deficient mice, 
control of the initial peak of parasitaemia was attributed to an influx of reticulocytes, 
which are not the preferred host cell for Pcc (Podoba and Stevenson 1991). It should 
be noted that the reduction in RBC density is small (approx 3.5%) and transient, so 
that the simple explanation of reduced RBC availability may not be satisfactory to 
explain the subsequent effect on peak Pcc parasite density. Indeed it is not obvious 
from the dynamics of Pcc parasite density that establishment of asexual parasites in 
co-infection is negatively affected by Nb-induced changes early in infection (see 
Chapter 2 Figure 1a). It may be that more subtle effects on the age structure of RBCs 
are important. Following reduction in RBC density erythropoiesis is induced to 
redress the balance and results in an influx of reticulocytes (immature red blood 
cells)(Savill, Chadwick et al. 2009). P. chabaudi shows a preference for the invasion 
of normocytes (mature red blood cells) early in infection (Ott 1968), so if Nb-
induced anaemia increases the proportion of reticulocytes this may reduce parasite 
numbers. However, the preference of P. chabaudi for normocytes is just that- a 
preference - and not an absolute requirement as P. chabaudi can also successfully 
invade reticulocytes (Jarra and Brown 1989) and some research suggests they may 
even replicate more effectively within them (Mideo, Barclay et al. 2008). A full 
understanding of the changes in RBC age structure brought about by Nb infection 
and the potential for this to affect Pcc parasite replication will require integration of 
data – of the sort I have collected – with sophisticated mathematical modelling (e.g 
(Mideo, Barclay et al. 2008; Savill, Chadwick et al. 2009; Miller, Raberg et al. 
2010)). Some (qualitative) insight to the proposed Nb-induced change in RBC 
population age-structure may be gained by counting infected/ uninfected 
reticulocytes in Pcc versus Pcc-Nb mice in the model of simultaneous co-infection or 
transfusing mice with reticulocytes (to mimic the proposed change in RBC age-
structure) and assessing changes in Pcc parasitaemia. To definitively address the role 
of resource limitation in this model it would be crucial to directly manipulate this 
parameter. For example an experimental group in which erythropoietin was used to 
increase RBC availability could be included. 
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The results presented here are contrary to the findings in some other malaria-
helminth co-infection systems where reduction of the Th1 immune response results 
in exacerbation of malaria parasitaemia (Helmby, Kullberg et al. 1998; Su, Segura et 
al. 2005; Tetsutani, Ishiwata et al. 2009). Nb infection is short-lived (i.e., acute), with 
worms being expelled from the host (BALB/c) within a week p.i, which contrasts 
with the chronic helminth infections used in the other studies. Remarkably, the Nb-
induced reduction in IgG2a Pcc-specific responses is still evident 7 weeks after the 
parasite has been cleared (day 55 p.i). It is possible that chronic helminth infections 
exert a greater down-regulatory effect on Th1 responses than acute Nb infection, 
which results in exacerbation of Pcc parasitaemia. There are many other potential 
explanations for the contrasting affects of co-infection on malaria disease outcome, 
such as: host heterogeneity, environment, species of co-infecting parasite, level of 
exposure, and timing of infection (Hartgers and Yazdanbakhsh 2006; Supali, Verweij 
et al. 2010). Given that the reduced Th1 response to Pcc seen here and in 
simultaneous infection with Nb and Pcc (Chapter 2) did not adversely affect the 
control of Pcc parasitaemia, it is interesting to speculate that the ancient relationship 
between helminths and the vertebrate immune system has led to the evolution of an 
immune system which functions optimally in the context of helminth infection 
(Jackson, Friberg et al. 2009). Under this hypothesis, the reduction of the Th1 
response to Pcc in co-infected mice actually reflects the status quo for a host whose 
ancestors are unlikely to have evolved without worms and thus would not be 
considered impaired in this more natural setting (co-infection). 
 
Although the main focus of manipulating the timing of Nb-infection was to elucidate 
the relative influence of bottom-up/ top-down mechanisms of regulation on Pcc 
infection, this experimental design also allowed further investigation of the 
significance and development of cross-reactive antibody responses. As seen 
previously (Chapter 2), Nb-induced infection resulted in production of cross-reactive 
antibodies to Pcc antigens. However the fact that there was no ‘protective’ effect of 
co-infection in this model suggests that Nb-induced cross-reactive antibodies do not 
have a functional role in Pcc parasite clearance in-vivo.  
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The infection regime used in this study is analogous to a vaccination protocol: mice 
were ‘immunised’ with Nb and then subsequently ‘challenged’ with Pcc. If as is 
suggested by Nb-induced cross-reactivity (Fairlie-Clarke, Lamb et al. 2010) these 
parasites share epitopes, then the antigen-specific response induced by Nb should be 
‘boosted’ on exposure to Pcc antigens, as they should stimulate the B-cells that were 
induced during Nb-infection. However no such ‘boosting’ of the anti-NbA response 
was observed in Nb--Pcc mice. Responses were not significantly different to the 
cross-reactive response induced by Pcc alone. The fact that Pcc-only mice recognise 
(bind to) NbA in-vitro (Figure 7) supports the notion that these parasites have shared 
epitopes. Why then was ‘boosting’ of the NbA response not evident in Nb--Pcc mice 
(Figure 7)? There is clear evidence that the passage of Nb larvae through the lung 
causes persistent immunological and physiological changes to the pulmonary 
environment (Marsland, Kurrer et al. 2008; Reece, Siracusa et al. 2008) and it has 
been suggested that an antigen-depot may be responsible for sustaining the 
inflammatory infiltrate associated with these changes (Marsland, Kurrer et al. 2008). 
If antigen does persist long-term in the lungs of Nb-infected mice, perhaps due to 
dead or dying larvae, then there is potential for B-cells to be continually stimulated 
by worm antigen. This on-going active response to Nb antigen may reduce the 
possibility of these B-cells being stimulated by Pcc antigens so that the proposed 
‘boosting’ effect of Pcc infection would not be observed.  It is also likely that only a 
small proportion of Nb and Pcc antigens cross-react so that it may be difficult to 
detect a ‘boost’ by measurement of antibody titre to a crude homogenate of Nb 
(NbA). 
 
In summary, manipulating the timing of Nb infection – and so Nb-induced anaemia- 
with respect to Pcc infection resulted in the loss of the ‘protective’ effect on peak 
parasitaemia and severity of anaemia that was observed when these infections were 
administered simultaneously. This regime did not alter the reduction in Pcc-specific 
Th1 antibody responses and so strongly suggests that bottom-up mechanisms (i.e., 
resource-mediated) of Pcc parasite control are more influential than top-down 
mechanisms (i.e., immune-mediated parasite killing) in this model of malaria-
hookworm co-infection. However, it should be noted that some Nb-induced immune 
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responses are now also removed in time from Pcc infection and further investigation 
of the influence of these mechanisms would be required to establish the relative 
contribution of these top-down mechanisms in disease outcome. This approach to 
understanding within-host dynamics of co-infection is not new (Pedersen and Fenton 
2007; Graham 2008), but this study is one of the few that addresses the role of top-
down/ bottom-up mechanisms by explicitly measuring them. This study 
demonstrates the importance of bringing together immunology and ecology in future 
research aimed at understanding how co-infection affects disease ecology and 
epidemiology. Important interactions between immunological and ecological factors 
make it hard to understand mechanisms driving infection dynamics while ignoring 
one of these elements. Finally, this study also serves to highlight the importance of 
the timing of co-infection on disease outcome and attempts to identify the 
mechanisms that underpin these effects.  
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In theory a diverse repertoire of T and B cell receptors enables the adaptive immune 
system to recognise (bind to) every potential parasite antigen (Pancer and Cooper 
2006). Unlike T-cell receptors, which recognise peptide antigens, B-cell receptors 
and so antibodies recognise conformational epitopes. Having bound to their cognate 
antigen, B-cells proliferate and undergo rounds of somatic hypermutation, which 
result in changes to the antigen-binding site of the receptor (and thus the secreted 
antibody). These altered receptors are then retested for their ability to bind antigen 
and those with the greatest avidity (strength of binding to antigen) are selected, 
culminating in the production of highly specific antibodies (Tarlinton and Smith 
2000). However, this exquisite specificity is not observed in reality, as cross-
reactivity (binding to more than one antigen) is common (Naus, Jones et al. 2003; 
Endy, Nisalak et al. 2004; Losada, Chacon et al. 2005; Casadevall and Pirofski 2007; 
Nguyen, Zemlin et al. 2007; Nagao, Kimura-Sato et al. 2008). 
 
Cross-reactive antibodies as effector molecules of the adaptive immune response 
have the potential to influence disease outcome or susceptibility to re-infection. This 
has been particularly well studied for viral infections. Indeed, the generation of 
cross-reactive responses that recognise antigenic variants of hemagglutinin or 
neuraminidase is key to the success of influenza vaccination programs (Sandbulte, 
Jimenez et al. 2007; Levie, Leroux-Roels et al. 2008). The importance of 
understanding the influence of cross-reactive antibody responses is particularly acute 
in the case of dengue virus; cross-reactive antibodies induced by infection with one 
of the four serotypes can be protective against secondary infection (Endy, Nisalak et 
al. 2004) but can also facilitate invasion of cells resulting in exacerbation of disease 
to dengue haemorrhagic fever (Balsitis, Williams et al. 2010). The outcome seems to 
depend on the order in which the host is exposed to the different dengue serotypes 
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(Rothman 2004).  
 
Cross-reactivity also occurs between pathogen species and is particularly evident 
amongst parasitic helminths; for example antibodies induced by the human filarial 
parasite Wuchereria bancrofti recognise surface antigens of adult Brugia pahangi 
worms (Maizels, Sutanto et al. 1985) and sera from individuals living in an area 
endemic for Necator americanus cross-reacts with antigens from Oesophagostomum 
bifurcum which is non-endemic (Pit, Polderman et al. 2001). Such cross-reactivity 
between helminth species can be beneficial as demonstrated by Fasciola hepatica 
infection protecting mice against subsequent infection with Schistosoma mansoni, in 
this case a common antigen “FhSmIII” seems to be responsible for the induction of 
cross-immunity (Hillyer 1985). Similarly S. mansoni infection has been shown to 
reduce the number of Strongyloides venezuelensis larvae that survive migration to 
the gut and this is most likely due to cross-reactive antibody-dependent cell-mediated 
cytotoxicity (Yoshida, Maruyama et al. 1999). The occurrence of cross-reactive 
antibodies that recognise different strains of the same parasite species, or indeed 
different species of the same phylum, are intuitive to understand in systems where 
similar effector mechanisms are required to control or eliminate parasites.  
 
Perhaps more remarkable is the cross-reactivity that arises between taxonomically 
distinct parasites such as protozoa and helminths. Immunisation of mice with 
Trichinella spiralis antigens resulted in the production of antibodies that recognise 
Leishmania infantum (Dea-Ayuela, Rama-Iniguez et al. 2007). Antibody cross-
reactivity to Leishmania major was also demonstrated in mice infected with the 
filarial parasite Litomosoides sigmodontis (Lamb, Graham et al. 2005). Similarly 
cross-reactivity between Litomosoides sigmodontis and Plasmodium chabaudi has 
been reported (Fairlie-Clarke, Lamb et al. 2010). Of particular interest to the study of 
malaria-helminth co-infection is the cross-reactivity that has been reported between 
Schistosoma mansoni and Plasmodium falciparum in human populations (Naus, 
Jones et al. 2003). Further research in this area led to the identification of a novel 
Schistosome antigen (SmLRR) that has 57% similarity to a putative gene product in 
P. falciparum and was recognised by sera from individuals who had only 
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experienced P. falciparum infection (Pierrot, Wilson et al. 2006). In areas co-
endemic for these two parasites cross-reactive antibodies may influence disease 
severity, as exposure to malaria and subsequent induction of the cross-reactive IgG3 
response seems to increase the risk of developing hepatosplenomegaly in 
schistosome infected individuals (Mwatha, Jones et al. 2003). 
 
The question as to why antibodies induced by malaria and helminths cross-react can 
be answered from a biochemical, physiological or evolutionary perspective. For 
example, the biochemical composition of the cross-reacting antigens can be 
important in determining the level of cross-reactive antibody binding that occurs. 
Broadly speaking antigens are made up of protein and carbohydrate moieties and 
often cross-reactive antibodies target carbohydrates (van Remoortere, Bank et al. 
2003; Paschinger, Fabini et al. 2005). Whether cross-reactive antibodies target the 
protein or carbohydrate moiety of an antigen can be determined experimentally by 
periodate treating antigens to disrupt the carbohydrate epitopes and then assessing 
whether antibody binding is conserved (Xu and Powell 1991; Dell, Haslam et al. 
1999). In this context IgG3 is often analysed, as in mice this isotype has been shown 
to be involved in carbohydrate-recognition (Snapper, McIntyre et al. 1992; Dea-
Ayuela, Martinez-Fernandez et al. 2000). For malaria and nematodes, there is 
potential for carbohydrate induced cross-reactive antibodies to arise because the 
outer layer (cuticle) of nematodes, which forms the interface between host and 
pathogen, is heavily glycosylated as are many of the excretory/ secretory antigens 
(Dell, Haslam et al. 1999). Similarly, protozoan parasites express carbohydrates on 
the cell surface and on secreted molecules (Mendonca-Previato, Todeschini et al. 
2005) although this is restricted to expression of glycosylphosphatidyinositol (GPI) 
anchors in Plasmodium species (von Itzstein, Plebanski et al. 2008). This is 
discussed further in the following section. The carbohydrate moieties of antigens 
may be more likely to be the target of cross-reactive antibodies if they are conserved 
amongst parasites but there is also evidence that cross-reactive antibodies can target 
protein antigens (Pierrot, Wilson et al. 2006). In this chapter I use periodate 
treatment to explore whether the cross-reactivity I observed in the N. brasiliensis- P. 
chabaudi model (see Chapter 2 and (Fairlie-Clarke, Lamb et al. 2010)) is directed 
 95 
toward carbohydrate or protein antigens. Determining whether proteins or 
carbohydrates drive certain isotype responses may also be important in vaccine 
design and diagnostic serology.  
 
Antibody cross-reactivity could also be accounted for if there is a physiological 
constraint or limit to the specificity of antigen-antibody binding. For example, in a 
host with a reduced number of lymphocytes the full repertoire of receptor diversity 
may not be expressed as discussed for T-cell receptors (Regner 2001). In this case 
cross-reactive responses may compensate for reduced lymphocyte numbers by 
providing recognition of several antigens – a “two for the price of one” offer on 
antigen-recognition, if you will!  Similarly if there were a limit to the number of 
rounds of somatic hypermutation that a B-cell undergoes (perhaps under nutritional 
restriction; e.g. (Martin, Navara et al. 2008)), then perfect antigen-specificity may 
not be achieved.  Indeed, the relative abundance of lymphocytes versus antigen may 
shape the specificity that develops.  The potential for increasing availability of 
antigen to affect the specificity of antibody is explored in the next chapter.  
 
Given that mounting an immune response is energetically costly (Demas, Chefer et 
al. 1997; Derting and Compton 2003; Martin, Scheuerlein et al. 2003) and that a host 
will have limited resources to invest, due to the energy demands of growth and 
reproduction, it is possible that the production of cross-reactive antibodies is an 
evolutionary adaptation to offset some of the immune costs involved in combating 
multiple pathogens. Testing the concepts that cross-reactive responses may arise 
through physiological constraints or evolutionary adaptation is complicated. The data 
presented here focuses on ruling out one potential biochemical reason for the cross-
reactivity observed in the Pcc-Nb model, namely that these antibodies target 
conserved carbohydrates on the parasite antigens.  
 
5.2 Experimental Design 
 
The data presented here and in chapter 2 was generated from the same experiment 
(i.e., “Experiment 1”). Female BALB/c mice were infected with Pcc at a dose of 
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1x105 parasitised RBC (i.p) with or without co-infection of 200 Nb L3 larvae (s.cut) 
on day 0. A group of mice infected with Nb only (200 L3 larvae s.cut) were also 
included in addition to a control group, which received nRBC (1x105) and PBS as 
sham injections for Pcc and Nb respectively. Bodyweight, RBC density and asexual 
parasite density were measured daily throughout the course of infection (data 
reported in Chapter 3). Serum was collected on day 20 p.i and ELISA was used to 
measure antibody binding to Nb crude antigen (NbA), crude malaria antigen (pRBC) 
and recombinant malaria antigen MSP-119 (data also reported in Chapter 2). For 
details of how antigens were generated and antibody titres were calculated see 
Materials and Methods chapter. In parallel to this standard ELISA, antibody binding 
to periodate treated antigens was also analysed (see Materials and Methods chapter). 
Periodate oxidises carbohydrate to aldehydes and so disrupts any carbohydrate 
epitopes on the antigen. By comparing antibody titres measured in ELISA to 
periodate treated and untreated antigens I was able to determine whether antibodies 
targeted the protein or carbohydrate moiety of the antigen.  
 
5.3 Statistical Analysis 
 
The analyses of antibody titres at day 20 p.i included 24 mice (n=8 per infection 
group). All analyses were carried out in the statistical package JMP 8.0 (SAS) using 
generalised linear models (GLM). The generation of antibody titre creates ordinal 
data that were log10 transformed to satisfy the model assumptions of homogeneity-
of-variance and normal distribution. Infection status (Nb, Pcc or Pcc-Nb) and 
treatment (periodate or control) were included as fixed categorical factors and their 
ability to predict antibody titre was formally evaluated. Mouse identity was fitted as 
a random effect to account for non-independence of titres (with and without 
periodate treatment) measured for a given mouse. The maximal model was fitted first 
and minimal models were reached by sequentially removing non-significant terms 
(P-value > 0.05), beginning with interactions.  Finally, whenever a factor was 
significant (P < 0.05), an All Pairs Tukey post-hoc test was carried out to identify 
which groups of mice differed significantly in antibody titre, with respect to infection 
status and/or periodate treatment. 
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5.4 Results          
          
IgG3 antibody responses indicate binding to the carbohydrate moiety of Pcc and Nb 
antigens. 
 
In mice, the antibody isotype IgG3 is associated with binding to carbohydrates 
(Snapper, McIntyre et al. 1992; Dea-Ayuela, Martinez-Fernandez et al. 2000) and 
was detected in sera of infected mice against the malaria antigens MSP-119 and 
pRBC (Figure 1a, 1b and Table 1). Responses in mice that had experienced Pcc 
infection (i.e. Pcc and Pcc-Nb) mounted significantly greater responses than Nb mice 
(Figure 1a, 1b and Table 1). IgG3 responses were also detected against Nb antigen 
(NbA), interestingly the IgG3 response to this antigen was greater in co-infected 
(Pcc-Nb) than Nb mice (Figure 1c and Table 1). However, there was no significant 
difference between Nb and Pcc singly infected mice, which suggests that in co-
infection Pcc effected the induction of the IgG3 isotype. This is consistent with the 
effect that malaria induced IFN! may have on the production of IgG3 (Snapper, 
McIntyre et al. 1992). Disruption of carbohydrates, via periodate treatment of 
antigens, significantly reduced IgG3 recognition of the Pcc antigens but responses to 
NbA were unchanged (Figure 1 and Table 1). This may reflect incomplete disruption 
of carbohydrate epitopes on the helminth antigen. However T-independent type 2 
antigens that due to highly repetitive structures are able to cause activation by cross-
linking multiple B-cell receptors {Murphy, 2008 #472} also induce the IgG3 isotype 
{Snapper, 1992 #249}. This mechanism of IgG3 induction may be more likely to 
occur in the presence of large multicellular organisms such as helminths. Although 
not definitively associated with carbohydrate binding the occurrence of significant 
IgG3 titres to the parasite antigens and the effect of periodate on the detection of 
these antibodies led me to further investigate IgG1 and IgG2a recognition of the 










TABLE 1: Results of GLM for antigen-specific IgG3 antibody responses at day 20 
p.i. F statistics and P values of significant terms (P<0.05) come from the minimal 
model. Significant pairwise differences were determined from the Tukeyʼs adjusted 
P-values of the most complex significant term in the model and are shown in Figure 
1. 
Response Variable df  Factor F ratio P value 
     
Anti-MSP-119 IgG3 F2,20 Infection 84.92 <0.0001* 
 F1,22 Periodate 13.46 0.0013* 
 [F2,20 Infection*Periodate 1.85 0.1834] 
     
Anti-pRBC IgG3 F2,20 Infection 6.47 0.0068* 
 F1,20 Periodate 9.90 0.0018* 
 F2,20 Infection*Periodate 3.43 0.0525 
     
Anti-NbA IgG3 F2,20 Infection 10.42 <0.0007* 
 [F1,22 Periodate 0.34 0.5657] 
 [F2,20 Infection*Periodate 1.30 0.2946] 
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Figure 1: Comparison of IgG3 antibody responses to parasite antigens treated (or not) with 
periodate. Mice were infected with 200 Nb L3 larvae and/or 1x105 Pcc-infected RBCs. Serum 
antibody titres were measured at day 20 p.i to malaria antigens MSP-119 a) pRBC b) and 
worm antigen NbA c). IgG3 responses to untreated antigen (periodate -) and treated antigen 
(periodate +) are shown. All titres are above the mean +3 standard deviations of control mice 
at serum dilution of 1/200 represented as 0 on the y-axis. Single Pcc infections are shown in 
white bars, single Nb infections in black bars and co-infected mice (Pcc-Nb) are shown in the 
chequered bars. Graph shows mean and SEM of 8 mice per group. Significant pairwise 
differences according to Tukeyʼs post-hoc test and the corresponding P-values are 





Th2 antigen-specific and cross-reactive responses to Nb antigens target 
carbohydrates. 
 
Analysis of the Th2 antibody response (IgG1) to malaria antigens was unaffected by 
periodate treatment (Figure 2a, 2b and Table 2), suggesting that both Nb-induced 
cross-reactive and Pcc-specific antibodies recognise a protein moiety of these 
antigens. In contrast there was a significant reduction in the IgG1 response to the 
helminth antigen NbA following periodate treatment (Figure 2c and Table 2). The 
reduction in the antigen-specific response of Nb infected mice lends support to the 
idea that the heavily glycosylated worm cuticle is the target of host immune 
responses (Dell, Haslam et al. 1999) (Figure 2c). Interestingly the Pcc-induced cross-
reactive response to NbA was completely ablated when the antigen was treated with 
periodate, indicating that the atypical IgG1 response in Pcc-infected mice recognises 
carbohydrates (Figure 2c).  
 
This has significance for the interpretation of immune bias in co-infected mice (Pcc-
Nb); as the anti-NbA IgG1 response to periodate treated antigen was solely driven by 
Nb infection, the significant difference between Nb-only and Pcc-Nb mice must 
reflect the influence of Pcc infection on the bias of the Nb-specific response. In 
summary, Th2 antibody responses to the helminth antigen, both cross-reactive and 
antigen-specific, were mainly targeted to carbohydrates whereas the Th2 response to 


























































Figure 2: Comparison of Th2 antibody responses to parasite antigens treated (or not) with 
periodate. Mice were infected with 200 Nb L3 larvae and/or 1x105 Pcc-infected RBCs. Serum 
antibody titres were measured at day 20 post-infection to malaria antigens MSP-119 a) pRBC 
b) and worm antigen NbA c). IgG1 responses to untreated antigen (periodate -) and treated 
antigen (periodate +) are shown. All titres are above the mean +3 standard deviations of 
control mice at serum dilution of 1/200 represented as 0 on the y-axis. Single Pcc infections 
are shown in white bars, single Nb infections in black bars and co-infected mice (Pcc-Nb) are 
shown in the chequered bars. Graph shows mean and SEM of 8 mice per group. Significant 
pairwise differences according to Tukeyʼs post-hoc test and the corresponding P-values are 




TABLE 2: Results of GLM for Th2 antibody responses at day 20 p.i measured 
before and after treatment of antigens with periodate. F statistics and P values of 
significant terms (P<0.05) come from the minimal model. Significant pairwise 
differences were determined from the Tukeyʼs adjusted P-values of the most 





Th1 responses recognise the protein moiety of malaria antigens. 
 
Overall there was a significant effect of periodate on the detection of IgG2a 
responses (Th1) to malaria antigens pRBC and MSP-119 (see Table 3). Within an 
infection group, responses following treatment with periodate were either 
significantly increased – e.g. anti-MSP-119 in Pcc-Nb mice (Figure 3a) and anti-
pRBC in Pcc mice (Figure 3b) – or showed a trend in this direction (anti-MSP-119 in 
Pcc and anti-pRBC in Pcc-Nb mice - Figure 3a and 3b respectively). In each case 
this indicates that IgG2a antibodies recognised the protein component of malaria 
antigens. In other words both a lack of change in response or an increase following 
periodate treatment indicated binding to the protein moiety. Increases in response 
following periodate-treatment of the malaria antigens suggest that protein epitopes 
may have been masked by glycosylation. Plasmodium species lack the 
glycosyltransferases required for glycosylation of antigens with the exception of GPI 
anchors (von Itzstein, Plebanski et al. 2008) but expression of the recombinant 
antigen in the Pichia system may have resulted in inappropriate glycosylation of the 
antigen (von Itzstein, Plebanski et al. 2008). In other words periodate treated 
Response Variable df Factor F ratio P value 
     
Anti-MSP-119 IgG1 F2,21 Infection 10.53 0.0007* 
 [F1,23 Periodate 0.0002 0.9883] 
 [F2,21 Infection*Periodate 2.37 0.1176] 
     
Anti-pRBC IgG1 F2,21 Infection 14.52 <0.0001* 
 [F1,23 Periodate 0.24 0.6268] 
 [F2,21 Infection*Periodate 0.90 0.4214] 
     
Anti-NbA IgG1 F2,21 Infection 19.94 <0.0001* 
 F1,23 Periodate 34.47 <0.0001* 
 [F2,21 Infection*Periodate 1.61 0.2215] 
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antigens may more accurately reflect those that are seen in the context of Pcc 
infection. It is interesting that detection of Nb-induced cross-reactive responses 
(Figure 3a and 3b) was also unaffected by periodate treatment, suggesting that these 
too target the protein portion of the antigen. This is in contrast to my proposal that 
carbohydrates, with the potential to be conserved across parasite species, would be 
the targets of cross-reactive responses.  
 
Investigating responses to periodate treated antigens has again proved useful in 
determining the effect of co-infection on immune bias. For untreated-pRBC IgG2a 
responses there was no significant difference amongst infection groups (Figure 3b 
and Chapter 2 Fig 1c). Following periodate treatment, however, the antigen binding 
by serum of Pcc infected mice was significantly greater than that of Nb mice (Figure 
3b) such that at least some of the binding of periodate-treated antigen by sera from 
Pcc-Nb mice can be attributed to Pcc-specific responses.  
 
Cross-reactive Th1 responses to Nb antigen recognise proteins whereas antigen-
specific responses target carbohydrates. 
 
Detection of anti-NbA IgG2a responses following periodate treatment was reduced 
in Nb and Pcc-Nb mice, although this was only statistically significant in Nb mice 
(Figure 3c). Interestingly the response in Pcc mice was unaltered, suggesting that 
cross-reactive responses recognise the protein moiety of this crude antigen 
preparation.  
 
Prior to periodate treatment there was no difference in the cross-reactive responses of 
Pcc mice and the antigen-specific response of Nb mice to Nb antigen (Figure 3c and 
Chapter 2, Fig 1e). After periodate treatment of antigens however a significant 
difference between Pcc and Nb mice was apparent (Fig 3c) due to the ablation of the 
antigen-specific response (Nb-mice). This result is crucial for the interpretation of 
immune-bias in co-infection (Pcc-Nb) as the apparent increase in Th1 response in 
comparison to Nb mice can be attributed to Pcc-induced cross-reactivity rather than 









































Figure 3: Comparison of Th1 antibody responses to parasite antigens treated (or 
not) with periodate. Mice were infected with 200 Nb L3 larvae and/or 1x105 Pcc-
infected RBCs. Serum antibody titres were measured at day 20 post-infection to 
malaria antigens MSP-119 a) pRBC b) and worm antigen (NbA) c). IgG2a (Th1) 
responses to untreated antigen (periodate -) and treated antigen (periodate +) are 
shown. All titres are above the mean +3 standard deviations of control mice at 
serum dilution of 1/200 represented as 0 on the y-axis. Single Pcc infections are 
shown in white bars, single Nb infections in black bars and co-infected mice (Pcc-
Nb) are shown in the chequered bars. Graph shows mean and SEM of 8 mice per 
group. Significant pairwise differences according to Tukeyʼs post-hoc test and the 
corresponding P-values are summarised in the text boxes. 
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TABLE 3: Results of GLM for Th1 antibody responses at day 20 p.i measured 
before and after treatment of antigens with periodate. F statistics and P values of 
significant terms (P<0.05) come from the minimal model. Significant pairwise 
differences were determined from the Tukeyʼs adjusted P-values of the most 






The cross-reactive antibody responses that are observed in the N. brasiliensis and P. 
chabaudi co-infection model (Chapter 2 and (Fairlie-Clarke, Lamb et al. 2010)) are 
not a novel finding but rather add to a body of evidence that suggests the host 
immune system ‘perceives’ certain helminth and malaria antigens as similar. The 
most well characterised cross-reactivity occurs between S. mansoni and P. 
falciparum and has been attributed to the protein SmLRR (Naus, Jones et al. 2003; 
Pierrot, Wilson et al. 2006). Antibody recognition of this S. mansoni protein is 
induced both by P. falciparum infection in humans and P. berghei infection in rats 
(Pierrot, Wilson et al. 2006). Although Helmby et al (Helmby, Kullberg et al. 1998) 
report that infection of mice with P. chabaudi does not elicit cross-reactive responses 
to Schistosome egg antigen (SEA), my own observations in a pilot experiment 
indicate that P. chabaudi infected mice do mount sizeable responses to SEA (data 
not shown). This discrepancy may be due to a difference in host genotype: Helmby 
et al (Helmby, Kullberg et al. 1998) infected C57BL/6 mice with P. chabaudi 
whereas I used BALB/c mice. Reciprocal cross-reactive antibody responses are also 
evident in the P. chabaudi – L. sigmodontis co-infection model (Fairlie-Clarke, 
Response Variable df Factor F ratio P value 
     
Anti-MSP-119 IgG2a F2,21 Infection 56.48 <0.0001* 
 F1,21 Periodate 37.64 <0.0001* 
 F2,21 Infection*Periodate 6.14 0.0079* 
     
Anti-pRBC IgG2a F2,21 Infection 10.50 <0.0001* 
 F1,21 Periodate 11.65 0.0026* 
 F2,21 Infection*Periodate 8.92 0.0016* 
     
Anti-NbA IgG2a F2,21 Infection 22.65 <0.0001* 
 F1,21 Periodate 12.69 0.0015* 
 F2,21 Infection*Periodate 6.56 0.0051* 
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Lamb et al. 2010). The potential for these cross-reactive responses to be of biological 
importance in co-infection warrants further understanding of why they might arise. 
In this co-infection model the precise antigen that the cross-reactive antibody 
response is targeting has not yet been characterised. In order to infer the biological 
relevance of the observed cross-reactive response it will be important to ensure that 
host-proteins or bacterial contaminants in the antigen preparations are not 
responsible. For the recombinant MSP-119 protein however this is unlikely.   
 
The question of why antibodies induced by malaria and helminths cross-react is 
particularly interesting from an immunological perspective as, in theory, the adaptive 
immune response should be capable of mounting a specific response to every 
potential antigen (Pancer and Cooper 2006). The occurrence of cross-reactive 
antibodies indicates that this exquisite specificity is not always realised. It can be 
difficult to predict which antigens antibodies may cross-react with as the antibody 
recognises conformational epitopes, the structure of which is not easy to determine 
from amino-acid or protein sequences (Smith, Lapedes et al. 2004). Many parasite 
antigens are glycosylated (Dell, Haslam et al. 1999; Mendonca-Previato, Todeschini 
et al. 2005) and display carbohydrates on their surface, the conformation of which 
could be conserved across species and so provide a source of cross-reactivity. In this 
chapter I used periodate treated antigens to explore whether the carbohydrate 
moieties of Pcc and Nb antigens were the target of cross-reactive antibodies. It 
should be noted that periodate is not the only way in which carbohydrate epitopes 
could be disrupted, and indeed there are caveats to this method that should be 
acknowledged. For example oxidation of carbohydrates to aldehydes by periodate 
might not completely disrupt all carbohydrate epitopes and could potentially alter the 
protein moiety of the antigen.  An alternative approach would be to use enzymatic 
cleavage of the carbohydrates from the protein backbone, although this too could 
alter binding to the protein moiety. The Pcc-induced cross-reactive Th1 response 
(IgG2a) to NbA recognised proteins, as did anti-Pcc IgG2a antibodies induced by 
Nb. Similarly Nb-induced Th2 (IgG1) antibodies recognised the protein moiety of 
Pcc antigens. The only cross-reactive response that recognised carbohydrate was the 
Pcc-induced IgG1 response to NbA. On the whole, cross-reactive antibodies in the 
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Pcc-Nb model recognise the protein moiety of antigens, which is in line with the 
findings from the S. mansoni and P. falciparum study, where the SmLRR protein 
was conserved between parasites (Pierrot, Wilson et al. 2006). Cross-reactivity in 
that case is therefore not a failure to discriminate between antigens but recognition of 
a common epitope expressed by both parasites. Determining if this is also true for Nb 
and Pcc will require in depth proteomic analysis, but as a starting point I was able to 
visualise helminth proteins that are recognised by Pcc anti-sera via Western Blot (see 
results section Chapter 6).  
 
The experimental focus of this chapter has been biochemical, in that I have addressed 
the following question: “would disruption of carbohydrate epitopes reduce cross-
reactivity?” This question is based on the hypothesis that the glycosylation of 
antigens is more likely to be conserved amongst parasite species. Yet the occurrence 
of cross-reactive responses raises questions as to how accurate the fine-tuning of 
antibody-antigen specificity during the adaptive response actually is. As outlined in 
the introduction, there are various points in the process of producing highly-specific 
antibody that could be constrained in such a way that cross-reactive antibodies would 
result. Initially the number of B-cells will determine the repertoire of B-cell receptor 
(BCR) diversity that is available to bind antigen.  In a host with fewer B-cells, a 
constraint on the B-cell repertoire may necessitate the ability to bind more than one 
antigen (cross-reactivity). This proposed constraint can be somewhat counteracted by 
B-cell somatic hypermutation and the re-binding of antigen to select for a more 
specific BCR (and antibody). The potential for antigen availability to constrain 
antibody specificity (and thus increase cross-reactivity) is explored further in the 
following chapter.  
 
It is of course possible that cross-reactive antibodies do not result from constraints 
that are imposed on the immune system but that the host adopts a strategy to 
maintain a level of cross-reactivity that is beneficial. By employing cross-reactive 
responses a host may be able to invest less in immune responses whilst still 
achieving good coverage of antigenic space (Fairlie-Clarke, Shuker et al. 2009). This 
last proposal is the hardest to test experimentally but some knowledge as to the 
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extent to which this mechanism might be operating could be gleaned – for example, 
by investigating whether responses in individuals who are energetically challenged 
are more cross-reactive, or whether individuals that have evolved under the selection 
force of exposure to multiple parasites have more cross-reactive responses than those 
exposed to single parasites. 
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Chapter 6: “Who goes there?” How antigen dose informs the 





Th1/ Th2 polarisation is ultimately determined by the cytokine milieu and and 
varying antigen dose has been shown to affect this (Constant and Bottomly 1997). 
Although the effect of varying antigen dose is often explored in model systems the 
findings are pertinent to natural infections where parasite load (dose) will be 
anything but uniform. Despite helminth infections characteristically inducing Th2 
responses and intracellular parasites Th1, in both the Trichuris muris and Leishmania 
major system low doses of parasite can induce Th1 cell mediated responses whereas 
high doses can lead to a Th2 response (Menon and Bretscher 1998; Bancroft, Else et 
al. 2001). In L. major infection this dose-dependent bias in Th1/Th2 polarisation was 
also apparent in the isotype of antibody produced by the B-cell population. Mice 
infected with a low dose of parasites produced predominantly IgG2a whereas those 
infected with high dose favoured IgG1 (Kaur, Kaur et al. 2008). From these and 
other studies (Caulada-Benedetti, al-Zamel et al. 1991; Wakelin, Goyal et al. 1994; 
Power, Wei et al. 1998) it is tempting to surmise that as the dose of parasite moves 
from low to high so immune bias shifts from Th1 to Th2. However, the effect of 
antigen dose on the immune response is not straightforward and there is certainly no 
general rule that low dose antigen equals Th1 and high dose Th2. In fact the exact 
opposite has been demonstrated where low doses of Hen Egg Lysozyme (HEL), 
Keyhole Limpet Haemocyanin (KLH) and Toxic Shock Syndrome Toxin (TSST) all 
elicit Th2 responses (Cho, Chang et al. 2000; Brandt, van der Bosch et al. 2002; 
Barwig, Raker et al. 2010). The reasons for this discrepancy are not clear but it is 
worth noting that in the majority of cases where low dose elicits Th1 the host was 
exposed to live infection with a parasite, as opposed to immunisation with a discrete 
soluble antigen. Although not explicitly tested in the studies of parasite infection 
described here it is possible that for the immune system a ‘low dose’ of parasite 
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broken down into its component antigens and presented to T and B cells may in fact 
constitute a high dose in terms of immune stimulation (Constant and Bottomly 
1997). This may be further compounded by parasites that replicate within the host.  
 
Thus, when trying to understand how antigen dose will affect immune bias the 
complexity of the antigen and the context in which it is seen are important. 
Consideration must be given to the fact that infection with parasitic organisms will 
cause tissue damage as they invade, expose the immune system to multiple complex 
antigens, potentially from different parasite life cycle stages and that molecules 
produced through parasite metabolism or reproduction could all influence the 
environment in which the immune response is elicited.  For instance, parasite 
infection is associated with ‘danger signals’, both endogenous resulting from tissue 
damage and inflammation and exogenous, in the form of pathogen-associated 
molecular patterns (PAMPS). These danger signals in themselves can influence 
immune bias by signalling through different pattern recognition receptors known as 
Toll-like receptors (TLRs) on dendritic cells and B-cells (Xu, Liu et al. 2004). 
PAMPs are typically associated with bacterial infection but there are also a number 
of protozoan products that have been found to act as TLR ligands (Gazzinelli and 
Denkers 2006). The effect of TLR stimulation on immune bias is likely to be 
exaggerated with increased parasite dose. Greater numbers of parasites will cause 
more tissue damage and display more PAMPs, intuitively this increase in 
endogenous and exogenous TLR ligands will result in increased TLR ligation.  
Exposure to different antigens associated with development of the parasite within the 
host may also influence immune bias; in Schistosome infection progression through 
initial infection with the larval stage (cercariae) to the onset of egg production by 
mature adults results in a switch from Th1 to Th2 responses, suggesting that the egg 
antigens interact with immune cells in a way that drives the production of cytokines 
that skew the immune bias toward Th2 (Pearce and MacDonald 2002).  
 
I am interested in the effect of varying the inoculating dose of Pcc on immune bias 
and I hypothesise that increasing the dose of this particular parasite will skew 
immune bias toward Th1. Acute malaria infection induces a potent Th1 response 
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characterised by the secretion of the pro-inflammatory cytokines IL-12, TNF-# and 
IFN-!. The initial induction of these cytokines has been attributed to the direct 
interaction of schizonts and merozoites with TLR-9 on dendritic cells (Seixas, Cross 
et al. 2001; Wu, Gowda et al. 2010). Similarly haemazoin, a by-product of 
haemoglobin digestion by malaria parasites, has been shown to stimulate TLR9 on 
dendritic cells (Engwerda and Good 2005). The Th1 cytokine response initiated early 
in infection will influence the bias of the adaptive response as IFN-! drives 
production of IgG2a antibody from murine B-cells (Collins and Dunnick 1993). In 
addition to this cytokine-mediated antibody production the direct stimulation of 
TLR9 on B-cells can result in the production of IgG2a (Jegerlehner, Maurer et al. 
2007). It is feasible that the TLR9 ligand haemozoin produced during malaria 
infection could also interact with B-cells in this way to further skew the antibody 
response toward Th1 (IgG2a). The recognition of protein antigens by T and B-cells is 
important for determining parasite-specific responses and there is evidence that 
protein antigens also carry motifs that preferentially induce Th1 or Th2 responses 
(Guy, Krell et al. 2005). For example the P. falciparum antigen MSP-2 has an 
epitope that induces IgG2b (Th1) antibody production in mice (Tongren, Corran et 
al. 2005). In summary, infection with Pcc induces a heavily Th1 biased environment 
and I would envisage that increasing the dose of this parasite would only exacerbate 
this skew in immune bias, reflecting increased exposure to the Th1 inducing malaria 
antigens and the potential adjuvant effect of haemozoin and malaria parasite DNA 
via TLR signalling.  
 
Mounting an appropriate immune response to an invading parasite is not simply a 
case of managing Th1/ Th2 (or Treg/Th17) immune bias. Discrimination of one 
parasite from another and a specific targeted effector response are also crucial. In 
theory a diverse repertoire of B cell receptors enables the adaptive immune system to 
recognise (bind to) every potential parasite antigen (Pancer and Cooper 2006). On 
recognition of antigen the B-cell proliferates and subsequent targeting of the parasite 
is achieved through the production of parasite-specific antibodies. Antigen dose may 
affect this process, as higher doses of antigen will increase the chance of a B-cell 
encountering its antigen and proliferating.  
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The relationship between antigen dose and antibody specificity is of further 
importance as B-cell receptors that have bound their antigen undergo rounds of 
somatic hypermutation to become even more specific to that antigen. This 
mechanism involves mutation of the antigen-binding site of the B-cell receptor and 
re-binding of antigen to select for the cell bearing the receptor with the greatest 
affinity, culminating in the release of highly specific antibody molecules by plasma 
cells (Tarlinton and Smith 2000). Given that antigen is required for this process it is 
reasonable to predict that when there is more antigen available the B-cell could 
undergo more rounds of somatic hypermutation producing antibodies of even greater 
specificity to the antigen in question. One way to investigate how antibody-
specificity is affected by antigen-dose is to assess the potential of the antibody to 
bind other antigens, for which it has not been selected, in other words test for 
antibody cross-reactivity. Antibody cross-reactivity arises when the immune system 
fails to discriminate between antigens. I am proposing that this could be overcome 
when there is the opportunity to gather more information on one of those antigens 
(information being provided in the form of increased antigen dose), such that hosts 
exposed to greater amounts of antigen produce more specific and consequently less 
cross-reactive antibodies. It is of course possible that two taxonomically different 
parasites actually share epitopes (Pierrot, Wilson et al. 2006) in which case dose 
would not affect the immune system’s ability to differentiate between them.  
 
Affinity refers to the strength of a single bond between antibody and antigen, 
whereas avidity refers to the combined strength of multiple bonds and in its simplest 
terms can be thought of as the sum of the affinities. Affinity (and so overall avidity) 
is a property that is selected for, as the antigen-binding site of the B-cell receptor 
becomes a more perfect fit to the antigen through rounds of somatic hypermutation.  
This being the case increasing antigen availability (by increasing dose) should allow 
for further somatic hypermutation and selection of antibodies with greater avidity for 
their antigen. Comparing the avidity of antigen-specific versus cross-reactive 
antibody responses will help to elucidate how information provision (antigen) affects 
the immune systems ability to fine-tune its response to a particular antigen/ 
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pathogen. For example if even after selection for its cognate antigen by somatic 
hypermutation an antibody was still able to bind another antigen it may only do so 
with weak avidity. Therefore, in the presence of its cognate antigen, for which it has 
high avidity, it is unlikely to bind to the other (cross-reactive) antigen and the 
immune system could be viewed as having successfully fine-tuned its response.  
 
As controlling infection with intracellular parasites often relies on Th1 responses and 
the clearance of nematodes Th2 responses, the effect of antigen dose on immune bias 
has serious implications for the host in terms of susceptibility to disease (Bretscher, 
Wei et al. 1992; Bancroft, Else et al. 2001). The potential for differing antigen dose 
to affect the bias and specificity of the immune response may also be particularly 
relevant in the control of co-infection, with parasites such as malaria and helminths, 
that require the host to mount Th1 and Th2 responses respectively. The fact that 
Th1/Th2 immune responses are counter-regulatory (Abbas, Murphy et al. 1996) 
prohibits the host simultaneously mounting a strong response of each type; instead 
the host is required to manage these opposing responses in an attempt to reach some 
optimal immune bias (Fenton, Lamb et al. 2008). This suggests that the immune 
system must ‘decide’ which parasite poses the greatest threat in order to focus the 
immune response to that parasite and implies that the host in some way assesses 
parasite load. Deenick et al (Deenick, Hasbold et al. 2005) report on a hierarchical 
order for cytokine-induced isotype class switching, where IFN! is dominant over IL-
4 and suggest that this is an adaptation to focussing the immune response toward the 
more ‘virulent’ parasite in a mixed Th1/Th2 cytokine setting such as co-infection. 
The assumption being that rapidly replicating parasites (e.g. malaria or viruses) pose 
a greater threat to the host than helminths and are associated with increased IFN! 
levels. It is interesting to speculate that identifying the greatest parasite threat could 
be achieved through quorum sensing of immune cells. If for example, a high dose of 
one parasite antigen relative to another indicates increased parasite load (or 
uncontrolled parasite growth) and results in greater proliferation of B-cells specific 
for that parasite (versus those specific for another) then antigen dose could provide 
the immune system with a proximate measure of parasite load. If this is the case 
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increasing the dose of malaria in co-infection should result in immune responses 
more comparable to those observed in malaria only infected hosts.  
 
The Pcc and Nb model of co-infection provides a useful tool for investigating the 
effect of antigen dose on immune bias, antibody specificity/ cross-reactivity and 
avidity (strength of binding) as the initial (inoculating) dose of Pcc parasites can be 
readily manipulated.  I propose the following hypotheses: 
  
i) Increasing the dose of Pcc will further skew immune bias toward Th1. 
ii) Increasing the dose of Pcc will decrease cross-reactivity to Nb antigen. 
iii) Increasing the dose of Pcc will increase antibody avidity to Pcc antigen.  
 
The rationale behind these hypotheses centres round the interaction of B-cells with 
malaria antigens and how this is affected by antigen availability. Low dose limits 
antigen availability meaning that there is less opportunity for B-cell proliferation to 
be initiated via antigen binding. When proliferation does occur somatic 
hypermutation ensues, as each round of somatic hypermutation requires that the new 
B-cell receptor be selected for by antigen binding, low levels of antigen may cap the 
number of rounds of somatic hypermutation that occur, which has implications for 
refinement of antibody specificity and avidity. Using a low inoculating dose of 
malaria parasites may not induce the same level of inflammatory cytokines as high 
dose and as with antigen availability I predict that parasite associated TLR ligands 
will also be fewer at low dose. Thus the environment in which the immune response 
is elicited at low dose is likely to be less Th1 biased, this combined with reduced B-
cell proliferation at low dose should be reflected in the antibody response as a lower 
magnitude of the IgG2a isotype. 
 
6.2 Experimental Design 
 
Female BALB/c mice were infected with a range of inoculating doses of Pcc-
infected RBC (1x103, 1x104, 1x105 and 1x106) with or without co-infection of Nb 
(200 L3) on day 0 (Figure 1). A group of mice were also infected with Nb alone (200 
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L3 larvae s.cut). In addition a group of control mice were included which received 
nRBC (1x105) and PBS as sham injections for Pcc and Nb respectively. There were 8 
mice per infection group and the experiment was performed twice.  
 
As the inoculating dose of Pcc increases by each order of magnitude the peak of 
asexual parasitaemia occurs one day earlier (Timms, Colegrave et al. 2001). 
Terminating the experiment on day 11 p.i should therefore result in the mice being 
exposed to different numbers of malaria parasites and by proxy, antigen. 
Bodyweight, RBC density and asexual parasite density were measured daily 
throughout the course of infection. Serum was collected on day 11 p.i and ELISA 
was used to measure antigen-specific antibody responses of both mixed and high 
avidity. For mixed avidity responses standard antigen-specific ELISA was performed 
(see Materials and Methods chapter). To measure high avidity responses the standard 
ELISA protocol was followed with an additional step introduced following serum 
incubation, in which the plates were washed with 6M Urea, a hydrogen-bond 
dissociating agent. This step removed antibodies that had bound weakly (with low 
avidity) to the antigen (for detailed protocol see Materials and Methods chapter). The 
antibody titre calculated after Urea treatment was divided by the antibody titre 
without Urea treatment to determine the ‘avidity index’, where a higher score 
corresponds to higher avidity. It should be noted that some of the values exceed 1, 
when higher titres of antibody were measured following elution of the low avidity 
antibodies by urea. This could be explained by steric interference if low avidity 
antibodies crowded around high avidity antibodies prevented binding of the 
secondary (detection) antibody in the ELISA reaction. 
 
6.3 Statistical Analysis 
 
The analyses presented here are from the combined data of two experiments (n=16 
per infection group). The analysis focussed on 153 mice, because 7 mice were 
excluded due to failed Pcc infection (peak parasite density < 0.05 pRBC 10^9/ml). 
All analyses were carried out in the statistical package JMP 8.0 (SAS) using 
generalised linear models. Antibody titre and the ‘avidtiy index’ data were log10 
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transformed to satisfy the model assumptions of homogeneity-of-variance and 
normal distribution. All other data (parasite density, day of peak parasite density and 
RBC minima) did not require transformation. Main effects were worm presence or 
absence (Nb), and malaria inoculation dose 1x103 – 1x106 (Pcc dose) fitted as 
categorical variables. The main effects and the interaction between them (Nb*Pcc 
dose) test whether the response variable (antibody titre) is affected by changes in Pcc 
dose or infection status or both. To address the question of whether Pcc dose was 
significant Nb-only mice were excluded, the final analysis of antibody titre was 
therefore carried out on 121 mice. The effects of dose and infection status were 
consistent between experiments. Including “experiment” as a factor in all the 
analyses controlled for any differences in the magnitude of the responses between the 
2 experiments. Maximal models were first fit to the data and the minimal models 
were reached by removing non-significant terms (p >0.05) beginning with 
interactions. Significant interactions with “experiment” were removed if they were 
purely quantitative and if their removal did not alter the significance of the main 
effects remaining in the model. Finally, significant pairwise differences (p<0.05) 
between groups were determined using the Tukey’s All Pairs adjusted p-values for 




Figure 1: Model of P. chabaudi- N. brasiliensis co-infection. 
BALB/c mice inoculated on Day 0 with 4 different doses of Pcc (1x103, 1x104, 1x105 
and 1x106 Pcc-infected RBC) are denoted as Pcc3, Pcc4, Pcc5 and Pcc6 
respectively. Their co-infected counterparts are denoted NbPcc3, NbPcc4, NbPcc5 
and NbPcc6. Singly infected mice were given a sham injection of naïve RBC or PBS 
to mimic the missing Pcc or Nb inoculation respectively. Control mice received both 
sham injections. Daily sampling for anaemia, bodyweight and Pcc parasitaemia was 




Varying the inoculating dose of Pcc exposes the host to different levels of antigen. 
 
Previous experiments in C57BL/6 mice infected with P. chabaudi genotypes CW 
and BC, revealed that increasing the inoculating dose of P. chabaudi resulted in the 
highest dose reaching the peak of asexual parasitaemia first (Timms, Colegrave et al. 
2001). This result was replicated here using BALB/c mice and the P. chabaudi 
genotype AS. A decrease in dose corresponded to a delay in peak parasitaemia of 
one to two days per order of magnitude difference (Figure 2a and Table 1). The 
dynamics of parasitaemia were not significantly different in co-infected mice (Table 
1, data not shown). Even though the kinetics of infection was altered there was no 
significant difference in parasite density at its peak between the groups (see Table 1). 
The minimum RBC density, which is associated with peak parasitaemia, however 
did differ in severity in a dose-dependent manner, as higher doses of Pcc caused 
more severe anaemia. There was a trend, although non-significant, for co-infected 
mice to suffer less severe anaemia than Pcc-only infected mice (Figure 2b and Table 
1). The rationale that terminating the experiment on day 11 p.i would result in 
exposure to different levels of antigen (parasites) amongst the groups was borne out 
as the cumulative parasite density throughout infection differed significantly between 
the groups. Co-infected mice showed a reduction in cumulative parasite density that 
bordered on significance (Figure 2c and Table 1). The overall effect of dose on 
cumulative parasite density was largely driven by differences between the highest 















TABLE 1: Results of GLM for malaria parasitology and anaemia data. Non-
significant terms come from last model before term was dropped and are shown in 
square brackets. F statistics and P values of significant terms (P<0.05) come from 
the minimal model. Significant pairwise differences were determined from the 







Factor df F ratio P value Experiment effect size 
estimates (mean ± SE) 
Peak Parasite 
Density 
     
 
Experiment F1,116 8.97 0.0034* -0.054 ± 0.018 
 Pcc Dose F3,116 1.94 0.1274  
 
[Nb F1,115 1.05 0.3084]  
 [Nb*Pcc Dose F3,112 0.99 0.4022]  







Experiment F1,116 1.10 0.1602  
 
Pcc Dose F3,116 39.25 <0.0001*  
 
[Nb F1,115 2.31 0.1312]  
 [Nb*Pcc Dose F3,112 2.07 0.1081]  
      
Cumulative 





Experiment F1,116 12.87 0.0008* -0.152 ± 0.044 
 Pcc Dose F3,116 5.98 0.0009*  
 [Nb F1,115 3.55 0.0622]  
 [Nb*Pcc Dose F3,112 2.63 0.0536]  
      
Day of Peak 
Parasite Density 
     
 Experiment F1, 116 15.80 0.0001* 0.228±0.057 
 Pcc Dose F3, 116 262.76 <0.0001*  
 [Nb F1, 115 0.24 0.6278]  
 [Nb*Pcc Dose F3, 112 1.85 0.1423]  
 120 
 
Figure 2: Malaria parasitaemia and anaemia data. Pcc was administered at 4 different 
inoculating doses with or without 200 L3 Nb larvae. Pcc inocula doses of 1x103, 1x104, 1x105 
and 1x106 Pcc-infected RBC are denoted as Pcc3, Pcc4, Pcc5 and Pcc6 respectively. Their 
co-infected counterparts are additionally denoted with Nb. Dynamics of Pcc parasite density 
throughout infection (a) Pcc single infections are shown as solid lines or as white bars in 
inset graph. Co-infection with Nb did not significantly alter infection dynamics (data not 
shown). The RBC minima experienced in single and co-infected mice are shown (b) and the 
cumulative parasite density experienced throughout infection (c). Single Pcc infections are 
shown in white bars and co-infected mice in chequered bars (mean and SEM n=16 per 
group). Significant pairwise differences according to Tukeyʼs post-hoc test and the 
corresponding P-values are summarised in the text boxes. 
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Increasing Pcc dose increases the Th1 bias of the immune response. 
 
To investigate how antigen dose affected Th1/Th2 immune-bias ELISA was used to 
measure antibody responses at day 11 p.i. Focussing initially on Pcc-only infected 
mice, Th1 (IgG2a) antibody responses to the malaria antigens Pc Lysate and MSP-
119 increased as Pcc-dose increased (Figure 3a, 3b and Table 2). Alongside this 
increase in Th1 antibody response was a significant dose-dependent decrease in the 
IgG1 response to Pc Lysate (see Figure 3d and Table 2), although this was not 
apparent for anti-MSP-119 (Fig 3e and Table 2). Overall this pattern of antibody 
isotype production indicated that the immune-bias was skewed toward Th1 as the 
host was exposed to increasing doses of Pcc. It should be noted that this observation 
was largely driven by pairwise comparisons to the lowest Pcc dose (Pcc 3). For Pcc-
only mice, titrating in malaria further skews the immune bias toward Th1.  
 
In order to determine if this dose-dependent Th1 skew in immune bias is also evident 
when a Th2 inducing worm is on the scene I investigated the response of co-infected 
mice (NbPcc) to increased doses of Pcc. Although IgG1 responses on the whole 
were greater in co-infected mice than Pcc-only mice (see Figure 3d, 3e, 3f and Table 
2) a reduction in the Th2 response as Pcc dose increased was evident for anti-Pc 
Lysate IgG1 and anti-NbA IgG1 responses (Figure 3d, 3f and Table 2). This decrease 
in Th2 response corresponded with an increase in the Th1 (IgG2a) response to the 
malaria antigen MSP-119 and worm antigen NbA (See Figure 3b, 3c and Table 2). In 
contrast to Pcc only mice, dose did not affect the IgG2a response to Pc Lysate in co-
infected mice (Figure 3a and Table 2). The overall shift in immune bias toward Th1 
in co-infected mice is supported by the analysis of total IgE antibody responses. Nb 
infection induced IgE antibodies characteristic of a Th2 response (Nb, F10, 141 
=460.88, p<0.0001) that were decreased during co-infection with Pcc in a dose-
dependent manner (Nb*Pcc Dose, F10, 141 =4.29, p=0.0026)(Figure 4). Again the 
effect of dose was largely driven by significant differences between the dose of 
1x103 Pcc-infected RBC (Pcc3) and 1x106 Pcc-infected RBC (Pcc6). 
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TABLE 2: Results of GLM for antibody responses of all avidities. Non-significant 
terms come from last model before term was dropped and are shown in square 
brackets. F statistics and P values of significant terms (P<0.05) come from the 
minimal model. Significant pairwise differences were determined from the Tukeyʼs 
adjusted P-values of the most complex term in the model and are shown in Figure 3 
and Figure 5. 
 
Response Variable df Factor F ratio P value Experiment 
effect size 
estimates 
(mean ± SE) 
anti-NbA IgG1      
 [F1, 116 Experiment 1.31 0.2557]  
 F1, 116 Nb 20.58 <0.0001*  
 F3, 116 Pcc Dose 7.61 0.0001*  
 [F3, 112 Nb*Pcc Dose 1.25 0.2952]  
      
anti-Pc Lysate IgG1      
 F1, 115 Experiment 6.34 0.0132* 0.207±0.082 
 F1, 115 Nb 6.61 0.0114*  
 F3, 115 Pcc Dose 6.77 0.0003*  
 [F3, 112 Nb*Pcc Dose 1.19 0.3164]  
      
anti-MSP-119 IgG1      
 F1, 115 Experiment 7.21 0.0083* 0.236±0.088 
 F1, 115 Nb 28.27 <0.0001*  
 [F3, 115 Pcc Dose 0.50 0.6835]  
 [F3, 112 Nb*Pcc Dose 0.42 0.7425]  
      
      
anti-NbA IgG2a      
 [F1, 115 Experiment 3.43 0.0666]  
 F1, 116 Nb 3.47 0.0649  
 F3, 116 Pcc Dose 12.37 <0.0001*  
 [F3, 112 Nb*Pcc Dose 1.29 0.2829]  
      
anti-Pc Lysate IgG2a      
 F1, 112 Experiment 63.17 <0.0001* 0.373±0.047 
 F1, 112 Nb 0.29 0.5913  
 F3, 112 Pcc Dose 23.06 <0.0001*  
 F3, 112 Nb*Pcc Dose 6.77 0.0003*  
      
anti-MSP-119 IgG2a      
 F1, 115 Experiment 7.65 0.0066* 0.081±0.029 
 F1, 115 Nb 3.60 0.0602  
 F3, 115 Pcc Dose 24.46 <0.0001*  
 [F3, 112 Nb*Pcc Dose 1.01 0.3903]  
      
anti-LsA IgG2a      
 [F1, 29 Experiment  2.33 0.1377]  
 F1, 30 Pcc Dose 18.66 0.0002*  
      
anti-HpA IgG2a      
 [F1, 29 Experiment  0.33 0.5708]  
 F1, 30 Pcc Dose 76.54 <0.0001*  
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Figure 3: Antigen-specific antibody responses in malaria and co-infected mice. 
Antibody titres to worm antigen (NbA) and malaria antigens (MSP-119 and Pc Lysate), Th1 
responses indicated by IgG2a and Th2 responses by IgG1. All titres are above the mean +3 
standard deviations of control mice at serum dilution of 1/200. This cutoff is represented as 0 
on the y-axis. Pcc doses of 1x103, 1x104, 1x105 and 1x106 Pcc-infected RBC are denoted as 
Pcc3, Pcc4, Pcc5 and Pcc6 respectively and are shown in white bars. Their co-infected 
counterparts are additionally denoted with Nb and are shown in chequered bars. n=16 per 
infection group.  Graph shows mean and standard errors of 16 mice per group. Significant 
pairwise differences according to Tukeyʼs post-hoc test and the corresponding P-values are 
summarised in the text boxes. 
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Figure 4: Total IgE responses in malaria and co-infected mice. IgE antibody 
concentration is shown. Pcc inocula doses of 1x103, 1x104, 1x105 and 1x106 Pcc-
infected RBC are denoted as Pcc3, Pcc4, Pcc5 and Pcc6 respectively and are 
shown in white bars. Their co-infected counterparts are additionally denoted with Nb 
and are shown in chequered bars. Nb-only mice are shown in black and control 
mice are shown in grey. Graph shows mean and standard errors of 16 mice per 
group. Significant pairwise differences according to Tukeyʼs adjusted P-values are 
indicated by letters. Groups that do not share letters are significantly different (P< 
0.01 for all comparisons). 
 
Increasing Pcc dose increases both antigen-specific and cross-reactive IgG2a 
antibody responses. 
 
Pcc antigen exposure was manipulated in order to investigate how this would affect 
targeting of the immune response to a particular antigen (parasite). This tested the 
hypothesis that increasing Pcc dose would result in the immune response focussing 
on malaria antigens. This targeting of the immune response would be indicated by 
increased production of Pcc-specific antibodies and, as a consequence of this 
selection for antibodies of greater specificity, a decrease in cross-reactivity (ability to 
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bind other antigens). As reported above infection with Pcc results in a Th1 biased 
immune environment and a dose-dependent increase in the production of malaria-
specific IgG2a antibodies, supporting the first part of my hypothesis.  To address the 
second part of the hypothesis cross-reactivity to NbA was assessed in Pcc-only mice 
that had not been exposed to worm antigens. The Pcc-induced cross-reactive IgG2a 
response to NbA increased in a dose-dependent manner (Figure 3c and Table 2).  
 
I wanted to investigate whether this Pcc-induced cross-reactive response to Nb was 
extended to other nematodes and so I performed ELISA assays with the same sera 
using Litomosoides sigmodontis antigen (LsA) and H. polygyrus antigen (HpA). 
IgG2a responses to these nematode antigens also increased with dose of Pcc (Figure 
5a, 5b and Table 2). Western blots were also performed in order to visualise which 
antigens of the crude preparations (HpA, NbA, LsA and Pc lysate) the Pcc anti-sera 
bound to. Western blot data supported the cross-reactivity to nematode antigens 
observed in ELISA; serum from Pcc6 mice recognised (bound to) several distinct 
bands in the H. polygyrus, L. sigmodontis and N. brasiliensis crude antigen 
preparations (Figure 6). Western blots from individual Pcc6 mice are shown in 
Appendix Figure 2. Importantly, the binding of antibodies in serum from control 
mice was negligible (data not shown). The magnitude (titre) of the cross-reactive 
response to other helminths was less pronounced than that seen for NbA (Figure 5c). 
The prediction that increased Pcc-dose would result in decreased cross-reactivity to 
worm antigens was thus not borne out.  Interestingly the change in immune bias 
toward Th1 with increasing Pcc-dose discussed earlier for antigen-specific responses 
is extended to the cross-reactive response of Pcc mice to worm antigen (NbA). The 
increase in cross-reactive IgG2a and decrease in cross-reactive IgG1 are shown in 
Figure 3c and 3f respectively (see Table 2 for statistics). 
 
Germinal centres are the site of T and B-cell interaction and B-cell proliferation 
during infection. We used fluorescence labelling of splenocytes to measure the size 
of germinal centres in Pcc infected mice (see Materials and Methods section). 
Representative images are shown in Appendix Figure 1. The increased production of 
serum antibodies with increased dose was reflected in the increased size of germinal 
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centres in the spleens of Pcc6 mice (see Appendix Figure 2a). Similarly the 
proportion of IgG positive plasma cells increased with dose, driven by the significant 
difference between control and Pcc6 mice (see Appendix Figure 2b). It is possible 
that the increase in both antigen-specific and cross-reactive serum antibodies is 
simply due to an overall increase in total antibody production. However, measuring 
total IgG antibodies in serum revealed no significant differences amongst the groups 









Figure 5: Malaria-induced cross-reactive antibody responses to nematode antigens. 
Th1 (IgG2a) cross-reactive responses induced by Pcc infection at low and high dose 
(Pcc3 and Pcc6) to L. sigmodontis, H. polygyrus and N. brasiliensis worm antigens 
(LsA, HpA and NbA) are shown (a,b and c). All titres are above the mean +3 
standard deviations of control mice at serum dilution of 1/200. This cutoff is 
represented as 0 on the y-axis. The fraction of the antibody response that is high 
avidity is presented as the avidity index in figures d, e and f (y-axis). Graph shows 
mean and standard errors of 16 mice per group. P-values indicate significant 













Figure 6: Western blot of nematode antigens probed with anti-sera from a pool of 
mice infected with malaria (1x106 Pcc-infected RBC). Antibody (IgG) binding to H. 
polygyrus antigen (HpA) at two concentrations (25ug and 50ug) is shown lanes 1 
and 2, to L. sigmodontis antigen (LsA) at two concentrations (25μg and 50μg) is 
shown lanes 3 and 4, to N. brasiliensis antigen (NbA) at two concentrations (25ug 
and 50ug) is shown lanes 5 and 6 and to P. chabaudi lysate (PcL) in lanes 7 and 8. 









TABLE 3: Results of GLM for antibody responses to nematode antigens. Non-
significant terms come from last model before term was dropped and are shown in 
square brackets. F statistics and P values of significant terms (P<0.05) come from 
the minimal model. Significant pairwise differences were determined from the 
Tukeyʼs adjusted P-values of the most complex term in the model and are shown in 
Figure 5 and Figure 7. 
 
 
Increasing Pcc dose differentially affected the avidity of cross-reactive responses to 
helminth antigens. 
 
Even though the ability of Pcc-induced antibodies to bind worm antigens was not 
decreased by increasing Pcc-dose, it is possible that the avidity (strength of binding) 
of these antibodies was altered. For example, mutation of the antigen binding-site 
through somatic hypermutation could result in antibodies that bind more strongly to 
their cognate antigen and less strongly to other antigens. Modifying the ELISA 
protocol to remove weakly bound (low avidity) antibodies enabled the avidity index 
for each antibody response to be measured (see Materials and Methods). The 
decreased avidity of IgG2a responses to LsA (Figure 5d Table 3) is in line with the 
hypothesis that increased Pcc dose results in decreased avidity of cross-reactive 
responses. Although not statistically significant this trend was also seen for IgG2a 
responses to HpA (Figure 5e Table 3). Contrary to hypothesis iii), the avidity of 
Response Variable df Factor F ratio P value 
     
High avidity anti-LsA IgG2a     
 [F1, 29 Experiment  2.45 0.1284] 
 F1, 30 Pcc Dose 5.56 0.0251* 
     
High avidity anti-HpA IgG2a     
 [F1, 29 Experiment  0.46 0.5048 
 F1, 30 Pcc Dose 2.15 0.1530 
     
High avidity anti-NbA IgG2a     
 [F1, 116 Experiment 0.21 0.6489] 
 [F1, 115 Nb 0.04 0.8517] 
 F3, 117 Pcc Dose 5.06 0.0013* 
 [F3, 112 Nb*Pcc Dose 0.27 0.8475] 
     
High avidity anti-NbA IgG1 [F1, 116 Experiment 2.08 0.1518] 
 [F1, 115 Nb 0.73 0.3931] 
 F3, 117 Pcc Dose 2.82 0.0422* 
 [F3, 112 Nb*Pcc Dose 1.44 0.2351] 
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cross-reactive responses to NbA (IgG2a and IgG1) increased with increased dose of 
Pcc (Figure 5f, Figure 7 and Table3).  This effect of dose also applied to co-infected 
mice (Table 3) but conclusions regarding cross-reactive responses are drawn from 
the response induced in Pcc-only mice. There was no change in the avidity of 



































Figure 7: High avidity antibody responses in malaria and co-infected mice. 
The antibody response to NbA that is of high avidity is presented as the avidity 
index (y-axis). Th2 responses indicated by IgG1 (a) and Th1 responses by IgG2a 
(b) Single Pcc infections are shown in white bars with the different Pcc inocula 
doses of 1x103, 1x104, 1x105 and 1x106 Pcc-infected RBC denoted as Pcc3, Pcc4, 
Pcc5 and Pcc6 respectively. Co-infected mice are additionally denoted with ʻNbʼ and 
are shown in the chequered bars. Graph shows mean and standard errors of 16 
mice per group. Significant pairwise differences according to Tukeyʼs post-hoc test 
and the corresponding P-values are summarised in the text boxes. 
 131 
 
For several of the antibody responses measured the observed variation was explained 
by Pcc dose (Table 2 and 3). I sought to determine if some factor associated with 
dose such as cumulative parasite density could account for this effect. Controlling for 
cumulative parasite density in the statistical model did not help to explain the effect 
of dose on antibody responses with the exception of IgG2a responses to MSP-119 
(Cumulative Density, F9, 111=4.49, p=0.0363). This suggests that some property of 
dose other than cumulative parasite density is important. Although earlier I reasoned 
that differences in cumulative density would equate to differences in antigen 
exposure it seems that this is insufficient to explain the dose-dependent effect. 
Cumulative density as a measure of antigen exposure may be too simple; perhaps, for 
example, the point at which parasite density exceeds a certain threshold could be 
key. This alternative explanation could also be dose-dependent; the change in the 
kinetics of parasitaemia observed for the different doses (Figure 2a) could result in 
the highest dose of Pcc exceeding the threshold first, so that induction of the 
antibody response occurs earlier and maturation of the antibody response takes place 




“Who goes there?” is a simple question that illustrates the immune system’s need to 
gather information to recognise when a host is under attack and from what. This 
information processing occurs at the molecular level via T- and B-cell receptors 
binding antigen. It is not enough to simply register infection: successfully combating 
infection requires the immune system to ‘make decisions’ regarding what type of 
effector response (e.g. Th1 or Th2) should be deployed and precise targeting of the 
immune response (pathogen-specificity) requires discrimination of different 
pathogens. When faced with co-infection these decisions are potentially further 
complicated by the need to manage counter-regulatory responses and prioritise 
immune targeting of the predominant pathogen.  A better informed immune system 
should help ensure the most appropriately balanced outcome. Indeed B-cells through 
production of affinity matured specific antibody display ‘immunological learning’ 
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when provided with information (antigen) (Rajewsky 1996). I increased the 
inoculating dose of Pcc (antigen dose) as a means of increasing information 
provision to assess the effect this would have on antibody responses in both single 
and co-infecion. Immune bias, antibody specificity/ cross-reactivity and avidity for 
antigen were used to determine whether the opportunity to gather more information 
on the Pcc antigen would improve immune targeting of this parasite.  
 
The dogma that increasing parasite dose causes a switch from Th1 to Th2 does not 
always hold true.  
 
The patterns of cytokine production that ultimately determine Th1/Th2 immune bias 
can be influenced by many factors such as the route of infection, antigen affinity and 
antigen dose (Constant and Bottomly 1997; Cho, Chang et al. 2000; Zinkernagel 
2000; Kaur, Kaur et al. 2008). In many model systems of parasite infection as 
antigen dose increases the response switches from Th1 to Th2 characterised by the 
production of IFN! or IL-4 respectively (Menon and Bretscher 1998; Ismail and 
Bretscher 1999; Bancroft, Else et al. 2001; Shata, Tricoche et al. 2003). The effect of 
dose on Th1/ Th2 bias can also be defined by the antibody isotype produced (Fairlie-
Clarke, Lamb et al. 2010). Characterisation of immune bias in this way reveals the 
same dichotomy for infectious agents and soluble antigens discussed previously; 
where low or high dose of the parasites L. donovani and T. muris results in 
production of IgG2a (Th1) or IgG1 (Th2) respectively (Bancroft, Else et al. 2001; 
Kaur, Kaur et al. 2008) whereas a shift from IgG1 to IgG2a is seen with increasing 
dose of the soluble antigen HEL (Cho, Chang et al. 2000). The induction of Th1 
responses at low dose is supported by studies of malaria infection in which T-cells 
exclusively produced IFN! during sub-patent infections (Pombo, Lawrence et al. 
2002).  
 
Experimental models that manipulate the dose of an antigen or pathogen aim to 
capture the variation in dose that arises through natural exposure to pathogens, as 
ethical constraints often restrict research in humans. Thus observations from ‘natural 
experiments’ are extremely valuable, for example a human population with natural 
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variation in malaria endemicity revealed increasing cumulative exposure to antigen 
resulted in a gradual skew toward IgG1 (Th1) antibody production (Tongren, 
Drakeley et al. 2006).  Interestingly, infection of human volunteers with sub-patent 
doses of P. falciparum resulted in exclusive production of IFN! (Pombo, Lawrence 
et al. 2002). Taken together, these data suggest that malaria elicits Th1 responses that 
increase with dose. My experimental set-up reflected changes in cumulative antigen 
exposure, albeit over a very short timescale, as introducing malaria infection with a 
range of inoculating doses and terminating the infection at day 11 capitalised on the 
shift in malaria parasite growth dynamics such that mice were exposed overall to 
different parasite densities. The results reported in this chapter support the findings 
of Tongren et al (Tongren, Drakeley et al. 2006) as the data indicates Th1 bias is 
more pronounced with increased Pcc dose. Of course it is important to acknowledge 
the limitations of extrapolating animal models to human populations as how the 
pathogen is introduced (e.g. route of administration, life cycle stage) may not 
accurately reflect induction of, for example, malaria-specific immune responses 
following the bite of an infectious vector. Nonetheless, the study of these dynamics 
in animal models can give us fundamental information that may help assess 
observations available from human studies. 
 
It is generally thought that the dichotomy of how antigen dose affects immune bias is 
due to the type of antigen used (Constant and Bottomly 1997; Cho, Chang et al. 
2000). Thus the results presented here (and those of Tongren et al (Tongren, 
Drakeley et al. 2006)) are contrary to the current thinking that increasing the dose of 
parasite antigen (as opposed to soluble antigen) will result in a Th2 biased 
environment. I would argue that attempting to apply this generalisation to the vast 
array of parasites and associated antigens that a host may encounter is unrealistic.  
Indeed there is evidence that this ‘rule’, which applies to T.muris (Bancroft, Else et 
al. 2001) does not hold for other helminths; infection with as little as 6 N.brasiliensis 
larvae induces a potent Th2 response that is only enhanced at higher doses 
(Lawrence, Gray et al. 1996). Similarly, low or high dose infection of BALB/c mice 
with the liver fluke F. hepatica induces a Th2 response. Interestingly, infection of an 
alternative host (C57BL/6 mice) with this parasite does induce a switch from Th1 to 
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Th2 with increasing dose (O'Neill, Brady et al. 2000), suggesting host genotype can 
also be an important consideration in attributing an effect of dose on immune bias. 
Other factors such as antigenic differences between parasites may also exert an 
influence over cytokine induction, this is elegantly demonstrated by infection with 
Trichinella spiralis or the subspecies T. pseudospiralis, which induce Th1 and Th2 
biased responses respectively (Wakelin, Goyal et al. 1994).  Understanding the effect 
of dose on immune-bias is certainly not straightforward and demonstrates the need 
for further research in this area.  
 
Co-infection with malaria and helminths can influence immune bias due to the 
counter-regulatory nature of the Th1 and Th2 response induced by each parasite 
(Abbas, Murphy et al. 1996).  Here I investigated how increasing the dose of Pcc 
could further influence immune bias and investment in Th1 immune responses 
during co-infection. In co-infected mice as Pcc antigen dose increased the magnitude 
of the IgG2a (Th1) response increased with a corresponding decrease in the IgG1 
(Th2) response. This bias toward Th1 was further supported by the dose-dependent 
reduction in total IgE responses in co-infected mice. On a proximate scale this shift 
in immune bias could be a consequence of increased Pcc parasite load (relative to 
Nb), registered via stimulation of TLRs and T-cell receptors. Several studies have 
shown that activation of TLR9 on innate immune cells (e.g. dendritic cells) by 
merozoites or hemazoin results in IL-12 induction by antigen presenting cells (e.g. 
dendritic cells) and subsequent production of IFN! from T-cells (Coban, Ishii et al. 
2005; Franklin, Parroche et al. 2009). The TLR-9 driven production of these 
cytokines increases with pathogen dose and may increase Th1 cell differentiation 
(Wu, Gowda et al. 2010). Due to activation by high levels of Pcc antigens these Th1 
cells are likely be Pcc-specific and will in turn drive the production of Th1 Pcc-
specific antibodies from B-cells. Such an antigen-dose-dependent increase in 
antibody production was observed by Coban et al (Coban, Igari et al. 2010) who also 
noted the adjuvant effect that TLR-9 stimulation had on this response. Increased 
production of Th1 antibodies can also be driven by direct stimulation of TLR-9 on B-
cells (Jegerlehner, Maurer et al. 2007; Eckl-Dorna and Batista 2009). The proximate 
cause of increased Th1 antibody production in this system is therefore increased dose 
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of Pcc antigen and in all likelihood the associated TLR ligands but the ultimate cause 
is to assess which parasite poses the greater threat and to mount an appropriate 
response to ensure survival of the host. 
 
Increasing Pcc dose does not reduce cross-reactive responses suggesting Nb and Pcc 
share antigens. 
 
For a host to successfully target a particular parasite relies on the adaptive immune 
system discriminating between invading pathogens by having a receptor to match 
every potential antigen. In theory this is possible as the process of somatic 
hypermutation results in a staggering degree of B-cell receptor diversity (Pancer and 
Cooper 2006). However, antibody cross-reactivity suggests that there is some 
limitation imposed on the system (Fairlie-Clarke, Shuker et al. 2009), and there are 
many cases of antibody recognising epitopes on two different pathogens (Xu and 
Powell 1991; Naus, Jones et al. 2003; Casadevall and Pirofski 2007; Nguyen, Zemlin 
et al. 2007). In earlier chapters and (Fairlie-Clarke, Lamb et al. 2010) I have 
demonstrated that this cross-reactivity is also observed in the Pcc-Nb model. It is 
possible that some degree of cross-reactivity is maintained when fewer rounds of 
somatic hypermutation are undergone, which might be the case when antigen is 
limiting. If cross-reactivity is simply a result of the immune system not having the 
opportunity of ‘getting to know’ the antigen then in this model increasing Pcc 
antigen should enable antibody to become specifically tuned to Pcc antigens and 
(cross-reactive) recognition of nematode antigens, for example, would diminish.  As 
predicted antigen-specific IgG2a antibody responses increased as Pcc dose increased 
however the suggested trade-off in ability to bind other parasite’s antigens was not 
evident; the cross-reactive IgG2a response of Pcc-mice to nematode antigens NbA, 
LsA and HpA also increased with Pcc dose. Both antigen-specific and cross-reactive 
IgG1 responses decreased in a dose-dependent manner, which reflects the dose-
dependent increase in Th1 bias discussed earlier.   
 
Increased specificity for an antigen is also reflected in the strength of antibody 
binding (avidity) and this can also be improved through rounds of somatic 
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hypermutation. At higher levels of antigen there is greater potential for cells to 
undergo more rounds of somatic hypermutation, each round being interspersed with 
the need to test antigen-binding (Gonzalez-Fernandez and Milstein 1998). Antibodies 
that have undergone somatic hypermutation and affinity maturation in the context of 
malaria infection should be selected for improved specificity (binding) to Pcc 
antigens. This leads to the prediction that increasing Pcc dose will increase the 
avidity of antibody for Pcc antigen and reduce avidity to nematode antigens. The 
proportion of antibodies that bound with high avidity was determined by comparing 
antigen binding in ELISA in the presence and absence of a hydrogen-bond 
dissociating agent (urea). Low avidity antibodies that rely more heavily on hydrogen 
bonds are preferentially dissociated from the antigen by this method (Bjorkman, 
Naslund et al. 1999; Yasodhara, Ramalakshmi et al. 2001).   
 
The avidity of cross-reactive antibodies to NbA in the Pcc mice increased with dose. 
This was true of both the IgG1 and IgG2a response. In contrast antibody binding to 
LsA and HpA was mostly of low avidity. It should be noted that there is some 
evidence that high doses of antigen in contrast to selecting for highly specific 
antibodies actually enhance selection of cross-reactive or low avidity antibodies. The 
idea behind this is that at lower doses when antigen is limited high affinity antibodies 
bind to antigen more rapidly and prevent the antigen-dependent selection of other 
less-specific B-cell clones (Gonzalez-Fernandez and Milstein 1998; Eisen and 
Chakraborty 2010).  Although we observed increased cross-reactivity at higher doses 
our data does not support this theory, as better avidity was not selected for at low 
dose. The propensity for this competitive exclusion of low-avidity antibodies to 
occur at low dose may depend on the nature of the selecting antigen (Eisen and 
Chakraborty 2010). A complex mixture of antigens such as a parasite inoculate may 
be more likely to select for antibodies capable of binding a variety of epitopes (with 
variable avidities), whereas a defined antigen such as MSP-119 may select for highly 
specific antibodies of uniform avidity. In support of this titrating in malaria results in 
a more linear increase in the antibody response to MSP-119 than to PcL. 
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The fact that cross-reactive responses to NbA increased in avidity with increasing 
dose strongly suggests that Pcc and Nb have shared antigens. In other words there is 
an epitope (antibody binding site) that Pcc-induced antibodies are capable of 
recognising on both Pcc and Nb. This is supported by western blot data, which shows 
that Pcc anti-sera binds to antigens present in both NbA and PcL.  Such shared 
antigens have previously been identified for S. mansoni and P. falciparum; a putative 
P.falciparum protein showed 57% amino acid identity to the 64kDa protein 
“SmLRR” from S. mansoni and this protein was bound by antibodies induced by 
both infections (Pierrot, Wilson et al. 2006). Often such cross-reactivity is found to 
be due to conserved carbohydrate moieties (Xu and Powell 1991; van Remoortere, 
Bank et al. 2003) but I have shown this is not the case in the recognition of NbA by 
Pcc-induced antibody (Chapter 5 and (Fairlie-Clarke, Lamb et al. 2010)). In the case 
of LsA and HpA it is feasible that cross-reactivity may be due to recognition of 
conserved carbohydrates and may offer an explanation as to why the avidity with 
which Pcc-induced antibodies bound these antigens decreased with increased Pcc 
dose. This begs the question as to why malaria-induced antibodies maintain the 
ability to recognise N. brasiliensis and not other nematodes (i.e. L. sigmodontis and 
H. polygyrus)? The asexual stages of Pcc infect erythrocytes and circulate in the 
blood and migration of Nb larvae causes significant haemorraghing in the lungs 
(Hoeve, Mylonas et al. 2009), as does adult feeding on the gut wall (Variyam and 
Banwell 1982). In contrast H. polygyrus resides in the gut lumen and L. sigmodontis 
in the lymphatics. Perhaps the propensity for both Nb and Pcc antigens to be 
encountered in the circulatory system has led to the selection of cross-reactive 
antibodies. It is possible that if a shared antigen does exist between these parasites its 
function may relate to the adaptation of these parasites to survive in the blood for 
periods of their life cycle.  Interestingly S. mansoni, which resides in the hepatic 
portal vein is recognised by P.falciparum induced cross-reactive antibodies, lending 
some support to the idea that a shared niche may be important for the maintenance of 
cross-reactive antibodies to these taxonomically distinct parasites.  
 
Earlier I hypothesised that cross-reactivity might be overcome with the opportunity 
to gather more information about one of those antigens. This appears not to be the 
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case for NbA and Pcc, rather the information given to the immune system (regardless 
of dose) is that these 2 antigens (NbA and PcL) are similar. As shown by the 
persistence of cross-reactive responses at high dose and the western blot data that 
revealed proteins common to both parasites. However, when we consider cross-
reactivity to the other nematode antigens (LsA and HpA) increasing information 
provision (Pcc dose) reduced the avidity of cross-reactive responses to these antigens 
so I would argue that the immune system is capable of discriminating between 
malaria and these other nematode antigens. Yet cross-reactivity, albeit of low avidity, 
persists at high Pcc-dose. It is interesting to speculate that maintaining some degree 
of cross-reactivity may benefit the host if it allows recognition of more than one 
antigen by fewer B-cells, this may be particularly important for a resource limited 
host (Fairlie-Clarke, Shuker et al. 2009; Eisen and Chakraborty 2010).  
 
What underlies the dose-dependent effect on antibody responses? 
 
As Pcc dose was found to have a significant impact on antibody production I sought 
to determine if cumulative parasite density, which differed significantly with dose 
was responsible. For all responses, except anti-MSP-1 IgG2a, cumulative density did 
not explain the observed variation in antibody response. This suggests that the dose-
dependent increase in Th1 antibody responses was not due to cumulative antigen 
exposure (cumulative parasite density). In trying to understand what factor may be 
responsible for the dose-dependent effect observed it is important to acknowledge 
the caveats of the experimental design used. Namely those dose-dependent effects 
that result in differences in cumulative parasite density are inextricably linked to 
changes in the kinetics of infection. Previous experiments (see Chapter 2 Figure 3 & 
Chapter 3 Figure 1a) have shown that antibody production initially occurs 
approximately 2 days after asexual parasites are measurable by microscopy in blood 
smears, indicating that antibody production may occur after some critical parasite 
density is exceeded. If the period of time available for B-cells to proliferate and 
differentiate into plasma cells, after stimulation by a critical level of antigen, has 
more influence on antibody production than stimulation by increased antigen 
exposure then the dose-dependent effect on infection kinetics may be crucial. In this 
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experimental design mice that experienced the highest dose of Pcc could have 
produced antibody from day 5 p.i onwards whereas those mice experiencing the 
lowest dose may only have begun producing antibody at day 9 or 10 p.i. Thus at 
higher dose the magnitude of the antibody response may not only be greater but 
exhibit enhanced specificity/avidity due to extended opportunity for affinity 
maturation. To untangle the effect of parasite-dose and changes in infection kinetics, 
inoculation with different concentrations of whole parasite antigen rather than live 
parasites could be used.  
 
In summary increasing the dose of Pcc antigen resulted in antibody responses that 
were increasingly Th1 biased in both single (Pcc) and co-infection. Increasing Pcc 
antigen dose did not result in the reduction of cross-reactive responses to Nb antigen. 
Antibody avidity to Pcc antigen was not changed by dose but avidity to Nb antigen 
was increased at higher doses.  Increasing the level of information provision to the 
immune system by altering antigen dose resulted in immune responses that were 
increasingly tailored to targeting malaria in terms of immune bias (Th1). However 
the anticipated trade off in reduced recognition of Nb antigen was not evident 
suggesting that cross-reactivity in this system was due to these antigens having 




Understanding how pathogen dose affects immune responses has important 
implications for disease outcome and health management. Dose-induced changes in 
immune bias can mean the difference between resistance/ susceptibility to disease 
(Menon and Bretscher 1998). The design of effective vaccine strategies often relies 
on the induction of Th1 or Th2 responses and dose is an important means of 
manipulating the desired response (Power, Wei et al. 1998). These issues have 
received due attention in the literature but whilst the influence of co-infection on 
immune bias and disease outcome is reported (Spiegel, Tall et al. 2003; Sokhna, Le 
Hesran et al. 2004; Lyke, Dicko et al. 2005; Ezenwa, Etienne et al. 2010) there is a 
paucity of data of the type reported here that investigates the effect of pathogen dose 
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on immune responses during co-infection, with the exception of (Montano M 2005). 
As animal models strive to reflect natural infection, incorporating co-infection and 
differential exposure to pathogens (dose) is important for capturing the situation in 
natural populations where co-infection is the norm and exposure to parasites is 
anything but uniform.  
 
To my knowledge this study is the first to show Pcc-induced cross-reactivity to Nb 
by Western blot and this data highlights the potential for interactions between these 
two pathogens to be mediated by immune targeting of cross-reactive antigens. 
However, the functional consequences of these cross-reactive responses have yet to 
be elucidated. From an evolutionary standpoint targeting cross-reactive antigens may 
be beneficial to the host if it enables recognition of various pathogens to be achieved 
by fewer B-cells. It would be interesting to determine if individuals with natural 
variation in their B cell population varied accordingly in production of cross-reactive 
antibodies. Genetic variants exist that result in a reduced response to stimulation via 
the B cell receptor (Rieck, Arechiga et al. 2007), potentially cross-reactive binding 
could ameliorate this effect by engaging more B cell receptors. Investigating the 

















Materials and Methods 
 
Immunocytochemistry 
Spleen sections from control, Nb, Pcc3, Pcc6, NbPcc3 and NbPcc6 mice (see 
Chapter 6 for nomenclature) were stained with fluorescent antibodies to identify 
germinal centres and IgG or IgM positive plasma cells.  
 
Tissue sectioning 
Whole spleens removed post-mortem from BALB/c female mice were placed in 
moulds and immediately covered in Tissue Tek O.C.TTM compound on dry ice. 
These frozen blocks were stored at -80oC prior to being cut into 5µ sections by 
Cryostat and mounted on microscope slides at the Queen Margaret Research Institute 
histology department (University of Edinburgh). Sections were left to air dry at room 
temperature for 1 hour and then stored at -20oC until use. 
 
Fixing tissue sections 
Sections were removed from -20oC and allowed to reach room temperature whilst 
remaining in a sealed box to prevent condensation forming. Sections were then 
submerged in acetone at 4oC for 20 mins to fix the sections. The sections were stored 
at -20oC until required for immuno-staining with fluorescent antibody.  
 
Staining sections 
Sections were removed from -20oC and allowed to reach room temperature whilst 
remaining in a sealed box to prevent condensation forming. Sections were then 
submerged in a blocking solution of 1% BSA: sterile PBS for 15 mins at room 
temperature. Primary antibodies were all used at 1:100 dilution in 1%BSA:PBS; 
PNA- Fluorescein Peanut Agglutinin (5mg/ml Vector laboratories FL-107), IgM- 
Goat anti-mouse IgM conjugated to Texas Red (1mg/ml Southern Biotech 1021-07) 
and IgG- Goat anti-mouse IgG conjugated to Biotin-SP (1.4mg/ml Jackson 
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ImmunoResearch laboratories 115-066-008). 50µl of this antibody cocktail was 
added to each section and incubated at room temperature for 2 hours in a hydrating 
chamber protected from light. The sections were then washed 3 times by quenching 
the slides in PBS for 5 mins. A secondary antibody Streptavidin Alexafluor 350 
(1mg/ml Invitrogen S11249) was added to label the primary IgG antibody (others 
were directly conjugated). 50µl of a 1:100 dilution of antibody: 1% BSA:PBS was 
added to each section and incubated at room temperature for 1 hour in a hydrating 
chamber protected from light. Sections were washed 3 times in PBS as before. 
Sections were then covered with a cover slip secured by Mowiol mountant medium 
with 2.5% DABCO (fluorescence stabilizer) added. Sections were stored at 4oC in 
the dark.  
 
Imaging 
Immuno-staining of the tissue sections was visualized by fluorescence microscopy 
x10 magnification. PNA labeled green by FITC stained germinal centers, B-cells and 
IgM positive plasma cells were stained in red by Texas Red and IgG positive B-cells 
and plasma cells were labeled blue by Alex Fluor 350. Individual photographs were 
taken for each stain and then merged to give a 3-colour image using Improvision 
Openlab 5.5.1 software.  
 
Image quantification 
ImageJ software version 10.2 (developed by NIH for the public domain) was used to 
quantify the size of the germinal centre and the proportion of IgG positive cells in a 
representative area of the tissue section. The germinal centre, identified by PNA 
staining, was outlined and the software calibrated so that the area of the germinal 
centre was recorded in mm2.  
 
Rather than counting individual cells the proportion of IgG postive cells in a 
representative microscope field was calculated. Fluorescence falling within the range 






The analyses presented here relate to a subset of mice from a single experiment. 
Female BALB/c mice were infected with two different inoculating doses of Pcc 
parasitised RBC (1x103and 1x106) with or without co-infection of Nb (200 L3) on 
day 0. A group of mice infected with Nb only and control mice, which received 
nRBC (1x105) and PBS as sham injections for Pcc and Nb respectively, were also 
included. There were 8 mice per infection group.  
 
The analysis focussed on 48 mice. All analyses were carried out in the statistical 
package JMP 8.0 (SAS) using GLM. Main effects were worm presence or absence 
(Nb), and malaria inoculation dose 1x103 or 1x106 (Pcc dose) fitted as categorical 
variables. The main effects and the interaction between them (Nb*Pcc dose) test 
whether the response variables (germinal centre size and proportion of IgG positive 
plasma cells) are affected by changes in Pcc dose, Nb status or both. Maximal 
models were first fit to the data and the minimal models were reached by removing 
non-significant terms (p >0.05) beginning with interactions. Finally, significant 
pairwise differences (p<0.05) between groups were determined using the Tukey’s 
All Pairs adjusted p-values for the most complex term in the minimal model.Results 









APPENDIX FIGURE 1: Representative spleen sections stained for germinal centres, 
IgG and IgM positive plasma cells. Section from control a) Nb infected b) 1x103 Pcc-
infected c) 1x103 PccNb infected d) 1x106 Pcc-infected e) and 1x106 PccNb infected 
f) are shown. Germinal centres are stained green, IgM positive plasma cells red and 





                                                                                                                 









































APPENDIX FIGURE 2: The size of germinal centres a) and the proportion of IgG positive 
plasma cells b) for mice infected with different doses of Pcc with or without Nb infection are 
shown. Control mice are represented by the grey bars, Nb only mice by the black bars, 
singly infected Pcc mice in white bars and co-infected mice (Pcc-Nb) by chequered bars. Pcc 
dose is denoted Pcc3 or Pcc6 corresponding to inoculating dose of 1x103 or 1x106 
respectively. Graph shows mean and standard errors of 8 mice per group. Significant 
pairwise differences were determined from the Tukeyʼs adjusted P-values of the most 























                 
 
 
APPENDIX FIGURE 3: Western blot of nematode antigens (25μg) probed with anti-
sera from individual mice infected with Pcc (1x106 Pcc-infected RBC).  Antibody 
binding (IgG) to H. polygyrus antigen (HpA), L. sigmodontis antigen (LsA), N. 
brasiliensis antigen (NbA) and P. chabaudi lysate (PcL) is shown. The size of the 
bands (kDA) is indicated by reference to the protein standard (L). 
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TABLE 1: Results of GLM for germinal centre size and proportion of IgG positive plasma 
cells. Non-significant terms come from last model before term was dropped and are shown in 
square brackets. F statistics and P values of significant terms (P<0.05) come from the 
minimal model. Significant pairwise differences were determined from the Tukeyʼs adjusted 
P-values of the most complex term in the model and are shown in Figure 1. 
 
Response Variable Factor df F ratio P value 
     
Germinal centre size     
 Pcc Dose 2,29 2.80 0.0773 
 
Nb 1,29 3.61 0.0672 
 Nb*Pcc Dose 2,29 9.44 0.0007* 
     





Pcc Dose 2,40 6.43 <0.0038* 
 
[Nb 1,37 1.83 0.1844] 
 [Nb*Pcc Dose 2,37 0.38 0.6876] 
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Chapter 7: General Discussion 
 
The underlying motivation for this thesis was to understand how a host preserves its 
own fitness when exposed to infection with an unpredictable diverse array of 
parasites each of which has evolved complex strategies to exploit the host. This is 
compounded by the likelihood that the host will be co-infected. To tackle the 
complexity implicit in this question I have used a murine model of malaria-
hookworm co-infection to investigate host-parasite interactions that may influence 
disease outcome. Utilising a mouse model means that variation in exposure to 
parasites, infection history, variation in host and parasite genotype can all be 
controlled, which in a natural population would be impossible. Of course it is 
important to acknowledge that the use of animal models also has its limitations in 
terms of the generalisation of my findings to other systems, in particular human 
populations. The specific findings of each set of experiments (Summarised in Figure 
1) are discussed in detail at the end of each chapter. Here I will address my general 
findings and how they relate to the concept of a host evolving an optimal strategy to 
contend with co-infection and the importance of considering host-parasite 






                        

























Figure 1: Summary of the specific findings of each results chapter. Arrows indicate 
chapters that are linked by themes or findings of previous chapters. 
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7.1 Do immune responses in co-infection represent an optimal strategy? 
 
The key role of the immune system is to defend the host from infection. This 
presents an enormous challenge when you consider the vast diversity of pathogens it 
could be exposed to. To efficiently combat infection the host must distinguish 
between different pathogens in order to mount appropriate effector responses and 
failure to do this can have serious health consequences (Mwatha, Jones et al. 2003; 
Balsitis, Williams et al. 2010). Pathogen infections can be broadly categorised as 
‘microparasites’ (e.g fungi, viruses, bacteria, intracellular parasites) and large 
extracellular parasites (e.g helminths). The effector responses that are required to 
control these different parasites also fall broadly into two categories; Th1 responses 
to ‘microparasites’ and Th2 responses to helminths (Abbas, Murphy et al. 1996; 
Ezenwa, Etienne et al. 2010; Kolbaum, Ritter et al. 2011). This is an 
oversimplification of the different arms of the immune system that extend to Th17 
and regulatory (T-reg) responses with the prospect of more on the horizon (Locksley 
2009). However it is a useful simplification for studies that address the question of 
immune-bias in ‘microparasite’-helminth co-infection. The focus on Th1 and Th2 
responses in this malaria- helminth (P. chabaudi (Pcc)- N. brasiliensis (Nb)) co-
infection study is further justified, as Th1 effector responses are crucial for the 
control of Pcc infection (Cavinato, Bastos et al. 2001; Stevenson and Riley 2004). 
Similarly Th2 responses are the main effector response initiated in response to Nb 
(Nel, Hams et al. 2011) whereas the involvement of T-regs in this acute helminth 
infection may be limited (Smits, Everts et al. 2010). 
 
A theme that runs throughout this thesis is the idea that hosts faced with co-infection 
by diverse parasites are required to mount optimal immune responses. During co-
infection due to the counter-regulatory nature of Th1 and Th2 responses it is not 
possible for a host to mount a strong response of both types (Mosmann and Sad 
1996), such that a host is required to balance these responses to arrive at some 
optimal immune bias (Fenton, Lamb et al. 2008). Why Th1 responses predominate 
over Th2 or vice-versa during co-infection is open to debate but it has been 
suggested that the optimal immune response may reflect the need to prioritise 
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defence against the most virulent parasite (that which causes most harm to the host) 
(Graham 2001). Increased parasite abundance is one mechanism by which parasites 
may cause harm to a host. Increased parasite load will be associated with an increase 
in the levels of antigen the immune system is exposed to. This could therefore 
provide a proximate measure of parasite abundance and ultimately lead to immune 
targeting of the more predominant parasite. This study explores these concepts in the 
Pcc-Nb model of co-infection by measuring immune bias (Th1/ Th2 balance) and 
how this is affected by parasite dose.   
 
This thesis provides two key results relevant to better understanding immune bias in 
co-infection. Firstly, helminth (Nb) co-infection resulted in a reduction in the 
malaria-specific Th1 antibody response, whilst Pcc infection negatively impacted the 
Th2 antibody response to Nb. This confirms the cytokine production observed in 
spleen cell culture (Hoeve, Mylonas et al. 2009) thus demonstrating that using a 
different sampling strategy (serum for antibody ELISA), more accessible to field 
biologists provides a robust measure of Th1/ Th2 bias. Secondly, increasing Pcc dose 
was associated with an increase in malaria-specific Th1 responses. Taken together 
these results support the idea that the host manages the Th1/ Th2 bias in order to 
simultaneously combat these diverse parasites and that the immune system responds 
to antigen (parasite) load by preferentially targeting the parasite that poses the 
greatest threat. Further investigation of this result is warranted in other murine 
models of co-infection. In particular understanding how immune bias is shaped by 
chronic -as opposed to acute- helminth infection or variation in dose of both 
helminths and malaria may help to determine the mechanisms that underlie the 
diverse effect of co-infection on disease outcome.  
 
In the course of analysing antibody isotype production to determine bias in the 
immune response I discovered that singly infected hosts produced cross-reactive 
antibodies that recognised antigens from parasites they had never been exposed to. 
The production of cross-reactive antibodies that convey protection against antigenic 
variants of the influenza virus (Sandbulte, Jimenez et al. 2007; Straight, Ottolini et 
al. 2008) or certain combinations of serotypes of Dengue (Endy, Nisalak et al. 2004) 
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can be viewed as an optimal host strategy. By mounting an antibody response 
capable of targeting different pathogen strains the host maximises the benefit, whilst 
conserving the cost, of mounting an immune response. This idea could be tested via 
nutritional restriction of laboratory mice. Admittedly, it stretches the imagination to 
consider this antibody ‘multi-tasking’ applied to parasites as diverse as malaria and 
helminths. Indeed cross-reactivity is viewed by some as nothing more than 
‘background’ binding as a result of non-specific interactions between hydrophobic 
ligands and antigen binding sites (hydrophobic stickiness) (Padlan 1994). However, 
the ability of antibodies to bind unrelated antigens through specific hydrogen bonds 
and by displaying conformational binding-site diversity has been shown (James, 
Roversi et al. 2003; James and Tawfik 2003). This in addition to the magnitude of 
the cross-reactive titres observed in this model implying immune investment lends 
weight to the argument that production of cross-reactive antibodies may be a 
deliberate strategy of the host to increase the antibody repertoire (and so recognition 
of antigens/ parasites) at reduced ‘cost’; the ultimate in ‘two for one’ offers.  
 
It is of course possible that the production of cross-reactive antibodies is not a 
deliberate strategy of the host but rather arises because of some constraint on the 
immune process that leads to increased antigen-specificity and avidity (strength of 
binding to antigen) i.e. somatic hypermutation. For example reduced rounds of 
somatic hypermutation due to limited antigen availability may mean that, even if it is 
advantageous, the host is not able to produce antibodies that distinguish between Pcc 
and Nb antigens. The attempt to determine if this was the case did not support the 
idea that constraints on immune specificity resulted in cross-reactive antibodies; at 
higher Pcc doses (increased antigen availability) antibodies of greater avidity to Pcc 
antigens were selected, however these antibodies also bound Nb antigens more 
avidly.  
 
Importantly cross-reactive binding to different parasite antigens could occur because 
two different antigens share an epitope, as is the case for S. mansoni and P. 
falciparum (Pierrot, Wilson et al. 2006). In this sense antibodies are only cross-
reactive in that they bind (recognise) phylogenetically different parasites. In the co-
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infection model studied here Pcc-induced cross-reactive antibodies bound to Nb 
antigens but whether these antibodies exhibit binding because the antigens share an 
epitope or because flexibility in the antigen-binding site of the antibody permits 
binding of unrelated antigens is yet to be determined. Antigen cross-absorption 
assays of the kind described by (Naus, Jones et al. 2003) could clarify if the same 
antibody molecule is binding to both Nb and Pcc antigens. Western blot assays 
suggest that there may be a shared antigen as proteins of similar molecular weight 
were bound in malaria and Nb antigen preparations. Further proteomic analysis (e.g. 
mass spectrometry) of the Nb and Pcc antigens that are recognised by Pcc anti-sera 
in Western blots could identify shared antigens. If these (putative) shared antigens 
represent an adaptation of the parasite to a particular niche within the host (e.g. the 
circulatory system) then immune-targeting of these conserved antigens, rather than 
being a strategy of the host, is due to a constraint imposed on blood-borne parasites. 
 
Although it appears that the host is managing the immune response in such a way as 
to combat the parasite that poses the greatest threat during co-infection this can only 
be considered an optimal strategy if it conveys some fitness benefit to the host. In the 
Pcc-Nb model helminth co-infection afforded protection from malaria indicated by 
reduced parasitaemia and less severe anaemia. Of course the underlying mechanism 
for this cannot be inferred without consideration of other factors such as the ecology 
of the co-infecting parasites.  
 
7.2 Considering within-host interactions in a community ecology framework. 
 
Community ecologists appreciate the importance of considering both top-down and 
bottom-up mechanisms of regulation in determining the numbers or biodiversity of 
species (Burkepile and Hay 2006; Elmhagen and Rushton 2007). These mechanisms 
are also relevant to the structuring of parasite communities within a host (Bradley 
and Jackson 2004; Jackson, Pleass et al. 2006; Stancampiano, Mughini Gras et al. 
2010; Telfer, Lambin et al. 2010). However few studies consider that both ‘top-
down’ and ‘bottom-up’ mechanisms of regulation may play a role in determining 
disease outcome and those that do e.g. (Pedersen and Fenton 2007; Graham 2008) 
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are a meta-analysis and review of the available literature. There is a paucity of data 
in which both factors have been measured explicitly, using the Pcc-Nb model meant 
that this was possible. To assess the influence of top-down regulation on disease 
outcome the potential for ‘bottom-up’ regulation via competition for red blood cells 
was alleviated by manipulating the timing of Nb-induced anaemia. Hosts in which 
resource (red blood cell)- competition was alleviated but effects of co-infection on 
immune response were maintained were not ‘protected’ from malaria peak 
parasitaemia or anaemia. Thus it seems that resource-mediated mechanisms were 
more influential than immune-mediated mechanisms in determining disease 
outcome, a finding that could easily have been overlooked if within-host interactions 
had not been considered from a community ecology perspective.  
 
7.3 How applicable are the findings to other co-infection studies?  
 
It is important to emphasise that animal models such as the one used in the 
experiments reported here are just that ‘models’ of infection in natural populations. 
Inevitably there are limitations to extrapolating the findings in animal models to 
humans particularly when there are known differences in the mechanisms that 
underlie disease pathology (as discussed in the General Introduction). Rather than 
dwell on these caveats I would like to highlight how the findings of this thesis relate 
to studies of co-infection in general.  
 
Perhaps the most basic finding of this thesis was the ability to discern immune bias 
via the analysis of Th1 and Th2 antibody isotypes provided that antibody titre is 
calculated. Importantly, this method of measuring bias should be applicable to all 
mammalian models of co-infection as the impact of cytokine bias on antibody class 
switching is a trait that is shared amongst species (e.g. lab mice, sheep, goats, 
rabbits). There is a growing interest in incorporating immune measures to ecological 
studies (Bradley and Jackson 2008) and I would advocate the use of antibodies for 
the following reasons. The immunological assays used to measure these molecules 
are technically simple and as such are accessible to ecologists who may not have 
access to the equipment needed for analysis of other immune molecules such as 
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cytokines e.g. tissue culture facilities. In addition, the sample volume required to 
measure antibodies is much smaller than that needed for cytokine analysis and this 
makes antibody analysis an attractive option for studies that aim to follow the course 
of infection as it negates the need for untimely sacrifice of individuals. I 
acknowledge that the application of reagents designed for use with Mus musculus to 
wild rodents such as Apodemus and Peromyscus may not be straightforward. 
However the manufacture of reagents tailored to specific species is becoming more 
affordable and in a pilot experiment I had some success in measuring total IgG in 
sera from wild rodents with laboratory reagents (data not shown).   
 
Just as disease ecologists can gain from investigating the immunological effects of 
co-infection on host-parasite interactions. So immunologists would do well to 
consider the potential for resource-mediated mechanisms to influence co-infection. 
In other words adopting a community ecology approach to the investigation of co-
infection may help to understand its diverse effects on disease outcome e.g. 
exacerbation or amelioration of malaria by helminth infection (Helmby, Kullberg et 
al. 1998; Yoshida, Maruyama et al. 2000). Two recent meta-analyses of experimental 
‘micro-parasite’-helmimth co-infection predicted that the ecology of co-infecting 
parasites would be particularly relevant to disease outcome when parasites competed 
for resources (Graham 2008; Knowles 2011). Importantly the analysis performed by 
Graham revealed that immunological interactions only took effect once resource-
mediated interactions were accounted for (Graham 2008). The current finding that 
Nb-induced anaemia played a critical role in mediating the ‘protective’ effect of co-
infection on malaria disease outcome strengthens the argument for considering 
resource-mediated interactions in co-infection studies. This result was discovered 
when helminth infection occurred prior to Pcc and highlights how the timing of 
infection can also result in differential effects on disease outcome.  
 
The final set of experiments involved manipulating the inoculating dose of Pcc, 
which can be likened to variability in exposure to parasites and so enhances the link 
between this experimental model and natural systems. Increasing the dose of Pcc 
parasites increased the Th1 bias of the antibody response; a result which adds to a 
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body of literature (Lawrence, Gray et al. 1996; O'Neill, Brady et al. 2000; Eschbach, 
Klemm et al. 2010), which is in contrast to the accepted dogma that increasing 
parasite dose results in a shift from Th1 to Th2 immune responses.  
 
The findings in this murine model indicate that changes in Th1/ Th2 immune-bias, 
the occurrence of cross-reactive antibodies, resource-mediated interactions and the 
timing of infection should all be considered when attempting to discern the influence 
of co-infection on disease outcome. Whilst this is achievable in animal models, the 
application of this to human studies is challenging. Both technical and ethical 
constraints mean that the influence of these different factors may prove extremely 
difficult to dissect. Nevertheless it is something we should aim for. Obviously it is 
not possible to deliberately infect individuals with parasites to assess how changes in 
the immune response may manifest so we must take advantage of the opportunity 
that ‘natural experiments’ afford e.g. differences in exposure or endemicity of 
helminths in malaria endemic areas. Measuring antibody responses in individuals 
infected or not with helminths could provide information on how this parasite affects 
immune responses to other parasites/ antigens. As previously discussed measuring 
antibody response may be more logistically feasible than cytokine analysis for field 
immunology.  With regard to how helminth-induced changes may affect malaria 
outcome it is the change in cytophilic (Th1) antibody responses that is particularly 
relevant. Admittedly finding the appropriate controls in order to assess cross-reactive 
responses is an additional problem. However differences in exposure to parasites on 
a micro-geographical scale within a community (Booth, Vennervald et al. 2004) may 
mean that ‘controls’ could be selected from within the population. In addition 
monitoring RBC / haemoglobin levels in helminth infected or non-infected 
individuals may allow information to be gathered regarding the potential for 
resource-mediated mechanisms to be playing a role. I do not say any of this lightly, 
realising what a massive undertaking this would be for any field study and even then 
the inherent variation (genetic and environmental) in these individuals may prevent 




As discussed, the constraints of human studies mean that in-depth investigation of 
the mechanisms underlying these outcomes may necessitate the use of an animal 
model. The findings described in this thesis; co-infection affecting the antibody bias 
of antigen-specific responses and the occurrence of cross-reactive antibodies are 
most similar to the findings of Mwatha et al in human populations exposed to  
S. mansoni and P. falciparum (Mwatha, Jones et al. 2003). In this study more severe  
S. mansoni-induced hepatosplenomegaly was correlated with an increase in  
P. falciparum antibodies (Th1 isotype) that cross-reacted with S. mansoni antigens. 
However, it was unclear whether the effect on hepatosplenomeglay was due to 
concomitant malaria-Schistosome infection or an effect of P. falciparum on the 
quality/ quantity of the anti-Schistosome response. More recently the exacerbation of 
hepatosplenomegaly in children co-exposed to S. mansoni and P. falciparum has 
been linked to amplification of pro-inflammatory cytokines (Wilson, Jones et al. 
2009). As the cellular source of plasma cytokines is unknown it is impossible to say 
if the enhanced pro-inflammatory response is a result of cross-reactive stimulation or 
due to the additive effect of anti-Schistosome inflammation. A mouse model in 
which malaria infection was administered prior to Schistosome infection may help to 
elucidate whether concomitant malaria infection per se or its effect on immune 
responses are more influential. Similarly manipulations such as serum transfers, 
whereby malaria-induced cross-reactive antibodies were transferred to a naïve mouse 
that was subsequently challenged with a Schistosome infection, could address the 
role of cross-reactivity in this system.  
 
7.4 Implications/ Outlook 
 
The results of this thesis have implications that relate to both evolutionary and 
applied biology. Here I discuss the potential for co-infection to influence, the 
evolution of both host and parasite traits, and vaccine design.  
 
One of the main themes of this thesis relates to the discovery of cross-reactive 
antibodies and the idea that these responses may either be beneficial to the host or 
result from constraints imposed on the immune system or the parasite its fighting. If 
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these cross-reactive antibodies are functional they could play a role in parasite 
clearance. However these antibodies could still be beneficial even if they are not 
functional as they may enable initial recognition of diverse parasites for less 
‘immune cost’. These ideas are difficult to test experimentally but some insight could 
be gained by investigating whether energetically challenged hosts mount more cross-
reactive responses. Similarly hosts that evolved under the selective force of multiple 
parasites may have more cross-reactive responses. If cross-reactive responses are 
beneficial to the host this could have implications for the evolution of parasites 
attempting to evade immune recognition. 
 
Helminth co-infection also has the potential to influence the evolution of virulence in 
malaria parasites.  Virulence, defined as harm to the host following infection, is 
thought to be an unavoidable side effect of host exploitation. Such virulence is 
thought to evolve as it increases parasite abundance within hosts and thus increases 
fitness through enhanced transmission. However, a proposed trade-off between the 
costs (e.g., host mortality) and benefits (e.g., increased transmission) of increased 
virulence may limit virulence evolution (reviewed in (Alizon, Hurford et al. 2009)). 
Virulence in malaria can be both parasite and immune-mediated (Long and Graham 
2011), which is an important consideration when addressing how helminth co-
infection may effect virulence evolution in malaria parasites.  For example if 
helminth infection moderates the pro-inflammatory responses, which contribute 
significantly to the immunopathology associated with malaria (Li, Seixas et al. 2001; 
Dodoo, Omer et al. 2002), this could have a positive impact on host health and thus 
alleviate the negative selection pressure (of costly host mortality) imposed on 
virulence. Thus malaria parasites would evolve to be more virulent (in line with the 
evolutionary consequences of other disease-minimising mechanisms; (Alizon, 
Hurford et al. 2009)). The potential for this to occur in helminth-infected hosts has 
serious implications regarding the administration of anthelmintics. If more virulent 
parasites evolved in a population of helminth-infected hosts but were transmitted to 
helminth-free hosts, the consequences for those individuals could be devastating. 
This scenario may readily occur if there is only partial coverage of anthelmintic 
treatment in the wider community. Another possibility is that any helminth-induced 
reduction of anti-malarial Th1 responses could reduce effector efficacy and lead to 
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an explosion in malaria parasite growth, which could increase host-mortality. 
Consequently these malaria parasites would pay the cost of virulence and would 
ultimately evolve to be less virulent.  
 
One of the major applied implications of the findings in this thesis relates to parasite 
control programs. Drug-resistance is a growing concern for the control of infectious 
diseases such as malaria and helminthiases (Sargison, Scott et al. 2010; Petersen, 
Eastman et al. 2011; Vercruysse, Behnke et al. 2011). The ultimate goal is to 
vaccinate individuals against these debilitating diseases. The success of vaccines 
often relies on the induction of Th1 or Th2 responses, and antigen dose can play an 
important role in determining this bias (Power, Wei et al. 1998). The current dogma 
suggests that increasing parasite dose increases the Th2-ness of the immune 
response. The findings reported here do not support this and reveal that for a range of 
Pcc dose Th1 responses predominate. It is important to note that this is not an 
isolated finding (Lawrence, Gray et al. 1996; O'Neill, Brady et al. 2000; Eschbach, 
Klemm et al. 2010) and is pertinent to vaccine design. If, for example, an anti-
helminth vaccine designed to induce a Th2 response were introduced to a population 
where exposure to malaria is high the Th1 bias in the host may reduce its efficacy.  
 
7.5 Concluding remarks 
 
Investigating the effect of co-infection on disease outcome in natural populations is 
complicated by variation in host and parasite genotype, unknown infection history 
and variable exposure to parasites. These variables can be compounded by host age 
and sex differences. Utilising an animal model of malaria-helminth co-infection 
controlled for much of this variation but I was keen to preserve some of this 
complexity in my study to increase the usefulness of the main findings. 
Consequently when I discovered cross-reactive antibodies I chose to pursue a line of 
questioning/ experimentation that incorporated the idea that they may be a deliberate 
strategy of the host to increase the antibody repertoire whilst conserving ‘immune 
costs’. Similarly incorporating a range of parasite doses and investigating immune 
responses under such conditions relates to natural variation in exposure to parasites. 
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In addition considering both immune- and resource-mediated mechanisms of 
regulation acknowledges the importance of variation in parasite ecology. I would 
hope that this thesis goes some way to bridging the gap between immunological and 
ecological approaches to understanding disease outcome in co-infection. Or at the 









































































































































































































































































































































































































































































































































































































































































































































































































THESIS APPENDIX: PUBLICATIONS 
RESEARCH ARTICLE Open Access
Antibody isotype analysis of malaria-nematode
co-infection: problems and solutions associated
with cross-reactivity
Karen J Fairlie-Clarke1*, Tracey J Lamb2, Jean Langhorne3, Andrea L Graham1,4, Judith E Allen1
Abstract
Background: Antibody isotype responses can be useful as indicators of immune bias during infection. In studies of
parasite co-infection however, interpretation of immune bias is complicated by the occurrence of cross-reactive
antibodies. To confidently attribute shifts in immune bias to the presence of a co-infecting parasite, we suggest
practical approaches to account for antibody cross-reactivity. The potential for cross-reactive antibodies to influence
disease outcome is also discussed.
Results: Utilising two murine models of malaria-helminth co-infection we analysed antibody responses of mice
singly- or co-infected with Plasmodium chabaudi chabaudi and Nippostrongylus brasiliensis or Litomosoides
sigmodontis. We observed cross-reactive antibody responses that recognised antigens from both pathogens
irrespective of whether crude parasite antigen preparations or purified recombinant proteins were used in ELISA.
These responses were not apparent in control mice. The relative strength of cross-reactive versus antigen-specific
responses was determined by calculating antibody titre. In addition, we analysed antibody binding to periodate-
treated antigens, to distinguish responses targeted to protein versus carbohydrate moieties. Periodate treatment
affected both antigen-specific and cross-reactive responses. For example, malaria-induced cross-reactive IgG1
responses were found to target the carbohydrate component of the helminth antigen, as they were not detected
following periodate treatment. Interestingly, periodate treatment of recombinant malaria antigen Merozoite Surface
Protein-119 (MSP-119) resulted in increased detection of antigen-specific IgG2a responses in malaria-infected mice.
This suggests that glycosylation may have been masking protein epitopes and that periodate-treated MSP-119 may
more closely reflect the natural non-glycosylated antigen seen during infection.
Conclusions: In order to utilize antibody isotypes as a measure of immune bias during co-infection studies, it is
important to dissect antigen-specific from cross-reactive antibody responses. Calculating antibody titre, rather than
using a single dilution of serum, as a measure of the relative strength of the response, largely accomplished this.
Elimination of the carbohydrate moiety of an antigen that can often be the target of cross-reactive antibodies also
proved useful.
Background
The geographical and socio-economic distribution of
malaria overlaps with areas in which a number of hel-
minth parasites are also endemic. It is the norm in these
areas for co-infection to occur and a growing body of
literature reflects this [1-12]. The influence of co-infec-
tion on the immune response may result in either
exacerbation or amelioration of disease [13-15]. It is
therefore crucial to understand the host-parasite rela-
tionship in the context of multiple infections, if vaccine
design and drug administration programmes are to be
managed effectively [16]. Animal models accurately
reflect many pathological aspects of malaria-helminth
co-infection with regard to impact on disease outcome
and also provide the opportunity to further examine
immunological mechanisms in detail [17-20].
We previously undertook an investigation to assess the
impact of a pre-existing chronic nematode infection on
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malaria-related pathology, utilising the rodent malaria
Plasmodium chabaudi chabaudi (Pcc) and the rodent
filarial nematode Litomosoides sigmodontis (Ls) [21]. We
found that co-infected mice (Pcc-Ls), particularly those
that did not have blood microfilaremia, had exacerbated
immunopathology. This was associated with increased
interferon-gamma (IFN-g) responsiveness but was inde-
pendent of Pcc parasitemia [21]. One of the primary
objectives in our previous malaria-nematode co-infec-
tion studies was to gather antigen-specific T-cell data to
determine whether nematode infection could alter the
cytokine bias of the Pcc-specific T lymphocyte response
towards Th1 and conversely, whether a potent Th1
response could alter the Th2 bias of the nematode-spe-
cific response.
Cytokine production by antigen specific T-cells can be
difficult to assess during malaria, due to immune sup-
pression associated with the peak of infection and apop-
tosis of splenocytes [22]. Additionally, the complex
nature of the target antigen (Pcc-infected red blood
cells) is a further complicating factor. Thus, gathering
antigen-specific T-cell data remains a technical chal-
lenge of studying immunity to malaria particularly in
human studies where there is the additional challenge of
obtaining and maintaining lymphocytes in the field.
Here we focus on the dissection and interpretation of
parasite antigen-specific antibody responses as an alter-
native to T-cell analysis. Antibodies of the IgG2a isotype
are mainly produced by B cells in response to IFN-g in
mice [23-25] whereas the Th2 cytokine IL-4 switches B
cells to produce IgG1 [24,26]. Although the generation
of IgG1 as a marker for Th2 cells is less definitive than
IgG2a as a marker of a Th1-type response, the ratio of
IgG1 to IgG2a provides a powerful indicator of immune
bias [27-30]. Measurement of antibodies can also be
achieved with smaller sample volumes and poses fewer
technical challenges than T-cell recall assays. Further-
more, antibody analysis can provide information on the
fuller history of infection as it reflects cumulative immu-
nological activity, whereas cytokine responses of T-cells
are an ex-vivo ’snapshot’ that can more readily be
altered by changes in the timing of sampling both in
vivo and in vitro. Antibody analyses of co-infected ani-
mals might therefore provide evidence of overall Th1-
Th2 cell cross-regulation even when cytokine analyses
may not.
In addition to their use as indicators of cytokine bias
during infection, antibody isotypes have direct functional
relevance to disease severity in helminth-malaria co-
infection. Antibodies are absolutely required for the
ultimate clearance of malaria parasites [31]. In mice,
antibodies of the cytophilic isotype IgG2a have been
shown to recognise infected erythrocytes [32] and facili-
tate their destruction by phagocytes [33]. Similarly, in
humans IgG1 and IgG3 are associated with enhanced
parasite clearance [34]. If helminth co-infection alters
antibody class-switching and consequently the produc-
tion of malaria-specific cytophilic antibodies then the
resolution of malaria infection may be affected. Indeed,
co-infection with the gastro-intestinal nematode Heligo-
mosoides polygyrus reduced Pcc-specific IgG2a responses
and resulted in exacerbated malaria parasitemia [18].
There are also important implications for vaccine effi-
cacy and administration. For example, immunisation
that protected mice from malaria failed to do so in mice
that also harboured a nematode infection [35].
In this study, the characterisation of antibody isotype
responses as an indicator of cytokine bias during co-
infection has proved unexpectedly challenging due to the
production of cross-reactive antibodies induced by sin-
gle-species infection. To establish the real effect of co-
infection on the Th1/Th2 immune bias from non-specific
reactivity to antigen we needed to determine how robust
the cross-reactive responses were in comparison to the
antigen-specific. We demonstrate that a combination of
calculating antibody titre, from a dilution series of test
sera, and periodate treatment of the parasite antigens can
control for most cross-reactivity. The magnitude and
robustness of some cross-reactivity, however merits
further investigation to explore the potential function of
these responses during co-infection.
Methods
Hosts, parasites and experimental infection
Specific pathogen free, 8-10 week old female BALB/c
mice (Harlan, UK) were maintained in individually ven-
tilated cages on diet 41b ad lib in a 12 h:12 h light-dark
cycle. All experiments were carried out in accordance
with the animals (Scientific Procedures) Act 1986, and
were approved by the UK Home Office inspectorate and
institutional review committee.
Pcc clone AS was originally isolated from thicket rats
(Thamnomys rutilans) and was cloned by serial dilution
and passage [36]. Parasites were recovered from frozen
blood stabilates by passage through donor mice. Experi-
mental parasite inoculations were prepared from donor
mice by diluting blood in calf serum solution (50% heat-
inactivated foetal calf serum, 50% Ringer’s solution [27
mM KCl, 27 mM CaCl2, 0.15 M NaCl, 20 units heparin
per mouse]). Each mouse received 0.1 ml of inoculum
intraperitoneally (i.p) corresponding to an infective dose
of 1 ! 106 or 1 ! 105 parasitized red blood cells (RBC),
depending on the experiment. An inoculum of naïve
RBC was given as a control for erythrocyte proteins.
The filarial nematode Ls was maintained by cyclical
passage between gerbils (Meriones unguiculatus) and
mites (Ornithonyssus bacoti) as described previously
[37]. Infection was initiated by subcutaneous (s.c)
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injection of 25 infective (L3) larvae. For co-infection
experiments in which the influence of malaria on
chronic nematode infection was addressed, 1 ! 106 Pcc
parasitized RBC were introduced i.p on Day 60 of an
established Ls infection and mice were sacrificed on day
20 post-Pcc infection, as described previously [21].
Whole blood was collected from the brachial artery and
serum recovered after clotting at room temperature.
Nb worms were maintained by serial passage through
Sprague-Dawley rats. L3 larvae were obtained by cultur-
ing the faeces of infected rats at 26°C for a minimum of
5 days [38]. For acute nematode-malaria co-infection,
infection was initiated by s.c injection of 200 infective
(L3) larvae on the same day that Pcc was introduced by
inoculation i.p of 1 ! 105 parasitized RBC. Mice were
sacrificed on Day 20 post-infection under terminal
anaesthesia. Whole blood was collected from the bra-
chial artery and was separated using Sera Sieve (Hughes
& Hughes Ltd).
Antigens
Two malaria antigens were used in this study: a recom-
binant protein and a crude antigen homogenate pre-
pared from parasitized erythrocytes. The recombinant
Merozoite Surface Protein-119 (MSP-119) was originally
sequenced, cloned and expressed from Pcc AS clone, as
described previously [39]. In brief, the MSP-119 nucleo-
tide sequence was inserted into Pichia pastoris vector
pIC9K and protein expression carried out in Pichia pas-
toris strain SMD1169. This antigen was used in ELISA
at a concentration of 1 !g/ml.
The crude malaria homogenate - lysed Pcc parasitized
red blood cell extract (pRBC) - was prepared from whole
blood of mice with a parasitemia in excess of 20%. Mice
were bled by cardiac puncture with a heparinised syringe
and blood stored at -80°C prior to 3 rounds of freeze-
thaw to lyse the parasitized red blood cells. The lysed
cells were sonicated, on ice, twice for 30 sec at 10 Amp
and centrifuged at 16060 g for 10 min. The supernatant
was stored at -80°C. Similarly, a naïve red blood cell
extract (nRBC) was prepared as a control for RBC pro-
teins; responses to this antigen amongst infected mice
were indistinguishable from naïve (data not shown). In
the Ls experiments this antigen was used in ELISA at 0.5
!g/ml and in the Nb experiments at 5 !g/ml.
Ls and Nb extracts (LsA and NbA) were prepared by
homogenisation of adult nematodes in PBS. The somatic
extracts were centrifuged at 1000 g for 20 mins and the
pellet discarded. The extract was stored at -20°C. LsA
was used in ELISA at 0.5 !g/ml and NbA at 5 !g/ml.
Antibody detection
ELISA was used to measure antigen-specific IgG antibo-
dies in the serum of nematode-infected, Pcc-infected or
co-infected mice. In the Pcc-Ls study, sera were added
in a serial dilution 1/100 - 1/400 and a dilution was
then chosen whereby all samples fell in the linear range
of the curve; for IgG1, a dilution of 1/200 and for IgG2a
1/100. For the subsequent Pcc-Nb study, serum samples
were added in a serial dilution 1/50 - 1/819200. Anti-
body titres were calculated as the reciprocal of the
greatest dilution at which optical density (O.D) was
greater than the mean plus 3 standard deviations of the
O.D values observed for control mouse sera at 1/200
dilution.
Antibody responses to MSP-119, pRBC, NbA or LsA
were determined for IgG isotypes IgG1, IgG2a, and
IgG3. 96 well maxisorp immunoplates (Nunc) were
coated at 4°C overnight with either recombinant or
crude antigens at the concentrations indicated (see Anti-
gens section) in 0.06 M carbonate buffer (0.04 M
NaHCO3, 0.02 M NaCO3, pH9.6) in a final volume of
50 !l per well. Non-specific binding was blocked with
5% FCS in carbonate buffer (200 !l/well) for 2 hours at
37°C. Wells were washed three times in Tris buffered
saline with 0.1% Tween (TBST) after each step. Serum
samples were added in serial dilutions as indicated using
TBST as a diluent, in a final volume of 75 !l per well
and incubated for 2 hours at 37°C. Isotype specific
detection antibodies were diluted in TBST in a final
volume of 50 !l per well. For IgG1, HRP conjugated
goat anti-mouse IgG1 (Southern Biotech 1070-05) was
used at 1/6000, HRP conjugated goat anti-mouse IgG2a
(Southern Biotech 1080-05) at 1/4000 and HRP conju-
gated goat anti-mouse IgG3 (Southern Biotech 1100-05)
was used at 1/1000. Plates were incubated for 1 hour at
37°C. An additional wash in distilled water was carried
out before developing with ABTS peroxide substrate
(Insight Biotechnology), 100 !l per well, at room tem-
perature for 20 minutes. O.D was read at 405 nm using
a spectrophotometer.
Polyclonal IgE levels were determined by sandwich
ELISA. 96 well maxisorp immunoplates (Nunc) were
coated overnight at 4°C with 100 !l of IgE capture anti-
body (2 !g/ml; clone R35-72 Pharmingen) diluted in
carbonate buffer. Plates were blocked with 5% non-fat
skimmed milk in carbonate buffer for 2 hr at 37°C.
Plates were washed 5 ! in TBST before addition of sera
at 1/10 and 1/20 dilutions in a final volume of 50 !l/
well and left overnight at 4°C. For the standard curve
two- fold serial dilutions of purified mouse IgE, !
monoclonal isotype standard (Pharmingen) were used.
After 5 washes in TBST, 100 !l of biotinylated detection
antibody (2 !g/ml; clone R35-118 Pharmingen) diluted
in TBST with 5% FCS was added and plates left at 37°C
for 90 mins. Plates were washed 5 ! in TBST prior to
incubation with ExtrAvidin peroxidase (SIGMA), diluted
1:8000 in TBST with 0.5% FCS, for 30 mins at 37°C.
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After a final wash in distilled water, plates were devel-
oped with 100 !l TMB microwell peroxidase substrate
system (Insight Biotechnology Ltd) and read at 650 nm.
In order to determine the extent to which carbohy-
drate or protein moieties contributed to the antibody
response the antigens were pre-treated with periodate.
Antigen-specific IgG1, IgG2a and IgG3 antibodies were
measured in response to antigens treated with periodate.
The ELISA was carried out as detailed for the Nb co-
infection experiment with untreated antigens but the
following additional steps were included after blocking
with 5% FCS: carbonate buffer, prior to sample addition.
TBST wash (!3) was followed by the addition of 10 mM
sodium (meta) periodate diluted in 50 mM sodium acet-
ate in a final volume of 100 !l/well. Plates were incu-
bated at 37°C for 1 hour and then washed in 50 mM
sodium acetate. To stop the activity of periodate, 100 !l
of 50 mM sodium borohydride solution was added to
each well.
Statistical Analysis
General linear statistical models allowed us to frame and
test questions such that we could determine whether
differences in infection status and/or presence of carbo-
hydrate antigen explained the observed variation in anti-
body responses. For more detailed explanation of the
statistical methods employed see Grafen and Hails [40].
Infection status and treatment with periodate (or not)
were included as categorical factors and their ability to
predict antibody response was formally evaluated via
Analysis of Variance (ANOVA). The serial dilution of
sera in an ELISA produces ordinal data, which were
log10 transformed prior to analysis to ensure the data
were approximately normally distributed, in accordance
with the requirements of linear models. Analyses were
carried out using the statistical package JMP 5.1 (SAS).
The maximal model was fitted first and minimal models
were obtained by sequentially removing non-significant
terms (P-value > 0.05), beginning with interactions.
Finally, whenever a factor was significant (P < 0.05), an
All Pairs Tukey post-hoc test was carried out to identify
which groups of mice differed significantly in antibody
induction, with respect to infection status or periodate
treatment.
Results
Antibody isotype responses are skewed by malaria-filaria
co-infection but cross-reactivity confounds data
interpretation
We had previously used a model of Pcc-nematode co-
infection in which Pcc is introduced into mice with pre-
existing chronic Ls infection to investigate the dynamics
of infection with regard to parasitological outcome and
cytokine bias [21]. In the Pcc-Ls model the peak of
malaria parasitemia was controlled by day 10 and
resolved by day 14 post Pcc-infection. For this study, we
envisaged that analysis of the antibody isotype response
from these mice would provide a method to rapidly and
quantitatively assess immune bias. We thus asked
whether we could use antibody isotype ELISA for IgG2a
and IgG1 to address whether nematode infection would
skew the Th1 cell response to Pcc to a more Th2 cell
biased response. Conversely, we wished to address
whether the powerful Th1 cell response induced by
malaria would have the capacity to alter an established
IgG1 response to a nematode infection. As is common
practice in many studies [41-48], especially with large
sample sizes as in this study, the ELISAs were per-
formed with a fixed serum concentration derived from
the linear point in a dilution series.
As expected from previous studies [49-51], we were
able to detect an IgG1 response against LsA in Ls mice.
Co-infected (Pcc-Ls) mice also produced LsA-specific
IgG1, but it was reduced in magnitude compared to the
Ls mice (Fig 1Ai). Thus co-infection with Pcc appeared
to down-regulate the anti-Ls specific IgG1 response. It
also appeared that responses in Pcc-Ls mice were further
biased toward a Th1 cell response through the induction
of IgG2a to LsA (Fig 1Aii). Also as expected [32,52], Pcc
mice mounted highly biased Th1-cell responses as indi-
cated by the predominance of Pcc (pRBC)-specific IgG2a
over IgG1 (Fig 1B). Once again, Pcc-Ls mice appeared to
alter this bias by increasing the amount of pRBC-specific
IgG1 in comparison to the Pcc mice (Fig 1Bi).
At first glance, the results strongly suggested that the
isotype and hence cytokine bias of each single-species
infection was significantly impacted by co-infection. In
support of this, polyclonal IgE was highest in Ls mice
and absent in Pcc mice with Pcc-Ls mice exhibiting an
intermediate level (Fig. 1C) although Pcc-Ls mice did
not differ statistically from Ls mice in this polyclonal
analysis. However, it was apparent that Pcc mice were
exhibiting sizable antibody responses to LsA (X1 in Fig
1Aii) and conversely Ls mice were exhibiting strong
antibody responses to pRBC (X2 in Fig 1Bi). Western
blot analysis confirmed that these Ls-induced cross-reac-
tive responses were directed against the parasite rather
than the RBC (data not shown). We thus had to ask
whether the shift away from LsA-specific IgG1 toward
IgG2a responses in the Pcc-Ls mice was due to the
influence of IFN-g on the Ls-induced response or simply
reflected the presence of cross-reactive Pcc-induced
IgG2a responses to LsA. Conversely, was the apparent
increase in pRBC-specific IgG1 responses in Pcc-Ls mice
due to Ls-induced antibodies that cross-reacted with
infected red blood cells? Because serum titres had not
been determined in this study, we could not assess the
relative strength of cross-reactive versus antigen-specific
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Figure 1 Antibody isotype responses in infection and co-infection with Litomosoides sigmodontis and malaria. Mice were infected with
25 Ls L3 larvae on day 0 and/or 106 Pcc-infected RBCs on day 60 post-Ls infection. Serum antibody responses measured by ELISA at day 80
post-Ls infection to (A) Ls antigen (LsA) and (B) crude Pcc infected RBC antigen (pRBC). Th2 isotype IgG1 is shown in (Ai) and (Bi) whilst the Th1
associated isotype IgG2a is shown in (Aii) and (Bii). Grey bars represent control mice, black bars represent Pcc mice, white bars the Ls mice and
the chequered bars co-infected mice (Pcc-Ls). The letter X highlights those responses that are cross-reactive. Groups not connected by the same
letter denote pairs that are significantly different according to Tukey’s Pairwise analysis while those that share the same letter do not differ
significantly. (C) Polyclonal IgE responses. Black squares represent Ls mice, white squares represent Pcc mice and grey squares represent co-
infected (Pcc-Ls) mice. White circles indicate control animals. Data shown in A & B are compiled from 3 experiments (control mice n = 13, Ls
mice n = 37, Pcc mice n = 14, Pcc-Ls mice n = 41).
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responses. Our observation that there was significant
cross-reactivity at the sera dilution tested thus con-
founded our ability to interpret any changes in immuno-
logical bias during Pcc-Ls co-infection.
Cross-reactive antibody responses are also observed
during malaria-Nippostrongylus brasiliensis co-infection
In order to address the utility of antibody isotype
responses further, we embarked on co-infection experi-
ments with Pcc and the nematode Nb. Because Pc-Nb is
an acute model, whereby the nematode is cleared by day
7 and the peak of malaria parasitemia is controlled by
day 10, the antibody data could be collected after only
20 days of co-infection, a more practical time frame
than the 80 days required for the Pcc-Ls experiments.
This also allowed us to address whether our observa-
tions of antibody cross-reactivity were a more general
feature of Pcc-nematode infection. Given the apparent
cross-reactivity observed at a fixed dilution of sera in
the Pcc-Ls ELISA we used endpoint titres derived from
a serial dilution (1:50 - 1:819200) in the Pcc-Nb assays
to address whether this readout would overcome cross-
reactivity problems. To determine if the specificity of
the assay could be improved with the use of recombi-
nant antigens we also included the malaria protein,
MSP-119 [39] not available to us for the Ls studies.
The antibody responses we observed on Day 20 of
Pcc-Nb co-infection (Fig 2) paralleled those we had seen
in the Pcc-Ls experiments at Day 80. For example, as
seen in Fig 2Aiii, Nb mice made IgG1 biased responses
against NbA, and responses in Pcc-Nb mice were inter-
mediate between Nb and Pcc mice. In addition, Pcc
mice mounted a strong MSP-119-specific IgG2a
response that was reduced in Pcc-Nb mice (Fig 2Bi). As
before, levels of polyclonal IgE in Pcc-Nb mice were
intermediate (data not shown). We again observed
cross-reactivity, whereby Nb mice mounted detectable
IgG1 and IgG2a responses to both recombinant and
crude malaria antigens (indicated by X1&2 in Fig 2A and
X4&5 in Fig 2B, respectively). The magnitude of the Nb-
induced IgG2a cross-reactive response is particularly
striking with titres against crude and recombinant
malaria antigens reaching 2500 and 200 respectively.
Similarly, Pcc mice mounted responses to NbA (X3 in
Fig 2A and X6 in Fig 2B). It is important to note that
these titres although low are markedly greater than
background responses (mean plus 3 standard deviations
of serum responses from control mice), which are repre-
sented as zero on the y-axis. The immune bias that is
apparent in serum antibody isotype responses is fully
supported by cytokine responses in the lymph nodes of
Pcc-Nb infected mice as we have recently described [53].
Of interest, no cross-reactivity was observed at the T-
cell level.
Cross-reactive IgG1 responses of malaria-infected mice to
NbA are lost at higher dilutions but IgG2a responses
remain
The analysis of both Pcc-Ls and Pcc-Nb co-infection
indicates that the issue of cross-reactivity is a factor
investigators are likely to routinely encounter. Determin-
ing the qualitative and quantitative aspects of the cross-
reacting antibody responses are not only important for
the practical analysis of immune deviation but could be
of real biological relevance during co-infection.
As expected, antibody responses were biased, in terms
of isotype, by infection status. The bias in isotype due to
a particular infection (Th2 associated IgG1 induced dur-
ing Nb infection, for example) was extended to non-spe-
cific antigens, as seen in the IgG1 response of Nb mice
to both MSP-119 and pRBC (X1 and X2 in Fig 2Ai +
2Aii). However, Pcc-specific IgG2a titres in Pcc mice
were significantly higher than the cross-reactive
response induced in Nb mice (Fig 2Bi). Thus, although
Nb mice made cross-reactive IgG2a responses, these
were no longer detectable with increasing dilution of
sera (Fig 2Bi). In this case capitalising on the differences
in strength of antigen-specific and cross-reactive
responses clarified interpretation of immune bias in co-
infected mice. Similarly, IgG1 responses to NbA were
significantly higher in Nb mice than the cross-reactive
response induced by Pcc mice (Fig 2Aiii). However, titre
of Pcc-induced cross-reactive IgG2a to NbA did not dif-
fer significantly from Nb mice (X6 in Fig 2Biii).
We can conclude from this analysis that cross-reactive
IgG1 responses to NbA were only detectable at dilutions
less than 1:100 and thus higher dilutions may be used to
avoid cross-reactivity when assessing antigen-specific
antibody isotype profiles for the purpose of interpreting
immune bias. However, increasing sera dilution did not
always overcome the cross-reactivity observed, as IgG2a
responses to NbA in Pcc mice were still observed at
1:2500. This cross-reactivity warrants further investiga-
tion, as it is likely to be important biologically. Indeed
even cross-reactive responses detectable only at high
serum concentrations may still have functional relevance
in vivo.
Cross-reactivity appears to lie predominantly with
carbohydrate epitopes and can be largely eliminated by
periodate treatment
Antibody cross-reactivity in a broad range of systems
can be attributed to reactivity with carbohydrate deter-
minants [54,55]. Additionally, the IgG3 isotype is often
associated with recognition of carbohydrates [56] and
we observed cross-reactive IgG3 antibody responses
during Pcc-Nb co-infection (Fig. 3). Nb mice mounted
IgG3 responses to both MSP-119 and pRBC antigens,
achieving titres of 200 and 3200 respectively (Fig 3Ci
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and 3Cii). Pcc mice mounted similar cross-reactive IgG3
responses to NbA (Fig 3Ciii). We thus chose to assess
whether cross-reactivity in our Pcc-Nb co-infection sys-
tem could be overcome by periodate treatment of the
parasite antigens. Periodate oxidises carbohydrate to
aldehydes, thus disrupting carbohydrate epitopes, which
allowed us to distinguish if cross-reactive responses tar-
get the carbohydrate or protein moiety of an antigen.
This could be of particular importance where detection
of cross-reactive responses was not overcome by
increasing serum dilution. In addition to clarifying the
interpretation of shifts in immune bias, determining
whether induction of specific isotype responses is driven
by protein or carbohydrate recognition has important
implications for vaccine design and diagnostic serology.
For the pRBC and MSP-119 antigens, periodate treat-
ment did not significantly affect recognition by IgG1
antibodies (P ! 0.7). Periodate treatment of NbA
however, significantly reduced anti-NbA IgG1 titres
across all infection groups (Fig 3Aiii), suggesting com-
mon recognition of a carbohydrate moiety. In particular,
the cross-reactive recognition of NbA, by IgG1 antibo-
dies from Pcc mice, was ablated (X7 in Fig 3Aiii).
Treatment of MSP-119 antigen with periodate resulted
in a significant increase in IgG2a detected in sera from
Pcc-Nb mice. Detection of IgG2a in singly-infected mice
also followed this trend but was not statistically signifi-
cant (Fig 3Bi). These results suggest recognition of a
protein epitope on the recombinant antigen previously
masked by glycosylation. Plasmodium species lack the
glycosyltransferases required for any glycosylation other
than attachment of GPI anchors [57,58]. However, inap-
propriate glycosylation of the recombinant protein can
occur in the Pichia expression system [57]. The increase
in protein-specific responses, following periodate treat-
ment of the recombinant antigen (MSP-119), may thus
Figure 2 Antibody isotype responses in infection and co-infection with Nippostrongylus brasiliensis and malaria. Mice were infected with
200 Nb L3 larvae and/or 105 Pcc-infected RBCs on day 0. Serum antibody titres (A) IgG1 (B) IgG2a to recombinant Pcc antigen MSP-119 (i), crude
Pcc antigen (pRBC) (ii) and crude Nb antigen (NbA) (iii) were measured at day 20 post-infection for 8 mice per infection group. Black bars
represent the Pcc mice, white bars the Nb mice and the chequered bars the co-infected mice (Pcc-Nb). Antibody titres are shown on the y-axis
and represent the reciprocal of the greatest dilution at which O.D was greater than the mean plus 3 standard deviations of the O.D values
observed for control mouse sera at a 1/200 dilution. The letter X highlights those responses that are cross-reactive. Groups not connected by the
same letter denote pairs that are significantly different according to Tukey’s Pairwise analysis.
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reflect the response to the natural non-glycosylated
parasite protein seen during infection. IgG2a recognition
of periodate treated pRBC antigen was enhanced in sera
from Pcc mice, though not in the Pcc-Nb or Nb mice
(Fig 3Bii). This suggests the cross-reactive IgG2a
response is not targeting carbohydrates, which could
potentially be conserved amongst parasite antigens.
For NbA, it was only after treatment with periodate
that differences amongst infection groups become
apparent, whereby significantly greater amounts of
(cross-reactive) IgG2a antibodies were detected in Pcc
mice in comparison to Nb mice (X8 in Fig 3Biii). Thus,
the Pcc-induced cross-reactive IgG2a response to NbA
(X6 in Fig 2Biii) that was not lost with serial dilution
was also maintained following periodate treatment (X8
in Fig 3Biii). In contrast, the Nb-specific IgG2a response
appears to target carbohydrate as periodate treatment
reduced recognition of NbA in both Nb and Pcc-Nb
Figure 3 Antibody responses to protein epitopes in infection and co-infection with Nippostrongylus brasiliensis and malaria. The
parasite antigens used in ELISA were pre-treated with periodate to disrupt carbohydrate epitopes, in order to determine if cross-reactive
responses target the carbohydrate or protein moiety of an antigen. Mice were infected with 200 Nb L3 larvae and/or 105 Pcc-infected RBCs on
day 0. Serum antibody titres (y-axis) were measured at day 20 post-infection for 8 mice per infection group and represent the reciprocal of the
greatest dilution at which O.D was greater than the mean plus 3 standard deviations of the O.D values observed for control mouse sera at 1/200
dilution. Antibody isotypes (A) IgG1 (B) IgG2a (C) IgG3 to recombinant Pcc antigen MSP-119 (i), crude Pcc antigen (pRBC) (ii) and crude Nb antigen
(NbA) (iii) before (-) and after (+) treatment with periodate are shown. Black bars represent Pcc mice, white bars the Nb mice and the chequered
bars the co-infected (Pcc-Nb) mice. (*) denotes pairs which are significantly different according to Tukey’s pairwise analysis.
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mice (Fig 3Biii) although only statistically significant in
the Pcc-Nb mice. This may indicate that atypical Th1-
type responses to helminth antigens are driven by
carbohydrate.
Disruption of carbohydrates via periodate treatment
significantly affected the recognition of Pcc antigens by
IgG3 antibodies. In particular, recognition of periodate
treated pRBC was reduced in serum from all mice that
had experienced Pcc infection; this was most evident in
the Pcc-Nb mice (Fig 3Cii). The recognition of periodate
treated MSP1-19 was also significantly reduced in Pcc
mice (Fig 3Ci). The more pronounced reduction in IgG3
response to the treated pRBC antigen may reflect the
greater proportion of carbohydrate components in this
crude antigen preparation in comparison to the single
recombinant protein.
Discussion
Antibody analysis should be able to provide critical
information on changes in cytokine bias due to co-infec-
tion. This is particularly important in human studies
where serum may be the only reagent available for
immunological analysis. Whilst we acknowledge that
there is a need to confirm the relationship between sple-
nic or serum cytokines and antibody responses in co-
infection if this strategy is to be used in human studies,
our focus is on the interpretation of antigen-specific
Th1/Th2 bias based on antibody isotype, which was
complicated by cross-reactivity in the two co-infection
models studied here. It is worth noting that cross-reac-
tive responses were observed regardless of whether
recombinant or crude antigens were used. We primarily
address technical strategies that will enable us, and
others, to draw conclusions regarding the influence of a
co-infecting parasite on immune bias using serum anti-
bodies. However, the functional implications of cross-
reactive responses are also discussed.
Murine models that aim to dissect the real effect of a
co-infecting parasite on immune bias must use large
numbers of animals to detect significant differences in
antigen-specific responses between single and dual
infection. Thus for antibody analysis of the large sample
size (see legend Fig 1 for details) in our Pcc-Ls study of
co-infection we chose a fixed serum concentration, pre-
viously determined to fall within the linear range of the
dilution curve. Although this saved time and reagents,
in retrospect, it provided insufficient information for
our purposes: it did not allow us to distinguish the rela-
tive strengths of cross-reactive versus antigen-specific
responses.
When antibody titres were calculated in the Pcc-Nb
study, we were able to determine whether apparent
alterations in antibody isotype profile on co-infection
were due to actual changes in parasite-specific responses
or reflected a cross-reactive response. For example,
determining that cross-reactive IgG2a antibody titres in
Nb mice (X4 in Fig 2Bi) were significantly lower than
the antigen-specific response of Pcc mice meant that
cross-reactivity was unlikely to influence the titre
observed in Pcc-Nb mice. This allowed us to conclude
that the reduction in Th1 type antibody in Pcc-Nb mice
was probably due to suppression of Pcc-specific Th1
responses by nematode infection. Further to this, had
we not calculated titre and relied on optical density data
derived from a single dilution of sera we may not have
observed the difference between Pcc and Pcc-Nb mice
and thus incorrectly concluded that there was no effect
of co-infection on Th1 responses. Similarly, analysis of
antibody titre enabled us to detect the reduction in anti-
NbA IgG1 antibody in Pcc-Nb mice (Fig 2Aiii), which
suggests a Pcc-mediated bias toward a Th1 cell
response. In other cases, cross-reactivity was observed
even at high dilutions with Pcc mice achieving IgG2a
titres equivalent to or greater than Nb mice (X6 in Fig
2Biii). In this case, calculation of titre did not help to
unravel potential cytokine influences and the enhanced
IgG2a response in co-infected mice may be due to
increased Th1 cytokines during co-infection and/or the
presence of cross-reactive antibody (Fig 2Biii).
Nematode surface antigens and the excretory/secre-
tory products from these parasites are heavily glycosy-
lated [59]. Similarly, Plasmodium species express
glycoconjugates on their surface and have abundant gly-
cophosphatidylinositol anchors [60]. In other co-infec-
tion systems cross-reactive epitopes have been shown to
derive from carbohydrate structures [61]. The sensitivity
of the carbohydrate component of an antigen to period-
ate treatment [59] has been beneficial in interpreting
our results. In particular, treatment of Pcc antigens
demonstrated that cross-reactive nematode-induced
IgG3 responses were largely attributed to the carbohy-
drate component. Interestingly, periodate treatment also
reduced apparent cross-reactivity by exposure of protein
epitopes, previously masked by carbohydrate, which
enhanced the detection of antibodies from mice that
had been exposed to the antigen during infection (e.g.,
anti-pRBC in Fig 3Bii). This allowed us to conclude that
levels of anti-pRBC IgG2a antibody in Pcc-Nb mice are
solely induced by the Pcc parasite. Further to this, detec-
tion of cross-reactive protein-specific antibodies enabled
responses, previously indistinguishable in magnitude
between singly-infected groups, to be differentiated. For
example, periodate treatment of NbA enhanced detec-
tion of Pcc induced cross-reactive IgG2a antibodies (X8
in Fig 3Biii) whilst the antigen-specific response of Nb
mice was ablated. This indicates that the level of Nb-
specific IgG2a observed in Pcc-Nb mice is due to Pcc
driving a cross-reactive IgG2a Th1 type response.
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We have demonstrated that the use of serial dilutions
and periodate treatment of the parasite antigens can
help overcome cross-reactivity for the purposes of ana-
lysing and interpreting Th1/Th2 cell immune bias.
However, some ‘true’ cross-reactivity remained (i.e. Pcc-
induced IgG2a responses to NbA (Fig 2Biii/Fig 3Biii)),
and the induction of these antibodies has important
implications with regard to biological function. For
example the immune responses to nematode infection
are typically characterised by a Th2 type (IgG1)
response, as we observed for Nb-induced responses to
the nematode antigen (NbA). The propensity for Pcc
mice to induce atypical IgG2a antibody isotypes to
nematode antigen is likely due to the malaria parasite
promoting Th1 cytokines in the environment where the
antibody response is established [45]. The biological
consequences of the Pcc driven IgG2a response to the
nematode antigen and the less pronounced IgG1
response of Nb mice to Pcc antigens remain to be inves-
tigated. In Trichuris muris infection, manipulation of the
immune environment to a Th1 type setting, charac-
terised by elevated IgG2a and IFNg, was shown to
enhance chronicity of this intestinal helminth [62]. Pcc-
induced IgG2a to nematode antigens may thus have real
consequences in terms of disease outcome. Effects of
nematode co-infection on the malaria parasite are also
evident; Pcc-Nb mice have reduced levels of malaria
parasitemia in comparison to Pcc mice [53] and it is
interesting to consider the possibility that cross-reactive
IgG2a antibodies induced by the nematode infection
may act in concert with the antigen-specific response to
control malaria parasites. The potential for cross-reac-
tive responses to have a functional role during infection
raises the intriguing possibility that their production is a
deliberate strategy of the host to combat diverse para-
sites [63]. To fully understand the relative contribution
of cross-reactive antibodies in parasite control would
require passive antibody transfer experiments.
Although schistosome parasites are phylogenetically
distinct from nematodes, helminth co-infection studies
that investigate Schistosoma mansoni provide evidence
that cross-reactivity is relevant in other co-infection
systems and can have a strong impact on disease
severity. Naus et al [43] report the induction of cross-
reactive IgG3 antibodies that recognise both Plasmo-
dium falciparum and S. mansoni antigens. Pierrot et al
extended this study, identifying the S. mansoni antigen
(SmLRR) that is recognised by both malaria and S.
mansoni singly-infected hosts. Interestingly, as we
observed in our Pcc-Nb model of co-infection, the two
infections induce different antibody isotypes to antigen:
cross-reactive malaria driven IgG3 and helminth driven
IgG4 [45]. In areas co-endemic for these two parasites,
exposure to malaria and subsequent induction of the
cross-reactive IgG3 response seems to increase the risk
of developing hepatosplenomegaly in schistosome
infected individuals [44].
Conclusions
In summary, our data illustrate that whilst cross-reactiv-
ity may confound observations of interest, it can largely
be overcome by a combination of increasing sera dilu-
tion and pre-treatment of antigens with periodate.
Adopting such strategies will enable antibody isotypes to
be used as an indicator of cytokine bias and clarify
interpretation of when Th1-Th2 cell shifts have
occurred as a result of co-infection. Arising from this
analysis is the opportunity to dissect antigen-specific
from cross-reactive responses and thus obtain informa-
tion pertaining to the relative strength of these
responses and recognition of carbohydrate versus pro-
tein epitopes. This will provide the foundation on which
to base more detailed characterisation of the antibody
responses during co-infection in order to investigate
their functionality.
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PERSPECTIVE ARTICLE
Why do adaptive immune responses cross-react?
Karen J. Fairlie-Clarke, David M. Shuker and Andrea L. Graham
Institutes of Evolution, Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories,
King’s Buildings, Edinburgh, UK
Introduction
One of the most startling and impressive features of the
vertebrate adaptive immune system is its ability to recog-
nize and bind diverse parasite antigens. As part of this
process, the immune system is able to generate extraordi-
nary specificity of antibodies to particular antigens. This
specificity is an axiomatic feature of the adaptive immune
system, but it is also an incomplete picture. Cross-reactiv-
ity of lymphocyte receptors and antibodies to parasite
antigens is common, with important consequences for
both host and parasite, in terms of host health (e.g., Fesel
et al. 2005; Urbani et al. 2005), antigenic variation (Lips-
itch and O’Hagan 2007), parasite strain structure (e.g.,
Recker and Gupta 2005; Koelle et al. 2006a), and epide-
miological dynamics (e.g., Adams et al. 2006; Koelle et al.
2006b; Wearing and Rohani 2006). However, the extent
to which we should expect to see cross-reactivity of adap-
tive immune responses has not been fully explored, espe-
cially for antibodies.
In this perspective, we consider whether cross-reactivity
is an evolved trait of the immune system, driven by
conflicting costs and benefits of antigen specificity, or
whether it is an inescapable side-effect of the problem of
recognizing and binding to an enormous range of puta-
tive antigens. Throughout, we will use ‘parasite’ in a gen-
eral sense, to include all infectious disease agents, and we
define ‘specificity’ as the ability of the immune system to
discriminate among antigens and ‘cross-reactivity’ as the
absence of discrimination, in accordance with general
(Janeway et al. 2001) as well as evolutionary (Frank 2002)
immunological usage. Cross-reactivity is also known as
‘heterologous immunity’ (Page et al. 2006) or, in some
contexts, by the more colorful term ‘original antigenic
sin’ (e.g., Liu et al. 2006). Here we use ‘cross-reactivity’
to cover all cases. We would also stress that specificity
and cross-reactivity should be considered endpoints of a
spectrum rather than strict alternatives, and we would
hope that our approach encourages thinking about quan-
titative predictions for the level of cross-reactivity we
might expect lymphocytes or antibodies to exhibit.
To address whether cross-reactivity of adaptive
immune responses is an evolved trait or a side-effect
of biological or chemical constraints, we explore the
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Abstract
Antigen specificity of adaptive immune responses is often in the host’s best
interests, but with important and as yet unpredictable exceptions. For example,
antibodies that bind to multiple flaviviral or malarial species can provide hosts
with simultaneous protection against many parasite genotypes. Vaccinology
often aims to harness such imprecision, because cross-reactive antibodies might
provide broad-spectrum protection in the face of antigenic variation by para-
sites. However, the causes of cross-reactivity among immune responses are not
always known, and here, we explore potential proximate and evolutionary
explanations for cross-reactivity. We particularly consider whether cross-reac-
tivity is the result of constraints on the ability of the immune system to process
information about the world of antigens, or whether an intermediate level of
cross-reactivity may instead represent an evolutionary optimum. We conclude
with a series of open questions for future interdisciplinary research, including
the suggestion that the evolutionary ecology of information processing might
benefit from close examination of immunological data.
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problem facing the immune system in terms of the infor-
mation it needs in order to function correctly. First, the
immune system must obtain information about the para-
sites attacking it as efficiently as possible, in order to rap-
idly combat infection. Thus we expect T- and B-cell
repertoires, in terms of their overall size and the binding
specificities of component cell lineages, to have been
influenced by natural selection in their ability to search
‘antigenic space’ with a certain degree of cross-reactivity.
However, the immune system then faces a second prob-
lem: how specific should antibodies be, to achieve a
major ultimate aim of the immune system, the destruc-
tion of parasites? For both of these problems, we consider
the theoretical work to date on cross-reactivity, and we
then review empirical data on the costs and benefits of
specific versus cross-reactive antibodies. We start by
introducing parasite detection as an information problem.
The immune system as an information gatherer
and processor
Precise phenotypic adaptation to environmental condi-
tions requires that organisms process information about
their surroundings in order to make appropriate context-
dependent decisions (Dall et al. 2005). Optimal foraging
decisions, for example, depend upon the ability of a for-
ager correctly to perceive the relative resource value of
different patches of food, in light of associated costs of
foraging such as threats of predation (Stephens et al.
2007). Optimal offspring sex ratios for a given intensity
of local mate competition require that female parasitoid
wasps accurately perceive the number of other females
laying eggs on a patch (Shuker and West 2004; Burton-
Chellew et al. 2008). The mammalian immune system
must similarly tailor action to context by processing
information about the world of antigens: in the face of
unpredictable exposure to diverse parasites, a host must
perceive infections, identify parasites, and then mobilize
the appropriate mechanisms to kill those parasites.
In each of these examples of phenotypic adaptation,
understanding the mechanisms by which information is
gathered and translated to action – i.e., information pro-
cessing – can help to explain why organisms may fail to
be perfectly adapted to their environments (West and
Sheldon 2002; Shuker and West 2004; Dall et al. 2005).
For the immune system, is the apparent imperfection in
discrimination of parasite antigens (manifested as cross-
reactivity) a deliberate strategy to fight parasites across
antigenic space with cross-reactive antibodies, or merely
an information constraint imposed by the task faced by
the immune system?
The antigen recognition task of the adaptive immune
system is not easy: it must distinguish self from nonself,
and one parasite from the next, in a sea of molecules.
The innate immune system drives the process of sifting
through this antigenic information (Janeway and Medzhi-
tov 2002), but it is the adaptive immune system, via T
and B cells, that possesses the remarkable machinery nec-
essary for posing ‘search terms’ over antigenic space, and
for recognizing matches to those terms (Fig. 1). We thus
consider that the immune system gathers information by
binding to parasite antigens, with a failure to obtain that
information (a failure to recognize and bind to a parasite
antigen) posing a serious risk to the organism’s health
(and we also note that avoiding being observed by
immune systems is a legitimate and not uncommon strat-
egy of parasites (Maizels et al. 2004; Tortorella et al.
2000)). The capacity of lymphocyte receptors to recognize
antigen is in theory infinite (Pancer and Cooper 2006).
However, this initial searching of antigenic space is only
the first step taken by the immune system (Fig. 1). Via
somatic hypermutation, B cells generate more specific
receptors for a given antigen, which can be construed as a
form of ‘local searching’ of antigenic space, or gaining
very specific information about the antigen to inform fur-
ther action, which in this case is the generation of anti-
bodies by plasma cells (Fig. 1). B cells may provide a
more focused information-gathering capacity, as they pro-
vide very fine-grained information about a certain part of
antigenic space.
Despite this sophistication, antibodies often do cross-
react with, and take action against, antigens displayed by
parasite strains or species other than the one that induced
the initial response. Is this cross-reactivity a deliberate
feature of the overall strategy of the immune system, or
an unselected constraint posed by the realities of antigenic
variation? To address this, we first turn our attention to
the initial searching problem faced by T and B cells.
How should the immune system search antigenic
space?
Given the huge range of possible antigens that an
immune system might have to recognize, how best should
the immune system cover, or search, antigenic space? In
particular, in terms of the adaptive immune system, how
specific should the T and B cell repertoire be?
Energetic and other constraints affect many aspects of
immunological function (Viney et al. 2005; Martin et al.
2007), and the degree of antigen specificity is probably no
exception. Hosts may be constrained by lymphocyte num-
bers as well as the need to avoid self-damaging responses
in their search of antigenic space. For example, the lym-
phocyte pool of each person bears millions of different
T-cell receptors and billions of different B-cell receptors,
but every mammalian cell may display 1012 potential
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protein antigens on its surface (Sun et al. 2005), and par-
asites of mammals span a huge range of biological (and
probably antigenic) diversity – from archaea (Lepp et al.
2004) to metazoa (Maizels et al. 2004). Given these con-
straints, attempts have been made to predict the informa-
tion-gathering potential of lymphocytes. Empirically
grounded theoretical work suggests that, prior to expo-
sure to antigen, a certain degree of cross-reactivity in the
lymphocyte search algorithm is essential (Langman and
Cohn 1999). Indeed, hosts may ensure recognition of a
large parasite set, or a rapidly evolving parasite set of any
size, by coarse-graining antigen recognition (Oprea and
Forrest 1998), enabling production of antibody libraries
that are strategically placed to generalize over antigenic
space (Oprea and Forrest 1999). Moreover, the optimal
level of cross-reactivity increases with decreases in reper-
toire size – i.e., fewer lymphocyte receptors must cross-
react more, to cover antigenic space – but that strategy
risks autoimmunity (Borghans et al. 1999). To balance
these factors for the size range of the human repertoire, a
low degree of cross-reactivity is optimal for both T (van
den Berg et al. 2001; Borghans and De Boer 2002) and B
cells (Louzoun et al. 2003).
Theory further suggests that a receptor’s cross-reactivity
should be adapted to the portion of antigenic space in
which it binds (Fig. 2). By this logic, receptors very
unlikely to bind self antigens should have wide circles of
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Figure 1 How the mammalian adaptive immune system explores antigenic space with lymphocyte receptors. The receptor of each clonal T or B
cell lineage determines the antigens it can bind. Receptor repertoire formation involves the generation of ‘search terms’ – i.e., T- or B-cell recep-
tors – via gene segment swapping. Cells with receptors that meet basic criteria shown to left of filter A are released into circulation. When the
receptor matches antigen encountered in the body (filter A), cell division is triggered at a rate influenced by binding kinetics, co-receptors, and
co-stimulatory signals. When a B cell encounters its antigen, a second process of diversity generation takes place: somatic hypermutation, a form
of ‘local searching’ in which point mutations are generated (filter B). The resulting receptor is again tested against antigen. B cells that bind more
avidly are selectively favored and thereby more likely to contribute to the antibody repertoire, once cells of the lineage differentiate into plasma
cells (filter C). See Janeway et al. (2001) for further details. Although the generation of receptor diversity is largely somatic, there is strong poten-
tial for genetically encoded regulatory genes to act at many steps along the way (e.g., filters A–C). Thus the regulatory aspects of antigen specific-
ity, at least, should be accessible to natural selection.
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with plastic cross-reactivity set by proximity to self
antigens, both strategies eliminated self-reactivity but the
latter achieved greater coverage of antigenic space, includ-
ing the space near self peptides (van den Berg and Rand
2004; Scherer et al. 2004). If cross-reactivity is good for
the information gathering phase of an immune response,
what about the next phase?
Fine-grained information: the problem of
discrimination
If lymphocytes search antigenic space efficiently by being
initially cross-reactive, then discriminating between closely
related antigens is not a problem for them. However, the
task assigned to antibodies in the immune response is
one that may require discrimination, if antigen-specificity
is advantageous. Discrimination is a key component of
information processing theory (reviewed by Stephens
2007); also see Fig. 3). From this theory, we should
expect the binding specificity of a given antibody to be a
function of the difference between two antigens (i.e., the
target and any nontarget antigens) and the relative costs
and benefits of specificity versus cross-reactivity. First we
will consider how easy or difficult it might be to discrimi-
nate between antigens using the concept of antigenic
distance.
If we are going to predict when cross-reactivity will
occur, when it will help or hinder the host, or to identify
the optimal degree of cross-reactivity for a given context,
we need to understand the antigenic distance between
parasites: how different do different parasites appear from
the perspective of the immune system? The analogy from
behavioral ecology is working out what an animal can
perceive, in order to make sense of behavioral responses
to environmental change (Boomsma et al. 2003; Shuker
and West 2004). The problem of antigenic distance is a
difficult one, and not just for the immune system. In this
era of whole-genome sequencing of parasites, it has
become clear that antigenic distance can bear a decidedly
nonlinear relationship to phylogenetic distance (Gog and
Grenfell 2002), partly because the recognition of antigen
can be as much about physical conformation as about
amino acid sequence (e.g., Donermeyer et al. 2006), and
partly because antigens can be conserved across taxa. For
example, cross-reactivity can occur between antibodies
induced by parasites with rather distant phylogenetic
BA
Figure 2 Contrasting degrees of cross-reactivity over two-dimensional antigenic space. Seven parasite antigens (P1–7) and five self antigens (S)
are represented on a grid. The size of the filled circle represents the range of cross-reactivity of a given lymphocyte receptor or antibody. The host
in (A) plays a more cross-reactive strategy than the host in (B). Both avoid self-reactivity and respond to all parasite antigens, but (A) covers more
antigenic space with fewer lymphocyte lineages. Is that a good thing? The answer probably depends upon context. For example, imagine both
hosts are sequentially exposed first to P3 and then P4. If P3 and P4 were different strains or species of malaria, the host using strategy (A) would
likely benefit from cross-protection (e.g., Mota et al. 2001). If P3 and P4 were different serotypes of dengue virus, however, the strategy depicted
in (A) could be lethal (e.g., Goncalvez et al. 2007). Figures are modified from Scherer et al. (2004), based on shape-space tools for immunological
reactivity developed by Perelson and colleagues (e.g., Smith et al. 1997).
Figure 3 Optimal discrimination among environmentals, depending
upon the perceived magnitude of the difference between cues, as
well as the benefits of the ability to perceive the difference. For exam-
ple, if the x-axis represents a cue that a forager can perceive regard-
ing the food quality of a patch, then low versus high food quality
may be more easily discriminated in (A) than in (B). Still, if there are
great rewards for perceiving the difference in (B), then optimal dis-
crimination may have the relatively high resolution depicted in (B).
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relationships, such as helminths and malaria (Mwatha
et al. 2003; Naus et al. 2003). Within parasite species,
phylogenies may largely parallel antigenic distances over
long genetic distances (Frank 2002), but a stepwise and
nonlinear relationship between genetic and antigenic
change may become evident when examined at higher
resolution. In influenza, for example, silent mutations
may move a parasite to new regions of antigenic space
that are realized with the occurrence of one last mutation;
such a mechanism can account for the way in which a
single amino acid change can release a strain from
immune pressure while the preceding 19 changes led to
little antigenic change (Koelle et al. 2006a). The func-
tional form of the relationship between genetic and anti-
genic change is likely to shape parasite strain structure
(Adams and Sasaki 2007) and epidemiology (Gog and
Grenfell 2002; Adams et al. 2006; Koelle et al. 2006b) as
well as the efficacy of vaccines (Gupta et al. 2006) and
memory responses (Deem and Lee 2003).
Various methods can be used to quantify antigenic dis-
tance. Much of the work in this area has been on influ-
enza, because annual attempts are made to match vaccine
antigens with antigens of the strain that caused the pre-
ceding year’s outbreak. Hemagglutination inhibition
assays, for example, measure the ability of ferret antibod-
ies induced by one strain of influenza A to block aggluti-
nation of red blood cells by another strain; if strong
cross-reactivity is evident, a small antigenic distance is
inferred (Smith et al. 2004; Koelle et al. 2006a). Such
measurements sometimes successfully predict the efficacy
of vaccines, but predictions can be improved by knowl-
edge of the antigenic distance between the dominant anti-
body binding sites rather than whole viruses (Gupta et al.
2006). Another way of assessing antigenic distance is to
measure the dilution of serum at which cross-reactivity
disappears (K. J. Fairlie-Clarke, T. J. Lamb, J. Langhorne,
A. L. Graham, and J. E. Allen, unpublished data). If
cross-reactivity persists at million-fold dilutions (and it
can), then the antigenic distance is small.
Such methods can be used to compare antigens from
different parasite lineages, as well as antigen samples from
a single lineage over time, and are necessary if we are to
understand whether cross-reactivity is something that
cannot be escaped by antibodies – two antigens are just
too alike to be separated, even if they are from very dif-
ferent strains (or kingdoms) of parasites – or whether
cross-reactivity is a deliberate, selectively advantageous
strategy. If antigenic distances were measured among a
wide array of parasite taxa, the data would enable assess-
ment of how fully or evenly occupied parasite antigenic
space may be. The data might also clarify how many cases
of apparent cross-reactivity are due to specific molecular
recognition of antigens that are conserved across parasite
taxa. Mapping antigenic space (sensu Smith et al. (2004),
but applied across a much wider set of parasites) would
therefore be extremely useful for understanding the causes
of antibody cross-reactivity and host–parasite interactions
more generally.
Differences among antigens might not be the only con-
straint on antibodies, however, because the mechanics of
the immune system may also be important. For example,
the persistence of cross-reactivity once antigenic informa-
tion is available (i.e., after filter A of Fig. 1) may be
explained by lymphocyte limitation in some contexts. The
clonal lymphocyte lineage whose receptor best binds a
given antigen replicates more rapidly than other clones
(Janeway et al. 2001), such that the best-matched lym-
phocyte lineage wins by competitive exclusion (Scherer
et al. 2006). This process tends to favor specificity, but
when lymphocytes are limiting, cross-reactivity may
result. For example, if B cells undergo fewer rounds of
cell division and somatic hypermutation when a host is
resource-limited, the antibodies produced may fall short
of the maximal possible specificity. Furthermore, lympho-
cyte dynamics during memory responses may constrain
the development of specific responses to new antigens.
For example, cross-reactive antibodies are produced in
preference to specific antibodies during secondary expo-
sure to dengue because memory B cells are so rapidly
activated and thus outcompete cells that are more specific
to the new virus (Rothman 2004), a phenomenon
observed in memory responses to various other viruses
(e.g., Brehm et al. 2002; Liu et al. 2006). The mechanisms
whereby the immune system permits recognition of all
possible antigens with limited lymphocyte numbers may
therefore constrain its ability to match antibody perfectly
to antigen. Given these possible constraints, what are the
possible costs and benefits of cross-reactive antibodies?
Is cross-reactivity of antibodies a deliberate
strategy?
Models have suggested that cross-reactivity at the lym-
phocyte level is an effective strategy, but what about at
the level of antibodies? For antibody cross-reactivity to be
favored by natural selection, the costs of cross-reactivity
need to be balanced by the benefits. The typical textbook
view is that antibody specificity is a good thing, and
indeed fine discrimination of parasite antigens can bring
fitness benefits to hosts. When a host precisely targets
antigen with specific antibodies, it is often rewarded with
efficient clearance of infection. For example, antigen-
specific antibodies, but not antigen-induced, cross-reac-
tive antibodies, protect mice against parasites such as the
intracellular bacteria Nocardia brasiliensis (Salinas-
Carmona and Perez-Rivera 2004) or lymphocytic chorio-
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meningitis virus (Recher et al. 2004). Furthermore,
specific antibodies are produced more rapidly when
memory B cells encounter the exact same antigen in a
subsequent infection – a major benefit of immunological
memory (Ahmed and Gray 1996), provided the parasites
are identical to those previously encountered.
When subsequently infected with antigenically different
parasites, however, those same antibodies can actually pro-
mote parasite replication. These apparent failures of speci-
ficity can have health consequences. A classic case is the
enhancement of dengue virus replication by cross-reactive
antibodies, alluded to above. Antigen-specific antibodies
provide long-lasting protection against reinfection with
the same serotype (Sabin 1952, cited by Goncalvez et al.
2007), but cross-reactive antibodies are associated with
dengue hemorrhagic fever during subsequent infection
with a different serotype, and the severity of disease varies
with the combination and order of appearance of sero-
types (Endy et al. 2004; Rothman 2004). Unable to neu-
tralize the virus, the cross-reactive antibodies instead
facilitate viral uptake to cells (Goncalvez et al. 2007). The
antibodies are specific enough to bind but not to kill para-
sites. Costs of cross-reactive responses are also observed
across parasite species. For instance, cross-reactive
responses induced by influenza A exacerbate liver disease
due to hepatitis C virus (Urbani et al. 2005).
Balanced against these benefits of specificity and costs
of cross-reactivity, it is apparent that cross-reactive
immune responses can, in some contexts, simultaneously
protect hosts against a wide array of parasites, a possibil-
ity that has not been lost on vaccinologists (Nagy et al.
2008). Indeed, cross-reactive antibodies induced by infec-
tion or immunization can protect hosts against other
infections. For example, mice experimentally infected with
a single malaria clone make cross-reactive antibodies that
can bind to antigens of other parasite clones (displayed
on the surface of infected red blood cells) and lead to
their phagocytosis by macrophages in vitro (Mota et al.
2001). Similarly, cross-reactive antibodies from a person
infected with Plasmodium vivax can inhibit the growth of
Plasmodium falciparum in vitro (Nagao et al. 2008). More
importantly, cross-reactive antibodies benefit human
hosts living in areas of multi-strain or multi-species
malaria transmission in nature (Fesel et al. 2005;
Haghdoost and Alexander 2007). Benefits of cross-reactive
antibodies are also observed amongst flaviviruses: St.
Louis encephalitis virus and Japanese encephalitis (JE)
vaccine both induce cross-reactive antibodies to West Nile
virus that ameliorate the disease in hamsters (Tesh et al.
2002). The induction of cross-reactive antibodies to West
Nile by JE vaccine was corroborated in humans (Yamsh-
chikov et al. 2005), though whether the antibodies are
protective remains to be seen. In the case of influenza,
cross-reactive responses induced by immunization with
one virus can protect hosts against other viral genotypes
(Sandbulte et al. 2007; Levie et al. 2008; Quan et al.
2008). Cross-reactive antibodies have also been implicated
in protection against fungal infection (Casadevall and
Pirofski 2007).
Imprecision of antibody responses can therefore benefit
the host in some contexts. Ideally, the degree of cross-
reactivity would match the infections at hand (see Fig. 2;
Scherer et al. 2004; van den Berg and Rand 2007). Varia-
tion in the activation thresholds of individual cells (van
den Berg and Rand 2007) or tuning mechanisms such as
the immunomodulatory molecules employed by regula-
tory T cells (Carneiro et al. 2005) should allow precise
targeting when needed and cross-reactivity when needed.
Recognizing need, however, would require lymphocytes to
gather information on the relatedness of parasite antigens
– e.g., during co-infections, or comparing remembered to
current antigens – to generate the optimal imprecision
for a given context. The likelihood of such additional
information processing ability is unclear, but even if the
immune system could not manage by itself, biomedicine
could potentially promote cross-reactive responses (i.e.,
help the immune system to see two parasites as related),
if the context were right. Predicting when imprecisely tar-
geted immune responses will occur, and when they will
be to the detriment or benefit of hosts, is therefore of
clear biomedical relevance, for vaccination programs and
other medical interventions.
Outlook
Why, then, do adaptive immune responses cross-react?
While we cannot give a definitive answer to this question,
we suggest that the answer is likely to depend on context.
In some cases, the true antigenic distance between phylo-
genetically distant parasites may be very small, such that
specificity becomes a biochemical impossibility (and the
‘information’ cannot be discerned by the immune system).
In other cases, strict constraints such as the physical limits
of binding strengths or physiological constraints such as
lymphocyte limitation may operate. We do not currently
know how common these constraints on the immune sys-
tem actually are. However, we also do not yet know
exactly how natural selection operates on the specificity of
adaptive immune responses, though we do know that the
effects of cross-reactive antibodies on host fitness are con-
text-dependent. Would natural selection always favor
greater specificity, but constraints intervene? Or might
variability in exposure to parasites over space and time,
for example, impose fluctuating selection on the specificity
of immune responses? We do at least know that the
genetic variation that selection could act upon to effect
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evolutionary change is present in the immune system
(Frank 2002). For example, thresholds for B-cell activation
or the number of rounds of somatic hypermutation, and
thus the timing of plasma cell differentiation, may be
polymorphic (Fig. 1). Hosts are known to be hetero-
geneous in the specificity of the antibodies that they make
to a given antigen (e.g., Lyashchenko et al. 1998; Sato
et al. 2004). What remains to be done is to measure the
selective consequences of variation in cross-reactivity in
the different components of the immune system.
One intriguing possibility, given the antigenic diversity
of parasites as well as the uncertainty of exposure to those
parasites, is that imprecision in antigen recognition might
ultimately be to the benefit of hosts. Might cross-reactive
antibodies represent an adaptation to an unpredictable
wide world of antigenic exposures? It has been suggested
that imprecision in the waggle dance of honeybees is an
adaptation that spreads foragers over an optimal patch
size: natural selection is proposed to have tuned the
amount of error in the waggle dance, to balance the bene-
fits of known nectar sources against benefits of wider
searching (Weidenmuller and Seeley 1999; Gardner et al.
2007); but see Tanner and Visscher (2006). An alternative
analogy from evolutionary ecology is that of ‘bet-
hedging,’ whereby life history decisions (such as how
much energy to invest in offspring, or where to lay eggs)
are deliberately variable, to try to cater for uncertainty in
the future environment (Seger and Brockman 1987). Bet-
hedging has had its conceptual problems over the years
(e.g., Grafen 1999, 2006), but it can be favored under a
range of circumstances (e.g., King and Masel 2007), and
it would be interesting to explore further the evolution of
imprecise antibodies in this context.
We envision several further potential contributions that
evolutionary ecologists could make towards understand-
ing and controlling the antigen-specificity of immune
responses. For example, evolutionary ecological analyses
could aid identification of contexts in which hosts would
do well to hedge their bets and make cross-reactive anti-
bodies, or clinics would do well to administer gamma
globulin shots. As epidemiologists are often able to char-
acterize exposure risks on local geographical scales, we
could combine such information with data on antigenic
distances and the relative efficacy of antigen-specific
responses to allow evolutionary optimization models to
advise which specificity strategy best suits a given setting.
Thus quantitative evolutionary ecology could enhance the
potential for biomedicine to tailor treatments to epidemi-
ological settings.
Another important issue for the attention of evolution-
ary ecologists is that biomedical success in generating
cross-reactive immune responses with vaccines (Nagy
et al. 2008) is likely to feed back on the structure of
parasite populations (Restif and Grenfell 2007). Calcula-
tion of the co-evolutionary risks of altered antigen-speci-
ficity of immune responses is therefore essential; might
cross-reactive vaccines impose strong selection for escape
mutants to make larger antigenic, and perhaps more viru-
lent, leaps than they do naturally? It will also be critical
to identify the role of parasite strategies in promoting
cross-reactivity of immune responses. The theory
reviewed here (e.g., van den Berg and Rand 2004; Scherer
et al. 2004) suggests that the closer the antigenic distance
between self and parasite antigens, the less likely that
infection will promote cross-reactive antibodies. Do para-
sites that mimic host molecules select for antigen-specific
immunity? These questions are amenable to both theoret-
ical and, more importantly, experimental study.
Finally, we suggest that evolutionary ecology might also
gain tremendous insights from the immunological data
itself. In particular, interactions between the mammalian
immune system and parasites present a rare and useful
combination of traits for studies of information process-
ing and adaptation. For a start, the molecular details of
the antigens and antibodies or receptors are either known
or knowable (Boudinot et al. 2008). Thus the informa-
tion-gathering system is likely to be better characterized
than is usually possible in behavioral ecology systems.
Such data might be powerfully combined with quantita-
tive tools such as statistical decision theory, an increas-
ingly important component of studies of information
processing (Dall et al. 2005). Statistical decision theory is
based on Bayesian approaches, and the parallels between
an organism making decisions based on updated knowl-
edge of the environment (formalized as ‘prior’ and ‘pos-
terior’ distributions, before and after information
acquisition) and the workings of the adaptive immune
system, with its updatable immunological memory, are
striking. Further, the functional consequences of changes
in specificity of immunological recognition can often be
measured in exquisite detail. Thus in the immune system,
as perhaps in few others, one might be able to discover
whether there are limits to the benefits of perfect knowl-
edge of the environment.
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Abstract
Background: Larvae of several common species of parasitic nematodes obligately migrate
through, and often damage, host lungs. The larvae induce strong pulmonary Type 2 immune
responses, including T-helper (Th)2 cells as well as alternatively activated macrophages (AAM ) and
associated chitinase and Fizz/resistin family members (ChaFFs), which are thought to promote
tissue repair processes. Given the prevalence of systemic or lung-resident Type 1-inducing
pathogens in geographical areas in which nematodes are endemic, we wished to investigate the
impact of concurrent Type 1 responses on the development of these Type 2 responses to
nematode larval migration. We therefore infected BALB/c mice with the nematode Nippostrongylus
brasiliensis, in the presence or absence of Plasmodium chabaudi chabaudi malaria parasites. Co-
infected animals received both infections on the same day, and disease was assessed daily before
immunological measurements were taken at 3, 5, 7 or 20 days post-infection.
Results: We observed that the nematodes themselves caused transient loss of body mass and red
blood cell density, but co-infection then slightly ameliorated the severity of malarial anaemia. We
also tracked the development of immune responses in the lung and thoracic lymph node. By the
time of onset of the adaptive immune response around 7 days post-infection, malaria co-infection
had reduced pulmonary expression of ChaFFs. Assessment of the T cell response demonstrated
that the Th2 response to the nematode was also significantly impaired by malaria co-infection.
Conclusion: P. c. chabaudi co-infection altered both local and lymph node Type 2 immune
activation due to migration of N. brasiliensis larvae. Given recent work from other laboratories
showing that N. brasiliensis-induced ChaFFs correlate to the extent of long-term lung damage, our
results raise the possibility that co-infection with malaria might alter pulmonary repair processes
following nematode migration. Further experimentation in the co-infection model developed here
will reveal the longer-term consequences of the presence of both malaria and helminths in the lung.
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Background
Many prevalent species of parasitic nematodes - such as
Ascaris lumbricoides, which infects over a billion people
[1], or Necator americanus, the most geographically wide-
spread of the human hookworms [2] - migrate through
host lungs as larvae. Lung tissue is ruptured as the larvae
burst out of the blood vessels to enter the alveolar spaces.
Although this process is typically asymptomatic in
humans, it can also be associated with acute respiratory
distress or longer term complications [3]. For example,
infection with lung-migrating helminths has been associ-
ated with bronchial hyper-reactivity and other asthma
symptoms among children in China [4] and Brazil [5].
The rodent parasite Nippostrongylus brasiliensis (Nb) has
proven a valuable laboratory model for nematode migra-
tion through the host body. In mice, L3 larvae injected
into the skin migrate via the lungs to the small intestine,
where the parasites develop into adults [6]. Peak abun-
dance of Nb larvae in the lung occurs around 2 days post-
infection (pi) in many strains of mice [7]. The lung migra-
tory stage of Nb is associated with a strong local Type 2
inflammatory response that includes T-helper (Th)2 cells,
eosinophils and basophils [8,9]. Alternatively-activated
macrophages (AAM ) have also been identified as a major
component of the pulmonary response to Nb infection
[10,11]. AAM  are characterised by IL-4/IL-13-dependent
production of chitinase and Fizz/resistin family members
(ChaFFs) including RELM  (also known as Fizz1), the
chitinase-like protein Ym1, and Arginase-1 [12-15], and
all three proteins are consistently observed in the Nb
infected lung [10,11,16-18]. Arginase-1 is the counter-reg-
ulatory enzyme to iNOS and can thus act to suppress NO
production and Type 1 effector function. Arginase-1 also
has well documented roles in tissue repair [19,20] and has
recently been implicated as an anti-nematode effector
molecule [21]. The functions of RELM  and Ym1 are less
well understood but, like Arginase-1, they have been
strongly implicated in the response to injury [22-24] and
have putative roles in the repair process, including extra-
cellular matrix deposition and angiogenesis [25,26].
However, recent data have shown that RELM  and macro-
phage-derived arginase can also negatively regulate Th2
effector responses and thus limit the pathology associated
with overzealous repair [27-29].
Although not formally proven, the association of Argin-
ase-1, RELM , and Ym1 with the tissue repair process sug-
gests that in the context of nematode infection, ChaFFs,
potentially produced by AAM , may be required to
orchestrate the repair of damage caused by larval migra-
tion in order to restore lung integrity. Two recent papers
have highlighted the potential for Nb migration to dam-
age the lung with potentially long term consequences
[16,18]. Both studies document haemorrhaging of lung
tissue and sustained increases in airway hyper-responsive-
ness. A striking novel observation in these studies is that
Nb causes disruption of the alveolar architecture that is
consistent with pulmonary emphysema many weeks after
infection. Dysregulated, AAM -mediated repair of the
damage caused by the nematodes may be responsible for
such detrimental outcomes [16].
Helminths with lung migratory stages are often co-
endemic with Type 1-inducing parasites such as malaria
[30-32]. Given the potential for cross-regulation between
Type 1 and Type 2 immune responses, we wished to use
mouse models to investigate the consequences of co-
infection for the pulmonary Type 2 immune responses
induced by nematode migration. We chose to focus on Nb
and a rodent malaria, Plasmodium chabaudi chabaudi (Pcc),
that induces a potent Type 1 immune response and non-
lethal infection [33]. We challenged hosts simultaneously
with these two acute infections, thus demanding polar-
ized, conflicting immune responses at the same point in
time. In addition, we expected Nb-Pcc co-infection to
induce conflicting responses in the same anatomical loca-
tion, because malaria-infected red blood cells (RBCs) of
many species, including Pcc, adhere to endothelial cells of
the microvasculature of the lung [34-36]. Furthermore,
malaria itself has been shown to cause lung injury [37,38].
Thus, we expected the lung and draining (thoracic) lymph
nodes to be potential sites of strong interactions between
Nb and Pcc. The idea that helminth-malaria co-infection
may impose Type 1-Type 2 immunological conflict is not
new [30], nor is the idea that parasitic co-infection may
alter the severity of pulmonary disease [39,40], but our
emphasis on the consequences of malaria for pulmonary
Type 2 responses has not previously been explored.
Using these model systems, we assessed production of the
ChaFFs, RELM  and Ym1 as primary read-outs of the Type
2 effector response in the lung. We also examined thoracic
lymph node (TLN) cytokine profiles, parasitology and sys-
temic pathology, to set the co-infected lung in its whole-
organism context. By 7 days pi, malaria infection had sig-
nificantly reduced the expression of ChaFFs in the lungs of
co-infected animals relative to those with Nb only. This
reduction correlated with changes in Th2 cytokines in the
TLN, with co-infected mice producing significantly less IL-
13, IL-10 and IL-5 than mice infected with Nb only. Pcc co-
infection thus reduced the extent of pulmonary Type 2
activation and Th2 polarisation in response to Nb. Future
long-term experiments (up to a year in duration [16]) in
the co-infection model established here will explore how
helminth migration may interact with malaria infection to
affect chronic lung pathology.
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Results
Nb infection caused loss of both body mass and RBC 
density but ameliorated Pcc infection
To investigate pulmonary immune polarization during
acute helminth-malaria co-infection, on day 0 we infected
female BALB/c mice with 200 Nb L3 larvae, in the pres-
ence or absence of co-infection with 105 Pcc-infected
RBCs. Our first goal in developing this model was to char-
acterise the systemic pathology induced by each infection
and co-infection. We thus measured body mass (to the
nearest 0.1 g), RBC density (billions/mL), and malaria
blood parasitaemia daily. We also assessed the presence of
malaria parasites in lung tissue of mice culled at 3 or 7
days pi.
Consistent with previous reports in rats [41], we found
that Nb infection induced loss of body mass in mice dur-
ing the first week of infection: Nb-infected mice reached a
significantly lower minimum body mass than mice with-
out Nb (Fig. 1A; F1,110 = 21.1; P < 0.0001). This amounted
to a mean loss of 0.7 g, or ~3% of body mass, and was
observed regardless of malaria co-infection. No further
changes in body mass among groups achieved statistical
significance, though Pcc-infected mice showed an
expected dip in weight around day 10 that was unaltered
by Nb.
In addition to weight loss, Nb infection caused RBC den-
sities to be reduced by ~5% (Fig. 1B; effect of Nb on min-
imum RBC density to 7 days pi: F1,110 = 8.8; P = 0.0037).
Unsurprisingly [33], Pcc also caused loss of RBCs by 7
days pi (F1,110 = 40.2; P < 0.0001). Between days 7 and 20
pi, Nb-induced RBC loss resolved, but Pcc induced further
loss of RBCs - up to 60% of original density (Fig. 1B; F1,110
= 385.4; P < 0.0001). However, this was slightly (~5%)
but significantly ameliorated by Nb co-infection (Fig. 1B;
t110 = 4.2; P = 0.0003).
Consistent with this slight protective effect of Nb on RBC
loss during peak Pcc infection, Nb co-infection was associ-
ated with a modest reduction in Pcc blood parasitaemia,
as determined by microscopic examination of blood films
(Fig. 2A; maximum parasitaemia F1,62 = 4.13; P = 0.0465).
By real-time PCR, the number of Pcc genome copies per
75 mg lung homogenate sample was assessed in Pcc-
infected versus co-infected mice. Malaria parasites were
present in the lung of most animals examined at 3 days pi
and all animals at 7 days pi (Fig. 2B). At 3 days pi, which
is shortly after Nb parasites have migrated through the
lung [7] and coincident with the loss of body mass in Nb-
infected mice (Fig. 1A), co-infected mice had more Pcc
genome copies per lung sample (Fig. 2B; P = 0.010). This
could be due to enhanced Pcc adherence to the lung
endothelia [34] during Nb co-infection. However, by
gross examination we observed substantial haemorrhag-
ing in all Nb-infected mice at this time point and thus it is
also possible that leakage of blood into the lung tissue
increased the number of Pcc parasites in day 3 samples. At
7 days pi there was no significant difference between the
Pcc and the Nb+Pcc groups.
Gut nematode burden at 3 days pi varied between experi-
ments: for example, Nb+Pcc and Nb mice bore 56+10 and
35+9 adult nematodes, respectively, in experiment one,
versus 6+4 and 1+1 nematodes in experiment two. Such
variation has been previously reported [7] and in the
present study is likely to be due to the very rapid infection
kinetics typically observed for our Nb strain, which is not
mouse-adapted (e.g., no nematodes remain in the gut at 5
days pi). A difference of a few hours in Nb injection times
on day 0 and/or in gut sampling times on day 3 could
therefore lead to the differences in nematode burden that
we observed. Indeed, two lines of evidence suggest that
the number of Nb larvae moving through the lung was
much more consistent than the observed gut burdens.
First, there were no significant differences among experi-
ments in the amount of Nb-induced weight loss (P~0.2)
nor RBC loss (P~0.4). Furthermore, Type 2 immunologi-
cal readouts were extremely consistent among experi-
ments. For example, TLN production of IL-4, IL-5, and IL-
13 in response to Nb infection did not differ significantly
among experiments (P~0.9, 0.8, and 0.9, respectively).
Still, in order to be certain that experimental variations
were not confounding any of our conclusions, we control-
led for experiment in all statistical analyses of combined
data (as described in Methods).
Nb-induced ChaFFs in the lung peaked around 5-7 days pi
Before we undertook studies of Type 2 immune responses
in the lung during co-infection, we assessed the time
course of Nb-induced pulmonary expression of ChaFFs.
Previous work has mainly focused on ChaFF mRNA
expression in the lungs [10,11,16,17]. We wished to also
ascertain protein expression in situ after Nb infection, to
more closely determine the location of these proteins in
vivo. Female BALB/c mice were infected with 200 Nb-L3s,
or injected with PBS as a control, and RELM  and Ym1
protein levels were determined in BALF (via Western
blots) and lungs (via IHC) at days 3, 5, 7, 15, 20 and 26
pi, to reflect the early events, peak Th2 time point and res-
olution stages of Nb infection [9].
RELM  and Ym1 were both detected in BALF at 3 days pi,
and rose to a peak around 5-7 days pi (Fig. 3A, B). Expres-
sion of both proteins dropped off by days 20-26 pi. Histo-
logical analysis of Ym1-stained lung sections from
infected mice illustrated this peak, with an increase in the
intensity and area of anti-Ym1 staining at 5-7 days pi (Fig.
3E, F). These representative micrographs also show the
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Pathology, measured as loss of body mass (A) and red blood cell density (B)Figure 1
Pathology, measured as loss of body mass (A) and red blood cell density (B). Mice were infected with 200 Nb L3 lar-
vae and/or 105 Pcc-infected RBCs on day 0, then weighed daily to the nearest 0.1 g. Daily samples of blood were taken for flow 
cytometric analysis of RBC density. (A) Nb infection induced significant loss of body mass during the first week of infection 
(lower minimum body mass than mice without Nb; P < 0.0001). (B) Nb also induced significant loss of RBCs that week (lower 
minimum RBC density to 7 days pi than mice without Nb; P = 0.0037), whereas Pcc-induced RBC loss was mainly apparent dur-
ing the second week of infection (lower minimum RBC density to 20 days pi than mice without Pcc; P < 0.0001). Nb co-infec-
tion significantly ameliorated this (higher minimum RBC density in co-infected compared to Pcc-infected mice; P = 0.0003). 
Means ± SEM from combined results of 3 independent experiments (each with 4-9 mice per group per time point) are shown. 
The vertical dashed line indicates the two time periods for which minimum weight and RBC density were analysed: up to 7 
days pi, and 7-20 days pi, as described in Methods. The symbol * indicates statistical significance of the Nb main effect, and § 
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influx of Ym1-positive inflammatory cells into the lung
tissue that was evident by day 7 - e.g., alveolar and peri-
bronchial inflammation. Of note, although infiltrating
cells were RELM + (data not shown) and Ym1+, epithelial
cells also appeared to be a major source of these mole-
cules. Reece et al. (2006) clearly demonstrate macro-
phages as sources of these proteins in the lung during Nb
infection but do not mention epithelial cells [11]. Our
data are more consistent with a recent study in which
RELM  was localized primarily to epithelial cells in Nb-
infected mice [29]. Further, several reports on inflamed
allergic (asthma model) and fibrotic (bleomycin- or gam-
maherpes virus-induced) rodent lungs, as well as our own
unpublished data, demonstrate expression of both Ym1
and RELM  by epithelial cells [26,42,43]. By 15-26 days
pi (Fig. 3G, H, I), Ym1 protein expression had returned to
near-background (Fig. 3C), with reduced inflammatory
influx and resolution of the thickened and disrupted epi-
thelial layer that was apparent at earlier time points. These
data are supportive of the idea that pulmonary activation
of AAM  is a highly dynamic process [44].
Pcc changed the dynamics of expression of Nb-induced 
ChaFFs, especially 7 days pi
To assess the effect of Pcc co-infection on the dynamics of
Nb-induced pulmonary AAM  and Type 2 epithelial cell
activation, we next analysed both mRNA and protein
expression of two ChaFFs, RELM  and Ym1, at a series of
time points during co-infection. We also measured local
mRNA expression of iNOS as a marker for Type 1 macro-
phage activation [19], which might be expected during
malaria [45]. Furthermore, we measured mRNA of Type 1
cytokines (IL-12p40, TNF- , and IFN- ), as well as mRNA
of IL-13, a key cytokine likely to drive production of Type
2 effector molecules such as the ChaFFs [12-15]. We chose
to examine the effect of malaria infection around the peak
of larvae-induced damage (i.e., ~day 3 pi) [7] and the time
of transition to adaptive Type 2 responses (i.e., ~days 5-7
pi) [9,11]. We also assessed a later time point well into the
adaptive immune phase: 20 days pi.
Analysis of ChaFF mRNA expression at 3, 5, 7 and 20 days
pi suggested that the strongest interactions between Nb
and Pcc-induced responses in lung tissue occurred 5-7
days pi (Fig. 4A, B). Indeed, because days 5-7 pi repre-
sented a time of strong ChaFF expression in Nb lung (Fig.
3) and day 7 pi coincided with the presence of Pcc there
(Fig. 2B), it is perhaps unsurprising that days 5-7 pi could
be the time of maximum effect of Pcc co-infection. At 3
days pi, there was a transient elevation of RELM  mRNA
in co-infected compared to Nb-infected mice (P = 0.0257)
that was reversed over the next few days: differences
between the groups were not significant at 5 days pi, but
RELM  gene expression was significantly reduced in co-
infected mice at 7 days pi (Fig. 4A; F1,25 = 7.5, P = 0.0113,
for combined analysis of experiments). Expression of
Ym1 mRNA was also significantly lower in co-infected
than Nb mice at days 5 and 7 pi (Fig. 4B: day 5 P = 0.0442;
day 7 F1,25 = 9.5, P = 0.005, for combined analysis of
experiments). In agreement with these observations, day 7
expression of Arginase-1 mRNA was significantly lower in
the lungs of co-infected mice than in mice that had Nb
only (data not shown; F1,24 = 7.7, P = 0.0104). Further-
more, ChaFF expression is known to be driven by engage-
ment of IL-4R  [24] by IL-4 and/or IL-13; accordingly, IL-
13 mRNA expression in the lungs of co-infected mice was
significantly reduced compared to Nb-infected mice at 5
days pi (Fig. 4C: P = 0.0169). This suggests that suppres-
sion of IL-13 by Pcc may be responsible for the reduced
ChaFFs in co-infected mice. At 20 days pi, mRNA expres-
sion for RELM  (P = 0.0101) was slightly elevated in co-
infected relative to Nb-only mice, but ChaFF and IL-13
mRNA expression had otherwise largely returned to back-
ground levels. Throughout this time course, Pcc-infected
and uninfected animals expressed little or no mRNA for
the ChaFFs.
In support of the mRNA data, when we analysed protein
expression in lung BALF using Western blotting, we saw a
significant day 7 pi reduction of both RELM  (Fig. 5A;
F1,25 = 8.7, P = 0.0067, for analysis of combined experi-
ments) and Ym1 (Fig. 5B; F1,25 = 7.7, P = 0.0104, for anal-
ysis of combined experiments) in co-infected mice
compared to Nb-infected mice. By day 20 pi, the pattern
had reversed, with co-infected mice expressing more
RELM  (P = 0.0398) and Ym1 (P = 0.0171) than Nb mice.
ChaFF expression in Pcc-infected mice did not differ from
near-null expression in uninfected control mice (Fig. 5A,
B). Importantly, BAL cell counts and cellular composition
did not differ significantly among groups at any time-
point. There was a non-significant elevation in total num-
bers of cells in co-infected mice at 3 days pi and in Nb
mice at 5 days pi, which might partly explain the elevation
in ChaFFs at these early timepoints. However, any appar-
ent differences were entirely absent from the 7 and 20 day
BAL samples. Therefore, the observed effects on ChaFF
protein expression are unlikely to be due to differences in
cellular makeup alone, particularly at 7 and 20 days pi.
Further, the inflammatory cells may not be the major
source of CHaFF proteins in lavage fluid. The pattern and
intensity of epithelial cell staining (see Fig 6C) suggests
that these cells may be largely responsible for the changes
in mRNA and BALF protein.
IHC scoring of lung sections further confirmed these
dynamics. At both day 5 pi and day 7 pi, the intensity of
RELM  (Fig 6A) and Ym1 (Fig 6B) staining in the lungs of
co-infected animals was reduced compared to Nb mice,
though the RELM  difference did not achieve statistical
significance at day 7 (day 5: RELM  P = 0.0056; Ym1 P =
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Malaria parasites in the blood (A) and lungs (B) of Pcc-infected and co-infected miceFigu e 2
Malaria parasites in the blood (A) and lungs (B) of Pcc-infected and co-infected mice. (A) Co-infected mice 
(Nb+Pcc) had a lower peak proportion of parasitized RBCs than Pcc-infected mice did (P = 0.0465), as determined by 1000! 
microscopic examination of Giemsa-stained thin blood films. Means ± SEM from combined results of 3 independent experi-
ments (each with 4-9 mice per group per time point) are shown. (B) Co-infected mice harboured greater numbers of Pcc 
genome copies per lung sample than Pcc mice at 3 days pi (P = 0.01), as assessed by real-time PCR of lung homogenates 
(derived from 75 mg lung) using MSP-1 specific primers. Genome copies were apparent in both Pcc infected groups at 7 days pi 
and the copy numbers no longer differed significantly between groups. This experiment included 4-7 mice per group. The sym-
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0.0153; day 7: RELM  P = 0.1011; Ym1 P = 0.0171). Rep-
resentative micrographs from day 7 pi show the reduced
intensity of RELM  staining in co-infected animals rela-
tive to Nb mice and no RELM  staining in Pcc mice (Fig.
6C). No differences among groups were detected by IHC
at days 3 or 20 pi. Therefore, the expression pattern of
ChaFF protein in situ was largely in agreement with mRNA
in whole lung tissue (Fig. 4) and protein expression in the
BALF (Fig. 5). As discussed above for the time course of Nb
infection (Fig. 3), although Ym1+ and RELM + macro-
phages were present in lung IHC sections, the predomi-
nant cell type expressing these molecules appeared to be
epithelial cells. Furthermore, lung macrophages in this
system do not appear to become classically activated, as
assessed by lung mRNA for iNOS and IL-12p40, which
were not detectable in any mice at any time point, and
TNF- , which was detectable but at low levels that did not
differ among groups (data not shown). However, IFN
was elevated in the lung tissue of all Pcc infected mice,
regardless of Nb co-infection, at day 7 pi (Fig. 7).
Cytokine production in local LN largely mirrored 
pulmonary ChaFF expression
To assess whether pulmonary ChaFF patterns corre-
sponded to immune responses in the draining thoracic
lymph node (TLN), we performed in vitro culture of TLN
Time course of protein expression of ChaFFs in Nb infected lungsF gure 3
Time course of protein expression of ChaFFs in Nb infected lungs. Western blot analysis of lung lavages harvested at 
different time points post Nb infection (4 Nb mice per timepoint) suggested that the secretion of ChaFFs RELM  (A) and Ym1 
(B) peaked around 5-7 days post infection. Data are expressed as percentage of a positive control sample (pooled lung lavages 
of three Nb-infected mice). Representative photomicrographs from Nb-infected lung tissue sections stained histologically for 
Ym1 at the indicated time points, plus an uninfected control lung (C), illustrate peak expression of brown Ym1 staining of epi-
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cells, in media alone or with antigen or ConA. At 3 and 5
days pi, there were no significant differences in superna-
tant cytokine concentrations among infection groups.
However, by 7 days pi, differences among the groups were
apparent, as outlined below. No antigen-specific
responses were observed (i.e., no cytokines in excess of
spontaneous secretion in media alone) until 20 days pi
(discussed below). Spontaneous and ConA-induced
cytokines exhibited identical patterns, though spontane-
ous responses were of lower magnitude.
At 7 days pi, Nb infection in singly as well as co-infected
mice was associated with significantly elevated ConA-
induced production of IL-4, IL-13, IL-5, and IL-10 com-
pared to uninfected and Pcc-infected mice (Fig. 8A, B, C,
D; all P for Nb main effect < 0.0001). Of interest, IL-6 and
sTNFR1 were also associated with Nb but not Pcc infection
(Fig. 8E, F; both P for Nb main effect <0.0001). TNF-  pro-
duction did not vary among infection groups (Fig. 8G),
but Pcc infection was associated with significantly ele-
vated IFN-  production compared to uninfected and Nb-
infected mice (Fig. 8H; P for Pcc main effect <0.0001). To
our knowledge, TLN polarization by systemic malaria
infection has not been previously reported. The Th1 bias
of the observed response to Pcc was unsurprising.
Co-infected mice differed from singly-infected mice in
ConA-induced production of some of these cytokines. For
example, IL-13, IL-5, and IL-10 production were signifi-
cantly reduced in co-infected compared to Nb-infected
animals (Fig. 8B, C, D; t61 = 7.3, 18.8, 8.1 and P = 0.011,
0.0001, 0.007, respectively), while IFN-  production was
ChaFF and IL-13 mRNA expression in the lungs of Nb, Pcc and co-infected miceFigure 4
ChaFF and IL-13 mRNA expression in the lungs of Nb, Pcc and co-infected mice. Real-time RT-PCR of mRNA from 
lung tissue harvested at 3, 5, 7 or 20 days pi showed that the effect of Pcc on Nb-induced expression of RELM  (A) and Ym1 
(B) changed over time. RELM  was transiently elevated in co-infected (Nb+Pcc) compared to Nb mice at 3 days pi (P = 0.0257), 
but expression of mRNA for RELM  (A), and Ym1 (B) was then found to be significantly lower in the lungs of Nb+Pcc mice 
than in Nb mice by 7 days pi (RELM , P = 0.0113; Ym1, P = 0.005). IL-13 mRNA expression (C) largely mirrored this pattern, 
as it was significantly reduced in Nb+Pcc mice compared to Nb mice at 5 days pi (P = 0.0169). At 20 days pi, however, RELM  
(A) was again significantly elevated in Nb+Pcc relative to Nb mice. (P = 0.01) Data are expressed as percentage of positive con-
trol samples (for RELM  and Ym1, peritoneal macrophages of a mouse implanted with Brugia malayi adult parasites for 3 weeks 
[72]; for IL-13, spleen of an MHV-68 infected IFN R-KO mouse [63]). Bars indicate mean ± SEM of 2 combined independent 
experiments, each with 4-9 mice per group per timepoint. The symbol ¶ indicates significance of the difference between co-
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reduced in co-infected compared to Pcc-infected animals
(Fig. 8H; t61 = 8.4 and P = 0.006). These results provide
evidence of cross-regulation between Th1 and Th2
immune responses in the local lymph node during the
first week of co-infection. This finding is consistent with a
wide range of studies of murine co-infection (reviewed in
[30,46]).
By 20 days pi, the overall strength of TLN cytokine
responses had waned, but antigen-specific responses were
detectable. Correcting for background (spontaneous)
secretion of cytokines in wells with media alone, antigen-
specific responses to crude helminth (Nb Ag) and recom-
binant malaria (MSP-119 Ag) antigens were each observed
for a subset of the cytokines measured (Fig. 9). For exam-
ple, Nb infection was associated with strong Nb Ag-spe-
cific IL-13 responses (Fig. 9A: P < 0.0001), regardless of
co-infection. Co-infection, however, had a significant
boosting effect on Nb Ag-specific IL-5 (Fig. 9B: P = 0.0025
for the comparison with Nb mice; P < 0.0001 for the com-
parison with Pcc mice). Co-infection was also associated
with significantly elevated MSP-119Ag-specific IL-6 (Fig.
9C: P = 0.0163 for the comparison with Nb mice; P =
0.0112 for the comparison with Pcc mice). TNF-  produc-
tion, though greater than background, did not differ sig-
nificantly among groups (Fig. 9D).
Discussion
Our primary aim in this study was to address the interplay
of two acute infections that place conflicting demands on
the host immune response, particularly in the lung. We
wanted to focus on Type 1-Type 2 cross-regulation rather
than any effects of regulatory T cells, so we opted for a
model of acute rather than chronic helminthiasis. In addi-
tion, although anatomical compartmentalization does
not preclude immunological interaction - for example,
gut-restricted helminths can induce a strong systemic Th2
bias [47] - compartmentalization can buffer the effects of
co-infection [48]. We thus chose murine infection models
that would pose an immunological conflict in anatomical
space as well as time post-infection (pi). The dynamics we
were investigating may have real life corollaries, because
nematode migration occurs in the lungs of over a third of
the world's human population [1,2], many of whom are
co-infected with malaria [31,32]. However, because both
of our murine models (Pcc and Nb) produce self-resolving
infections, the effects of co-infection on anaemia and on
pulmonary immunology reported here cannot be firmly
Western blot analysis of ChaFF protein expression in BALF of Nb, Pcc and co-infected miceFigure 5
Western blot analysis of ChaFF protein expression in BALF of Nb, Pcc and co-infected mice. Lung lavages har-
vested at days 3, 5, 7 and 20 pi indicated that the ChaFF proteins RELM  (A) and Ym1 (B) exhibited temporal dynamics that 
were similar to those observed for mRNA expression in lung tissue (Fig. 4). In particular, expression of both proteins was sig-
nificantly lower in the lungs of co-infected (Nb+Pcc) than in Nb mice at 7 days pi (RELM  P = 0.0067 and Ym1 P = 0.0104). This 
pattern had reversed by 20 days pi, with increased ChaFF protein expression in Nb+Pcc compared to Nb mice (RELM  P = 
0.0398 and Ym1 P = 0.0171). Data are expressed as percentage of a positive control sample (pooled lung lavages of three Nb-
infected mice). Bars indicate mean ± SEM of combined results of 2 independent experiments, each with 4-9 mice per group per 
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Immunohistochemical analysis of ChaFF protein expression in the lungs of Nb, Pcc and co-infected miceFigure 6
Immunohistochemical analysis of ChaFF protein expression in the lungs of Nb, Pcc and co-infected mice. Pro-
tein expression in lung sections corroborated BALF concentrations of ChaFF proteins observed around 7 days pi, as illustrated 
by days 5 and 7 pi staining intensity scores for RELM  (A) and Ym1 (B) as well as representative micrographs (at increasing 
magnification) of day 7 pi slides stained for RELM  (C). Down-regulation of ChaFFs was observed in co-infected mice (Nb+Pcc) 
compared to Nb mice; differences were significant for both RELM  and Ym1 at 5 days pi (RELM  P = 0.0056 and Ym1 P = 
0.0153) and for Ym1 at 7 days pi (P = 0.0171). Scores were obtained by analyzing bronchial epithelium in ten fields per mouse 
using a scoring system described in Methods. The whisker-and-box graphs with minimum and maximum values depict results 
from a representative experiment with 4-9 mice per group. The symbol ¶ indicates significance of the difference between co-
infected and Nb mice (P values included above and in Results text).
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associated with chronic disease outcomes until longer
term co-infection studies are performed.
We quantified the health of mice in our experiments using
two measures that have proven informative during Pcc
infection [49] and Pcc-nematode co-infection [50]: body
mass and RBC density. To our knowledge, this is the first
report demonstrating that murine Nb infection has a neg-
ative impact on both parameters, although reduced
weight gain in young Nb-infected mice has previously
been reported [40]. Nb caused a statistically significant,
transient ~3% loss of body mass from approximately 2-4
days pi, and in other experiments using a higher dose
(500 L3s), mice lost closer to 10% of their starting body
mass (unpublished data). Migration of Nb larvae through
the lungs has previously been shown to cause two spells
of inappetance and thus weight loss in rats, one associated
with migration of larvae and the other with establishment
of adults in the gut [41]. We detected only one period of
loss of body mass; mice may be spared the second spell
given the brief survival of adult Nb in mice, particularly for
parasite strains, such as ours, that are not mouse-adapted.
We also observed a transient loss of RBC density in Nb-
infected mice. It was rather surprising that this effect -
most likely caused by haemorrhaging of the lung follow-
ing larval migration - was detectable at the systemic level.
This suggests that the capillary damage and ingestion of
RBCs by alveolar macrophages following lung migration
of Nb [11,16] are associated with considerable blood loss.
A diverse range of outcomes is possible when helminths
and malaria co-infect a host. Co-infected mice in our
study experienced two periods of RBC loss in quick succes-
sion - first Nb-induced and then Pcc-induced. However,
they had slightly higher RBC densities than Pcc-infected
mice did, at the time of most severe malarial disease. This
was associated with a small reduction in malaria parasi-
taemia in the blood. These results contrast with several
studies of helminth-malaria co-infection in mice, in
which malaria parasitemia was increased [51-54], and/or
malarial symptoms exacerbated, in at least some groups of
co-infected mice [50-55]. For example, in contrast to the
lethal inflammatory liver disease recently described in
mice simultaneously co-infected with Heligmosomoides
polygyrus and Pcc [55], we observed subtle amelioration of
malarial disease and no deaths. This disparity in the sever-
ity of co-infection could be due to the fact that we worked
with a different mouse strain (BALB/c versus Helmby's
C57BL/6) as well as a different helminth species that
migrates differently through the host body. However, we
detected an elevation in MSP-119-specific IL-6 due to co-
infection, so it is possible that the emergent IL-17/IL-23
axis described by Helmby [55] may likewise be involved
in our co-infection system, though not in organs that neg-
atively impact short-term survival. Indeed, the mecha-
nisms underlying the slightly protective effect of Nb
observed here are not yet clear. We are investigating possi-
ble immunological causes of this protection, including
innate mechanisms such as IFN- + NK cells [56] and adap-
tive mechanisms such as cytophilic antibody isotypes [33]
that could promote malaria clearance; either might be
altered by acute Nb co-infection. However, it is also possi-
ble that lower parasitaemia might be the consequence of
the RBC density changes induced by Nb, as previous co-
infection studies have shown that helminths can limit
RBC availability to malarial parasites and thereby cap
their replication (e.g., [57]). Control of microparasites by
Th1 immunity and by RBC limitation are not mutually-
exclusive possibilities [58] and both might be operating in
our model system. Finally, it is possible that the sequestra-
tion habits of Pcc parasites [59] are altered by Nb. These
mechanisms remain to be investigated.
Our results largely resemble those reported for other Nb-
microparasite pairings. For example, during co-infection
of mice with Nb and either Toxoplasma gondii [60] or
Chlamydophila abortus [61], significantly reduced Th2
responses (compared to mice with Nb infection) have
been observed, independent of the interval between infec-
tions [60,61]. These data suggest that Pcc is not the only
Lung mRNA for the Type 1 cytokine IFN-  at 7 days piFigure 7
Lung mRNA for the Type 1 cytokine IFN-  at 7 days 
pi. Real-time RT-PCR of mRNA from lung tissue harvested 
at 3, 5, 7 or 20 days pi using primers for Type 1 markers 
iNOS, IL-12p40, TNF- , and IFN-  were largely negative. For 
example, no iNOS nor IL-12p40 was detected in any mice, 
and although TNF-  was detected at low levels, its expres-
sion did not differ among groups of mice. At 7 days pi, how-
ever, IFN-  was significantly upregulated in all mice with Pcc 
infection, with or without Nb co-infection, as depicted here. 
Data are expressed as percentage of a positive control sam-
ple (peritoneal macrophages of a thioglycolate-injected 
mouse [10]). Mean ± SEM from a representative experiment 
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ConA-induced cytokine release in TLN lymphocyte recall assaysFigure 8
ConA-induced cytokine release in TLN lymphocyte recall assays. Cytokine concentrations in supernatants of ConA-
stimulated TLN cells harvested at day 7 pi were measured with cytometric bead arrays. Groups did not differ in cytokine pro-
duction at 3 or 5 days pi, and no antigen-specific responses were detected until 20 days pi. Data on day 7 pi IL-4 (A), IL-13 (B), 
IL-5 (C), IL-10 (D), IL-6 (E), sTNFR1 (F), TNF-  (G), and IFN-  (H) production are shown. In these data, statistically significant 
down-regulatory effects of co-infection (Nb+Pcc) were found for IL-13 (P = 0.011), IL-5 (P = 0.0001), IL-10 (P = 0.007), and IFN-
 (P = 0.006), compared to relevant single-infection groups. Bars indicate mean ± SEM from 3 combined experiments, each with 
4-9 mice per group. The symbol ¶ indicates significance of the difference between co-infected and Nb mice, while § indicates 
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Antigen-specific responses in TLN lymphocyte recall assaysFigure 9
Antigen-specific responses in TLN lymphocyte recall assays. Cytokine concentrations in supernatants of TLN cells 
that were harvested at day 20 pi and then stimulated with antigen were measured with cytometric bead arrays. Nb Ag, a crude 
Nb adult lysate, and recombinant Pcc clone AS merozoite surface protein, MSP-119, were used as antigens in vitro. Although all 
cytokines shown in Figure 8 were measured, only IL-13 in response to Nb Ag (A), IL-5 in response to Nb Ag (B), IL-6 in 
response to MSP-119 (C), and TNF-  in response to MSP-119 (D) were above levels of spontaneous secretion. These figures 
thus depict antigen-specific cytokine (in ng/ml above background). Statistically significant differences among groups included 
increased NbAg-specific IL-13 in all Nb mice (P < 0.0001), increased Nb Ag-specific IL-5 in co-infected (Nb+Pcc) mice compared 
to both Nb (P = 0.0025) and Pcc mice (P < 0.0001), and increased MSP-119-specific IL-6 in Nb+Pcc compared to both Nb (P = 
0.0163) and Pcc mice (P = 0.0112). Bars indicate mean ± SEM for 4-8 mice per group. The symbol ¶ indicates significance of the 
difference between co-infected and Nb mice, while § indicates significance of the difference between co-infected and Pcc mice (P 
values included above and in Results text).
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microparasite that might reduce Th2 responses to Nb
infection. Mycobacterium bovis BCG co-infection, however,
does not significantly impact Nb-induced IL-4 in the
mesenteric lymph nodes [62]; it would be of interest to
know whether those lung-dwelling microparasites might
have had similar effects to Pcc on Th2 responses, had they
been measured in the TLN. Reported effects of Nb on the
course of microparasite infections are likewise mixed:
densities of T. gondii [60] and M. bovis BCG [62] are unaf-
fected by the presence of the nematode, while C. abortus
density increases dramatically [61]. Interestingly, the con-
current presence of influenza virus with migrating Nb lar-
vae in the lung exacerbates the severity of lung disease
compared to mice with influenza alone [40]. A two-week
delay between Nb infection and influenza infection, or
replacement of Nb with H. polygyrus, eliminates the added
pathology, suggesting that the simultaneous presence of
larvae and virus in the lungs is required [40]. Such may
also be the case for Pcc-Nb co-infection. The Nb-influenza
study did not include immunological measurements, so
the role of the immune system in generating the observed
pattern is not known. Indeed, this comparison illustrates
that many details of anatomical location and parasite life
cycles, as well as immunological interactions, must be
taken into account to explain the diverse outcomes of
helminth-microparasite co-infections [30,46].
Our most novel finding is that malaria infection has the
capacity to modulate the host's pulmonary Type 2
response to nematode migration. However, the long-term
impact of the altered Type 2 response is not possible to
predict, because the function of Type 2 immunity in this
setting is not yet fully understood. There are at least three
potential outcomes of a helminth-induced Type 2
response in the lung. First, it may contribute to protection
against incoming larvae [6]. Second, Type 2 responses are
likely to be involved in repairing the damage that is
inflicted by migrating parasites. Third, as recent studies
have shown [5,16,18], lung migration and the associated
Th2 responses have the potential to cause long-term lung
pathology. Appropriate repair versus lung malfunction are
likely to be flip sides of the same coin. Indeed, although
ChaFFs and Arginase-1 are implicated in tissue repair,
they are also associated with fibrosis, an overzealous
repair process [19,24,43,63-65] (see also review by Wynn
[66]). Predicting the effect of Pcc co-infection on long
term Nb-induced lung disease is further complicated by
recent data that suggest both Arginase-1 and RELM  can
negatively regulate Th2-mediated pathology [27-29]. By
this logic, inhibition of these molecules by malaria co-
infection may ultimately exacerbate Th2-mediated lung
damage.
However, our data suggest that the effect of malaria on
ChaFF expression is not direct but rather via reduced Th2
cytokines. The effect of Pcc on Nb-induced ChaFFs was not
apparent until 7 days pi, when the extent of the increase
in ChaFF expression was inhibited by co-infection. This
was correlated with differences in cytokine production in
lymphocyte recall assays, suggesting that changes in
ChaFF expression were driven by changes in the T lym-
phocyte populations after the onset of the adaptive Th2
immune response (around 5 days pi, as shown in Nb-
infected IL-4 reporter mice [9]). A role for adaptive immu-
nity is further supported by work showing that SCID mice
are not able to sustain AAM  responses in the lung follow-
ing Nb infection [11], and a demonstrated requirement
for T cells to sustain the AAM  response in a mouse peri-
toneal infection model [24]. Remarkably, in SCID mice,
in the absence of T cells and AAM , the Nb-induced cellu-
lar infiltrate does not resolve [11]. The capacity of malaria
to inhibit the transition to a full Th2 response by 7 days pi
may likewise be detrimental to full resolution of the
inflammatory response, a step necessary for appropriate
tissue repair [67,68]. By day 20 pi, however, the residual
Th2 responses in co-infected mice were as high as, or even
higher than, in Nb-only mice. In support of this, day 20
antigen-specific IL-5 responses were particularly high in
co-infected animals. Thus Pcc infection may protect
against airway hyper-responsiveness through a reduction
in peak Th2 activation, or else exacerbate it due to sus-
tained Th2 activity. Transient passage of Nb larvae
through the lung inflicts lasting damage [16,18]. Whether
transient impairment of pulmonary Th2 responses by
malaria co-infection also has lasting effects needs to be
investigated experimentally.
A perhaps surprising finding in our study was the appar-
ent absence of classical macrophage activation in the lung
despite the clear presence of malaria parasites: we did not
detect iNOS, IL-12p40 nor elevated TNF-  mRNA in lung
tissue of Pcc-only or co-infected mice at any time point.
One could argue that malaria parasites stay in the lung
microvasculature and do not cross into tissue. However,
this is unlikely to be the case, given the extensive lung
damage due to Nb in co-infected mice, as well as evidence
that malaria merozoites can be found dispersed in the
lung [34]. Furthermore, IFN-  mRNA was detectable in the
lung of all Pcc mice regardless of co-infection, suggesting
that lymphocytes were activated, perhaps by innate activa-
tion of NK or  T cells. The most likely explanation for
the failure to detect classical macrophage activation may
be that lung macrophages, which are exposed daily to
inhaled microbes, have a remarkably high threshold for
activation even in the presence of IFN-  and microbial
stimuli [69].
As with any laboratory model, it is important to acknowl-
edge the potential disconnection between natural co-
infections and the experimental systems and designs used
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here, including the relative timing of the two infections,
doses at which they were administered, and the fact that
we have only studied primary and self-resolving (rather
than secondary and/or chronic) infections. Permutation
of any of these parameters is likely to quantitatively, if not
qualitatively, alter outcomes. For example, repair proc-
esses might readily keep pace with lung damage when the
rate of exposure to nematode larvae is low, unlike in most
experimental models. We used a relatively low dose of L3
larvae (200 per mouse while others use ~500 [16,18] or as
many as 750-1000 [60-62]) but still exceeded natural
exposure levels. Furthermore, larval helminths and
malaria parasites are unlikely to arrive in the lung within
a few days of each other in nature, and it may be that pre-
existing malaria would have had a different effect on pul-
monary Type 2 responses to Nb migration, particularly if
malaria parasites do not remain long in the lung. Indeed,
the most likely natural exposure scenario may be chronic
malaria infection into which helminth larvae are "trick-
led" [32], but experimental studies that mimic this sce-
nario have yet to be carried out. Nonetheless, lung
dysfunction is seen as a consequence of helminth migra-
tion [4,5] and both acute and persistent malaria infection
[38] in people, so high-dose experimental Nb studies in
which long-term lung pathology can be observed [16,18],
combined with simultaneous malaria exposure, may pro-
vide useful models for disease states in people.
Conclusion
With the experiments reported here, we have established
an acute laboratory model of helminth-malaria co-infec-
tion that will be suitable for future work exploring the
details of how Type 1 inducing co-infections affect long-
term, Type 2-mediated repair of the damage caused by
migrating nematodes. Recently developed models of
malaria-induced lung damage (e.g., [37]) might be ana-
lysed in animals co-infected with Nb. Corroborative stud-
ies in human populations may also be feasible. Like
migratory helminthiases [3], severe falciparum malaria is
associated with detectable lung injury, as measured by
spirometry and clinical symptoms [38]. A study like
Brooker et al's analysis of whether the anaemia of hook-
worm and malaria are additive during co-infection [32]
that used spirometry to assess the pulmonary health of
malaria-infected, A. lumbricoides- or hookworm-infected,
and co-infected people could assess whether co-infection
exacerbates damage. Given the huge number of people
with such co-infections, it is possible that clinical studies
of malaria lung injury may gain insight from considering
the presence, however transient, of helminths in the lung.
Methods
Mice, parasites, experimental design, and monitoring
Specific pathogen free, 8-10 week old female BALB/c mice
(Harlan, UK) were maintained in individually ventilated
cages on diet 41b ad lib. Nippostrongylus brasiliensis (Nb)
was maintained by serial passage through Sprague-Daw-
ley rats, as described previously [70]. Cryopreserved Plas-
modium chabaudi chabaudi (Pcc) parasites of clone AS were
passaged through two generations of donor BALB/c mice
and inoculated into experimental mice as described previ-
ously [50]. The four co-infection experiments used a fac-
torial design, with uninfected controls, Pcc-infected, Nb-
infected, and co-infected mice. On day 0, 200 Nb L3 larvae
and/or 105 Pcc-infected RBCs were injected subcutane-
ously and intraperitoneally, respectively. PBS and naïve
mouse RBCs served as sham injections for Nb and Pcc,
respectively; uninfected control animals received both
sham injections. RBC density, body mass, and malaria
parasites were then monitored daily, as described previ-
ously [50]. Briefly, RBC densities were measured by flow
cytometry (Beckman Coulter), body mass was recorded to
the nearest 0.1 g, and the proportion of RBCs parasitized
was counted in Giemsa-stained thin blood films (at
1000! magnification). Mice were then culled 3, 5, 7, or 20
days pi (4-9 mice per infection type per timepoint). Nb
parasite burden was assessed in the gastrointestinal tract
of culled mice. Intestines were placed in PBS, slit length-
wise and the contents rinsed into muslin-lined funnels set
over tubes containing PBS warmed to 37°C. Nematodes
were left to filter through for >2 hours and counted via
microscopy (at 40!). To elucidate the dynamics of Nb-
induced alternative activation in the lung, a separate
experiment was conducted for Nb only, with mice culled
3, 5, 7, 15, 20 or 26 days pi (4 Nb-infected mice per time
point). All experiments were carried out in accordance
with the animals (Scientific Procedures) Act 1986, and
were approved by the UK Home Office inspectorate and
institutional review committee.
Lung lavage and tissue sampling
Following terminal anaesthesia, tracheas were cannulated
and lungs lavaged with 1 mL PBS. Cannulae were pre-
pared from fine bore polythene tubing (Portex) and a 23
G needle. Following lavage, the left lung lobe was tied off,
cut at the bronchus, and placed in RNAlater (Ambion) for
mRNA extraction, while the right lobe was perfused in 4%
formaldehyde and embedded in paraffin for immunohis-
tochemistry. BAL cell concentrations were determined
using a Scharf Instruments Casy Counter. BALF was centri-
fuged at 1,200 g for 5 mins and stored at -20°C for protein
analysis by Western blot.
Immunohistochemistry
Expression of RELM  and Ym1 in lung sections was
assessed by indirect immunoperoxidase techniques.
Briefly, the paraffin embedded tissue sections were depar-
affinised and rehydrated. After high temperature antigen
unmasking (Vector Laboratories, UK), endogenous perox-
idase was quenched with aqueous 2% H2O2 (Sigma
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Aldrich, UK) for 15 minutes. Slides were then incubated 2
h with primary antibodies: rabbit anti-RELM  (0.25 g/
mL; Peprotech) or rabbit anti-Ym1 (1/100; StemCell
Technologies) in antibody diluent (Dako Cytomation,
Denmark) at RT, followed by the secondary antibody
(goat anti-rabbit biotin, 1 mg/mL, Dako Cytomation,
Denmark). Peroxidase-labelled ABC reagent and DAB
substrate (Vector Laboratories, UK) were used for signal
visualisation. Finally, the sections were counterstained
with haematoxylin. RELM  and Ym1 staining intensities
were scored by two researchers, blinded to experimental
groupings, using a modification of a previously-published
lung inflammation scoring system [71]. For each mouse,
staining was assessed at 200! magnification for 10 fields.
Each field included correctly inflated lung tissue and a
complete transection of at least one bronchiole, blood
vessel and alveolar airway. Cytoplasmic staining strength
was scored in bronchial epithelial cells, infiltrating cells
and alveolar macrophages on a scale of 1-4 (1 = no stain-
ing, 2 = weak, 3 = moderate, and 4 = strong staining, using
a reference section of the same positive control sample
(lung of an Nb-infected mouse at 7 days pi). The percent-
age of positive cells in each of these compartments was
also scored on a scale of 1-4 (1 = none, 2<30%, 3 = 30-
60%, 4>60% positive cells). Average cytoplasmic and cell
positivity scores across the 10 fields were calculated.
Finally, the overall staining score for each mouse was cal-
culated by multiplying the average stain strength by aver-
age % positive cells. Control sections incubated with
antibody diluent followed by secondary antibody only, or
with normal rabbit serum alone, did not show any stain-
ing. Mouse lung pathology experts confirmed that stained
cell types were correctly identified. Photomicrographs of
representative sections were captured on a Zeiss Axioskop
microscope with QCapture Pro Software.
RNA isolation and real-time RT-PCR
RNA isolation from lung tissue was carried out using TRI-
zol (Invitrogen). After DNase treatment (10 U/mL
DNase1, Ambion), cDNA was synthesised using Moloney
murine leukaemia virus reverse transcriptase (Stratagene).
For quantification of Ym1, RELM , Arginase 1, iNOS, IL-
12p40, TNF- , IFN-  and IL-13 mRNA, real-time RT-PCR
was performed using a LightCycler (Roche Diagnostics)
and primers reported previously [63]. For each gene, five
serial 1:4 dilutions of cDNA of a positive control sample
(for RELM , Ym1 and Arg1, peritoneal macrophages of a
mouse implanted with Brugia malayi adult parasites for 3
weeks [72]; for IL-13, spleen of an MHV-68 infected
IFN R-KO mouse [63]; or for iNOS and other Type 1
markers, peritoneal macrophages of a thioglycolate-
injected mouse [10]) were used in each reaction. Amplifi-
cation was quantified and normalised using -actin as a
housekeeping gene. PCR reactions were carried out in 10
l buffer containing 1 l cDNA, 4 mM MgCl2, 0.3 M of
each primer and the LightCycler-DNA SYBR Green I mix,
under the following conditions: 30 s denaturation at
95°C, 5 s annealing of primers at 55°C or 63°C (Ym1),
and 12 s elongation at 72°C, for 50 cycles. SYBR Green
fluorescence was monitored after each cycle at 86°C
(85°C for Ym1).
Real-time PCR to detect malaria in lung tissue
Real-time PCR for Pcc genomic DNA was carried out on
DNA extracted with phenol/chloroform from homoge-
nized lung tissue (stored in Trizol, Invitrogen; 75 mg tis-
sue/mL). PCR was performed on an ABI Prism 7000
(Applied Biosystems), with primers for merozoite surface
protein (MSP)-1 of clone AS, as described previously [73].
Western blot for Ym1 and RELM
20 l BALF was mixed with sample buffer supplemented
with denaturing buffer (NuPage, Invitrogen), heat dena-
tured and resolved by SDS-PAGE using 4-12% gradient
Bis-Tris gels (NuPage, Invitrogen) followed by transfer
onto nitrocellulose membrane (Bio-Rad). Transfer and
loading intensity were assessed with Ponceau Red staining
(Sigma). After blocking with 0.05% Tween 20 in Starting
Block (Pierce), membranes were incubated overnight at
4°C with polyclonal rabbit anti-Ym1 [10] (0.12 ng/mL)
or rabbit anti-RELM  (0.2 g/mL; Peprotech). After incu-
bation with HRP-conjugated goat anti-rabbit IgG (heavy
plus light chains; Bio-Rad; 1/2000), signal was detected
with chemiluminescence (ECL kit, Amersham Pharmacia
Biotech) and exposure to Hyper ECL film (Amersham).
Control blots were incubated with secondary antibody
only. Band intensity was determined with the FluorChem
SP imager system and software (Alpha Innotech, USA)
and expressed as percentage relative to a positive control
(pooled lung lavages of three Nb-infected mice) on each
blot.
Measurement of cytokine and cytokine receptor responses 
in local lymph nodes
Thoracic lymph node (TLN) cells were cultured at 5 ! 105
cells per well, with 1 g/mL Concanavalin A (ConA), 10
g/mL adult Nb parasite extract, 1 g/mL of recombinant
Pcc Merozoite Surface Protein MSP-119, or medium alone
at 37°C. After 72 h, supernatants were harvested. Concen-
trations of IL-4, IFN- , TNF- , IL-5, IL-6, IL-10 and IL-13
were then measured using Cytometric Bead Array Flex Sets
(BD Biosciences), with slight modifications from manu-
facturer's instructions: 50 l samples/standards were incu-
bated with capture beads (0.5 l per sample per cytokine,
plus diluent to 25 l) in darkness with shaking for 1 h at
RT. Plates were washed, spun at 200 g for 5 min, and then
incubated with 25 l of PE-conjugated anti-cytokine anti-
bodies in darkness for 1 h. After washing and resuspen-
sion of beads, data were acquired on a FACSArray with
FCAP software (BD Biosciences). Soluble TNF Receptor-1
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(sTNFR1) concentrations were determined by sandwich
ELISA, using 2 g/mL capture antibody (clone MAB425),
200 ng/mL biotinylated detection antibody (BAF425),
and recombinant mouse sTNFR1 as standard (425-R1; all
from R&D Systems). Plates were blocked with 5% BSA in
TBS for 2 h at RT and washed with TBS/0.05% Tween
(TBST) before 50 l samples were incubated overnight at
4°C. Plates were washed, incubated with detection rea-
gent for 2 h at RT, washed again, and then incubated with
streptavadin-HRP (Sigma Aldrich) at RT for 20 min. Plates
were washed again and developed with TMB SureBlue
substrate system (KPL 52-00-03). The reaction was
stopped after 30 min with 1 M HCl and read on a spectro-
photometer at 450 nm.
Statistical analysis
Most data were analysed with SAS System 9.1 mixed-
model analyses of variance (ANOVA) or covariance
(ANCOVA) [74] (see exceptions below). To meet the
homogeneity-of-variance assumption of such analyses,
data were logarithmically transformed. To account for
slight differences among experiments in, for example, the
magnitude of ConA-stimulated cytokine production,
experiment was included as a random factor in all models.
All significant effects of infection reported below have
therefore remained significant after controlling for effects
of experiment, if any. To account for differences among
mice in starting body mass or RBC density, day 0 values
were included as covariates. Pathology analyses focused
on animals that experienced the full 20-day course of
infection, and minimum body weight and RBC density
were analysed in two time frames: the first week pi, and
the entire experiment. In accord with the factorial design
of the experiments, Pcc and Nb infection were fit as fixed
factors. Wherever the interaction term was significant
(indicating a potential effect of co-infection), post-hoc t-
tests adjusted for multiple comparisons were run. A
Tukey-Kramer-corrected P < 0.05 was used as the cut-off
for significance. For relevant subsets of mice, an Nb fixed
factor was used to test whether co-infection altered Pcc
parasitaemia, while a Pcc fixed factor tested whether co-
infection altered expression of ChaFFs.
Following logarithmic transformation to meet the
assumptions of parametric statistical analysis, the ChaFF
time courses, IHC scores, and lung Pcc data were analysed
with unpaired t-tests in Prism 4 (Graph Pad Software, Ber-
keley, USA), with a two-tailed P < 0.05 designated as sig-
nificant. Only two groups were compared per dataset, as
specified in the Results section.
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